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Foreword
Governance in Large Nonprofit Health Systems: 
Current Profile and Emerging Patterns
Nonprofit healthcare organizations are not exempt from good governance.  In fact, more today than ever, the 
hospitals and health care systems of this country must have the discipline and commitment to organize their 
governance structures and practices to provide forward-thinking leadership and stand up to scrutiny from any type of 
evaluation and review.  As we move from “sick care” organizations to “health care” organizations with accountability 
for the health of the population of our communities from birth to end-of-life, the role of governance becomes even 
more critical.
Fourteen of the largest and most notable health care systems in this country have been included in a research study to 
examine their governance structures and practices in relation to nine benchmarks.  The CEOs and board members 
of these organizations were interviewed about their structures, processes and cultures, and then compared to national 
best practices. The study also included close review of pertinent system documents. 
This report is a must read for hospital and health care system CEOs and boards.  It provides evidence-based 
outcomes that will assist an organization in advancing its governance practices.  This study outlines critical success 
factors for governance structure and performance.  It answers many questions that boards may be struggling with 
today and provides advancing actions.  The research methodology is thorough and reliable with specific outcomes 
that provide high-performance opportunities.
Each CEO who participated in the research study has written about a best practice in his or her respective 
organization that advances governance responsibility.  These insights add a personal dimension to this report.  
Sharing has always been a part of community-based, nonprofit healthcare.  This report is a true example of that 
commitment to learn from others.  As one who has been blessed to be a part of this remarkable “space” known 
as health care, I congratulate the research team who dedicated themselves to this important work.  As clinical, 
operational and financial performance continue to converge in health care organizations, quality and high-performing 
governance practices, structures and culture must prevail.
Douglas D. Hawthorne, FACHE
Chief Executive Officer
Texas Health Resources
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role in shaping organizational performance, and they 
are scrutinizing the practices of governing boards more 
closely than in the past.  As in other sectors, the boards 
of healthcare organizations are being placed in the 
“white-hot spotlight of public discourse.”4  Stakeholders 
are calling for more accountability, greater transparency, 
and better performance by the persons who manage and 
govern these organizations.
In recent years, the governance of nonprofit hospitals  
and health systems has received particular attention.   
It is widely acknowledged that the governance of these 
organizations has become more complex and that, on 
the whole, the caliber of governance can and should be 
improved.5 Except for basic requirements established 
by the IRS, the Joint Commission, and state statutes, 
universal standards for the governance of nonprofit 
healthcare organizations have not been adopted.  
However, over the past several years significant efforts 
have been made by governmental agencies, voluntary 
commissions and panels, and other parties to identify what 
they believe to be the core features of effective governance 
for boards and CEOs to use as benchmarks in efforts 
to assess and improve governance performance.6 Some 
of these benchmarks are well-established and widely 
accepted; others are in formative stages. In Section III of 
this report, a number of the benchmarks will be discussed, 
and current board structures, processes, and cultures will 
be compared to them.
I.  Introduction1
In the United States, the healthcare field and society-
at-large are in the midst of enormous turbulence. An 
aging and increasingly diverse population, global and 
nationwide economic problems of unprecedented 
complexity, a federal government beset with political 
conflicts that harm its ability to address important issues, 
growing evidence of major disparities in healthcare 
access, affordability, and quality,2 and the continuing 
explosion in medical science and technology are 
among the powerful forces that are affecting healthcare 
providers, payors, and consumers.
These forces create daunting challenges for the clinical, 
governance, and management leadership teams in 
America’s hospitals, health systems, and other health-
related organizations.  The healthcare needs of the 
communities they serve are growing while, at the same 
time, available resources are increasingly constrained.  
Meanwhile, the public’s satisfaction and trust in 
healthcare organizations have declined.3 
With respect to governance, the public’s unrest with the 
cost and quality of services they receive from healthcare 
organizations is accompanied by concerns about the 
effectiveness of their governing boards. Public and 
private organizations with oversight responsibilities for 
nonprofit hospitals and systems including the Internal 
Revenue Service (IRS), payors, rating agencies, and other 
parties recognize that governance plays an important 
According to the American Hospital Association, the total number of multi-unit health systems 
(governmental and private) increased from 311 in 2000 to 427 in 2010, an increase of 37% in a decade. 
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These large health systems include a large and growing 
proportion of the USA’s healthcare facilities and provide 
a substantial volume of inpatient and outpatient services.  
However, while the body of knowledge regarding 
governance in general has expanded in recent years, little 
research has been focused specifically on governing boards 
and governance practices in the nation’s largest health 
systems.10  This is especially the case for nonprofit systems 
as compared to investor-owned systems for which public 
reporting requirements are somewhat more extensive.  
The confluence of these developments — growing interest 
in the responsibilities and performance of governing 
boards in all sectors, advances in formulating benchmarks 
of effective governance, and limited research-based 
knowledge about governance in large nonprofit health 
systems — provided the impetus for this study.
Introduction
Concurrent with growing interest in improving 
governance, America’s healthcare delivery system has 
continued to evolve from mostly independent institutions 
into larger groupings.  According to the American 
Hospital Association, the total number of multi-unit 
health systems (governmental and private) increased 
from 311 in 2000 to 427 in 2010, an increase of 37% in 
a decade.  Meanwhile, the proportion of the country’s 
nongovernmental hospitals affiliated with nonprofit 
systems increased from 53% in 2000 (1,602 of 3,003) to 
65% in 2010 (1,876 of 2,904).7 
It is clear that consolidation of America’s hospitals into 
various forms of health systems is occurring and for many 
reasons — including the hospitals’ needs for access to 
capital and the support larger organizations can provide 
— this trend is likely to continue.8  One of the striking 
features of this transformation has been the development 
of big, geographically-dispersed health systems.  In 2010, 
83 health systems (governmental and private) had annual 
operating expenses of at least $1.5 billion and included a 
total of 2,109 hospitals.9   
  3 
It was found that the 20 largest nonprofit health 
systems collectively included 31% (573 of 1,876) of all 
nongovernmental hospitals affiliated with systems and, in 
addition, encompassed a broad array of other healthcare 
programs such as medical groups, health plans, and 
diverse health-related services.  AHA staff and the 
research team agreed these 20 organizations represent  
the USA’s largest private, nonprofit health systems.
The next step was to extend invitations to participate in 
this study.  Starting with the largest system on the list 
of 20, the team presented the research proposal to chief 
executive officers and invited their systems’ involvement 
in the study.  In some instances, supplemental 
information and/or conversations with other system 
officials were required.
The research proposal that provided the basis for grant 
support anticipated that at least 10 of the nation’s largest 
private, nonprofit systems would participate in the 
study.  Ultimately, 14 of the 15 largest systems agreed to 
participate and did so.11  Thus, these 14 systems comprise 
the study population.  They are:
• Adventist Health System Sunbelt Healthcare 
Corporation, Altamonte Springs, Florida 
• Ascension Health, St. Louis, Missouri
• Banner Health, Phoenix, Arizona
• Carolinas HealthCare System, Charlotte, North 
Carolina
• Catholic Health East, Newtown Square, Pennsylvania
• Catholic Health Initiatives, Englewood, Colorado
• Catholic Health Partners, Cincinnati, Ohio
• Christus Health, Irving, Texas
• Kaiser Foundation Hospitals and Health Plan, 
Oakland, California
• Mayo Clinic, Rochester, Minnesota
• Mercy Health, Chesterfield, Missouri
• Providence Health & Services, Renton, Washington
• Sutter Health, Sacramento, California
• Trinity Health, Novi, Michigan
Purpose and Objectives of the Study
The overall purpose of this study is to examine board 
structures, processes, and cultures in a set of the USA’s 
largest private, nonprofit health systems and compare 
them to several benchmarks of effective governance.  
The study’s objectives are to:
• Increase knowledge and understanding of governance 
in large health systems;
• Identify and describe some examples of “exceptional 
governance features” that are in place in these systems;
• Identify areas where, on the whole, the governance of 
health systems could be improved; and
• Produce information that can assist CEOs and board 
leaders in assessing and enhancing board effectiveness.
Research Methodology
The methodology for this study includes four phases.  
First, defining the study population and securing 
agreements by systems to participate; second, based on 
previous studies and expert panel reports, formulating a 
composite listing of benchmarks of effective governance; 
third, collecting comparable information regarding 
board structures, processes, and cultures from interviews 
with CEOs and board leaders using a structured 
interview guide and from system documents; and fourth, 
comparing this information to benchmarks of effective 
governance and examining the findings using selected 
variables and analytical tools.
These four phases can be described as follows:
Defining the study population and securing the systems’ 
participation. From its inception, the intent of this study 
was to focus on a set of the country’s largest private, 
nonprofit health systems.  Working with the American 
Hospital Association (AHA) in 2010, all of the country’s 
private, nonprofit systems were ranked using a blend 
of three measures of size: annual operating expenses 
for the systems’ hospitals, the number of hospitals in 
the system, and the number of counties in which these 
facilities are located.
II.  Purpose and Methodology
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Formulating a composite listing of contemporary 
benchmarks of effective governance.  Based on review 
of previous studies, current literature in the healthcare 
field and other sectors, and consultation with several 
experts in this realm, the research team formulated nine 
contemporary benchmarks of effective governance, and 
several basic indicators for each.  In the selection process, 
they were reviewed with current and former executives in 
health systems that are not part of the study population 
as an independent check on their appropriateness and 
relevance.  The benchmarks that were adopted are 
pertinent to the governance of large health systems, and 
the related indicators are considered to be reasonably  
well-established and measurable.  Certainly there are  
other benchmarks and indicators of effective governance; 
they are beyond the scope of this study.14
Site visits to systems in the study population. Studies 
regarding governance in both investor-owned and 
nonprofit organizations largely have been conducted 
from afar.  Several experts have advocated more field 
work and closer engagement with executives and board 
members.15  The intent of the site visits to the 14 systems 
in the study population was to supplement information 
obtained in advance and learn at first-hand the views 
of senior trustees and CEOs regarding their respective 
board’s structures, processes, and culture.
In preparation for the site visits, a standard set of 
documents was requested and received from each system; 
e.g., corporate articles of incorporation and bylaws; 
organization charts; listings of system-level board 
members and biographical information about them; 
listings of board committees and their “charters”; selected 
system-level policies pertinent to this study; position 
descriptions for the board chair and CEO; information 
about the system’s mission, vision, and goals; copies of a 
system-wide “balanced scorecard” recently prepared for 
the system board; and other documents.   
Purpose and Methodology
Of the 14 systems, eight are sponsored or controlled 
by Roman Catholic entities.  Three (Catholic Health 
East, Catholic Health Partners, and Christus Health) 
are sponsored by several religious communities and five 
(Ascension Health, Catholic Health Initiatives, Mercy 
Health, Providence Health and Services, and Trinity 
Health) have adopted the public juridic person model.  
This is an organizational arrangement that enables 
religious communities to transfer control of health care 
organizations to a new entity that, with substantial 
laity involvement, operates in the name of the Catholic 
Church and sustains the health ministry.12 
One of the health systems in the study population is 
affiliated with the Seventh-Day Adventist Church 
(Adventist Health System), and one is operated by the 
Charlotte-Mecklenburg Hospital Authority (Carolinas 
Healthcare System).  The other four systems (Banner 
Health, Kaiser Foundation Hospitals and Health Plan, 
Mayo Clinic, and Sutter Health) are independent, 
nonprofit entities that do not have parent organizations.
Collectively these 14 systems include 460 of the 1,876 
nongovernmental hospitals affiliated with private, 
nonprofit systems (25%), an average of 33 hospitals per 
system.  In all instances, their organizational mission 
and services include but extend beyond operating acute-
care hospitals.  For many, their hospital divisions are 
only one important component of an increasingly broad 
and diversified spectrum of health-related programs and 
services: e.g., the Mayo Clinic, Mercy Health, and Kaiser 
systems include four of the 11 largest medical group 
practices in the United States.13  In various fashions, 
all 14 systems are at present or are on the pathway 
to becoming comprehensive, integrated healthcare 
organizations.
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Comparing the data collected before, during, and after the 
site visits to selected benchmarks of effective governance. 
The data obtained from system documents, interviews 
with the CEO and board members, and discussion 
with system staff leaders were compiled by the research 
team and tabulated.  In doing so, the “data” about the 
systems’ governance structures, practices, and culture 
were transformed into “information.”  In Section III, this 
information is compared to the benchmarks of effective 
governance and related indicators to determine where 
they are being met and where gaps exist.  In addition, this 
information also is examined in relation to the system’s 
operating performance using various analytical tools.  
Information regarding limitations of the methodology 
used in this study is provided in Appendix A.
 
Baseline information about each system obtained from its 
documents and publicly-available sources was entered into 
a Data Collection Guide prior to the site visits.  This tool 
was designed as a framework for recording comparable 
information from official documents and from interviews 
with the CEOs and board leaders regarding the benchmarks 
of effective governance and related indicators. The team’s 
experience in conducting previous studies of governance 
in nonprofit hospitals and community health systems was 
helpful in creating an efficient and workable tool.16 
The team conducted site visits in the latter part of 2010 
and 2011.  The principal investigator participated in all 14 
site visits and senior co-investigators participated in some 
of them.  Individual interviews were conducted with all 
14 CEOs and a total of 57 board members.  In all but one 
instance, interviewees included the current board chair 
and at least three other senior board members. Because of 
scheduling factors, six interviews were conducted entirely 
or in part via conference call.  The interviews were 1.5 
to 2.0 hours in length.  Team members also met with 
senior staff personnel to augment information obtained 
from system documents and interviews.  All interviewees 
were assured of confidentiality, and consistently were 
cooperative and cordial.
In the process of reviewing the completed Data 
Collection Guides after the site visits, follow-up 
contacts were made with board members, CEOs, and/
or system staff when a response was missing or unclear.  
Subsequently, the interview data were entered into a 
Project Database and independently verified by another 
member of the research team.
Purpose and Methodology
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Formal Limits on the Number of Consecutive 
Terms a Member Can Serve
 
Establishing limits on the number of terms a person 
can serve has become widely-accepted as a sound 
governance practice in all types of organizations.17  
Some take the position that term limits may deprive the 
board of valuable experience and institutional memory.  
However, without clear limits and a formal requirement 
to balance new appointments with retirements of 
longtime directors, boards can become too large and/
or stale.  It also becomes difficult to develop and 
implement a meaningful board succession plan.  As 
stated in a recent Center for Healthcare Governance 
report, term limits enable the introduction of “…fresh 
thinking, expertise, and perspectives.”18  It is understood 
that careful attention must be devoted to the timing 
of term expirations to guard against losing an overly 
large proportion of experienced board members in any 
particular year.  This typically is managed through the 
use of staggered terms.
Eleven of the 14 large systems in this study population 
(79%) have embraced the concept of term limits and 
incorporated this provision into corporate bylaws 
or policies.  This compares to 64% for our country’s 
hospitals and health systems as a whole, as determined by 
a national survey conducted by the Governance Institute 
in 2011.19 
Among the 14 large systems that participated in this 
study, the length of term appointments and the number 
of consecutive terms a member can serve vary somewhat 
from system to system. A common provision is three-
year terms with a limit of three consecutive terms for a 
maximum of nine years on a board.
III.  Study Findings
An important responsibility in designing any study is 
defining the variables that will be examined.  Previous 
work in the healthcare field and other sectors has 
identified attributes that influence the performance of 
governing boards.  In recent years, considerable progress 
has been made in translating them into benchmarks of 
effective governance in healthcare organizations.  Using 
information provided by board members, CEOs, and 
staff members and from system documents, this report 
examines board structures, processes, and culture in 
the health systems included in our study population 
and compares them to nine benchmarks of effective 
governance and related indicators.
With respect to board structures, this study focuses on 
two key benchmarks of effective governance.  They are:
1.  Effective boards insist on governance policies and 
structures that facilitate their efforts to perform the 
board’s functions and fulfill its responsibilities.
2.  Effective boards are comprised of highly dedicated 
persons who collectively have the competencies, 
diversity, and independence that produce 
constructive, well-informed deliberations.
Indicators that relate to these two benchmarks include:
BOARD STRUCTURE
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Board Size
Neither in the healthcare field nor other sectors is there 
an exact answer to the question of “how large a board of 
directors should be.”  The 2007 report of the HRET- 
Center for Healthcare Governance Blue Ribbon Panel 
on Healthcare Governance advocated a range of nine 
to 17 voting members for hospital and health system 
boards.23  Several other authorities have offered similar 
recommendations.24   
As stated previously, the prevailing norm of America’s 
public companies is considerably below this range — 
averaging in the range of eight to nine voting members 
— and some authorities advocate even smaller boards.  
For example, Robert Pozen recently proposed that 
public companies move to what he terms “professional 
directorship.”  Pozen argues for boards composed of 
seven voting members including the CEO and six 
independent directors, all with “…extensive experience  
in the company’s lines of business” and with commitment 
to devote “…at least two days a month on company 
business beyond the regular board meetings.”25  
Table 1 shows the distribution of the 14 system boards 
by number of members. For 10 of the 14 systems, their 
board size is consistent with the Blue Ribbon Panel’s 
recommendation. Three boards have between 18 and  
28 voting members; one board has 60 members. The 
median size is 15 members, excluding the outlier with  
60 voting members.  
By any measure, the boards of these 14 health systems are 
larger than the boards of America’s hospitals and health 
systems as a whole and the boards of our country’s public 
companies. In 2011, 83% of America’s Fortune 500 boards 
had 12 or fewer voting board members.26  Only one of the 
14 boards in this study population meets this criterion.
Formal Limits on the Number of Voting 
Board Members
Traditionally, the boards of private, non-profit hospitals 
and systems have been larger than the boards of public 
companies.  While the gap has narrowed over the years, 
there continues to be a substantial difference.  For public 
companies, the average board size has remained in the 
eight to nine range for several years.20  For hospitals and 
health systems as a whole, the average size consistently 
has been between 12 and 14 from 2005 to 2011.21 
One mechanism for maintaining control of board size is to 
establish formal limits on the number of voting members.  
Establishing and honoring formal size limits is widely 
accepted as a sound policy. The basic logic is to ensure 
that the size is appropriate to meet the particular needs  
of the organization.  As expressed recently by the IRS:
“Very small or very large governing boards may not 
adequately serve the needs of the organization.  Small boards 
run the risk of not representing a sufficiently broad public 
interest and of lacking the required skills and other resources 
required to effectively govern the organization.  On the 
other hand, very large boards may have a more difficult 
time getting down to business and making decisions.  If an 
organization’s governing board is large, the organization 
may want to establish an executive committee with delegated 
responsibilities or advisory committees.”22 
All 14 systems in this study population have adopted 
limits on the number of voting members for their boards, 
either in bylaws or corporate policies.  Further, in all 
cases the actual number of voting members is consistent 
with their particular provisions.
Study Findings
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Senior board members who serve on the 60-person 
board recognize clearly that it is exceptionally large and 
somewhat unwieldy, but believe that — for their faith-
based system with multiple sponsors — the benefits of 
broad-based engagement in governance at the corporate 
level outweighs the downside of having a very large 
board.  As would be expected, this board’s “executive 
committee” (which includes 25 members) has substantial 
responsibility.
Study Findings
Table 2 shows the opinions of the systems’ board members 
and CEOs about the current size of their boards.  There 
is virtually no interest in expanding the size of their 
boards.  In combination, 24% of the CEOs and board 
members believe their board is somewhat too large, and 
several boards are considering some degree of downsizing.  
However, a majority are reasonably comfortable with the 
current size of their boards. 
TABLE 1
Size of System Boards
Fewer than 9 voting members
9 to 17 voting members
18 to 28 voting members
More than 28 voting members
                                                           
Total
0
10
3
1
14
0%
72%
21%
7%
100%
Number Percent
TABLE 2
Board Members’ and CEOs’ Views about the Size of Their Boards*
It’s somewhat too large to be efficient.
The present size is just about right.
We should expand its size to provide broader input.
Other
Total
15%
71%
7%
7%
100%
24%
65%
4%
7%
100%
CEOs 
(n = 14)
Total Responses 
(n = 71)
26%
63%
4%
7%
100%
Board Members 
(n = 57)
*Throughout this report, test results are shown only when the observed differences were found to be statistically significant.
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While the Sarbanes-Oxley Act currently applies only 
to public companies, many of its key provisions have 
been adopted voluntarily by nonprofit hospitals and 
health systems.  The Panel on the Nonprofit Sector 
has taken the position that “… [a] substantial majority 
of a public charity, usually meaning at least two-thirds 
of the members, should be independent.”29  Several 
authorities including the Coalition on Nonprofit Health 
Care and the IRS (using somewhat different criteria) 
have called for a majority of board members in nonprofit 
organizations to be independent.30  In the contemporary 
environment, this can be considered as a basic standard 
for nonprofit healthcare boards.
For the purpose of this study, the term “independent 
board member” was defined as persons who are “Not 
a member of a sponsoring body such as a religious 
congregation, not a full or part-time system employee, 
and not directly affiliated with the system in any way 
except serving as a voting board member.”  Table 3 shows 
that, in total, 60% of the members of the 14 system 
boards in this study population meet these criteria.
Board Composition 
Independence.  The Sarbanes-Oxley Act of 2002 
made the definition of “independence” more stringent 
and increased the requirements for independent board 
members on the boards of public companies.  Other 
regulatory and advisory bodies have adopted similar 
positions; for example, the New York Stock Exchange 
(NYSE) Listing Standards require a majority of a 
company’s board members to be independent.  
The overall impact on the composition of public 
company boards has been striking.  The proportion of 
independent directors on the boards of Fortune 500 
companies increased from 22% in 1987 to 84% in 2011.27  
In fact, some authorities have cautioned that this shift 
could have an adverse impact on board effectiveness by 
reducing the number of non-independent directors with 
great familiarity with the company and its sector.28 
Study Findings
TABLE 3
Independent vs. Non-Independent Board Members
Independent
Non-Independent
P < .01*
49%
51%
100%
60%
40%
100%
Board Composition in 
Faith-Based Systems
(n = 179)
Board Composition 
in all Systems
(n = 274)
82%
18%
100%
Board Composition 
in Secular Systems
(n = 95)
*The chi-square test demonstrates significantly different proportions of independent board members in faith-based vs. secular systems.
10  
A coalition of major healthcare associations including the 
American Association of Medical Colleges, the American 
College of Healthcare Executives, the American Hospital 
Association, and the Catholic Health Association are 
collaborating in a new initiative — “A National Call 
to Action” — to eliminate healthcare disparities in 
the United States.  One of this initiative’s three core 
components is to increase diversity in governance and 
management leadership.32 
Table 4 shows the proportion of non-Caucasians serving 
on the boards of the 14 large systems in this study 
population.  In total, 17% of the systems’ board members 
are non-Caucasians; the proportion of those serving on 
faith-based vs. secular boards is virtually identical.  This 
proportion is somewhat higher than the comparable 
figure (10%) for hospitals that participated in a 2011 
survey conducted by the AHA.33  The median proportion 
of non-Caucasians on the boards of the 14 systems 
was 17%; however, the proportion varied from no 
non-Caucasians on one system’s board to 25% on another.
Study Findings
However, 82% of board members in the six secular health 
systems meet the criteria for independence — virtually 
identical to the current composition of America’s public 
companies — while only 49% of faith-based system 
board members meet those criteria.  The difference 
is statistically significant, and mainly reflects that the 
composition of most faith-based system boards still 
includes a substantial proportion of persons who are 
affiliated with the previous or current religious sponsors.  
The range of independent member composition varies 
from 18% for one faith-based system to 100% for one 
secular system, the single system in the study population 
where the CEO is not a voting member of the board.
Diversity. In the healthcare field and other sectors, there 
is general agreement that the membership of governing 
boards must include persons with a strong blend of 
pertinent experience and skills in order to perform their 
fiduciary duties effectively.  It is increasingly recognized 
that the boards of nonprofit organizations also should 
include members with diverse backgrounds including, but 
not limited to, ethnic, racial, and gender perspectives.31 
TABLE 4
Racial Composition of Large System Boards*
Non-Caucasian Members
Caucasian Members
17%
83%
100%
17%
83%
100%
Board Composition in 
Faith-Based Systems
 (n = 179)
Board Composition 
in all Systems
(n = 274)
18%
82%
100%
Board Composition 
in Secular Systems
(n = 95)
*Test results are shown only when the observed differences were found to be statistically significant.
  11 
Since eight of the 14 systems were established by one or 
more congregations of religious women and all 14 are 
considered to be progressive, it is not surprising that the 
composition of their boards are more diverse than the boards 
of both America’s hospitals and health systems as a whole 
and public companies. It appears that our nation’s largest 
nonprofit health systems are responding to what is, on 
balance, a compelling case for diversity in board composition. 
This includes a growing body of evidence that suggests 
organizations and groups with more diversity in board 
make-up and perspectives will out-perform others.37 
With respect to executive leadership, during the period 
of time this study was being conducted (2010-2012), 
only one of the system’s CEOs was a woman (7%).  This 
is somewhat lower than the corresponding figure for 
America’s hospitals and health systems as a whole (12%) 
and somewhat higher than the figure for Fortune 500 
companies (4%).38  It is clear that disparity still exists in 
this segment of organizational leadership, both in the 
healthcare field and in other sectors.
Table 5 shows the gender mix of the 14 systems’ boards.  
While there is substantial variation from board to board, 
the overall proportion of women serving on the boards of 
the nine faith-based systems (40%) is significantly higher 
than the corresponding figure for the secular systems (21%).  
For the hospitals and health systems that participated in a 
nationwide survey by the Governance Institute in 2011, 26% 
of their board members were women.34 
As compared to America’s Fortune 500 companies, the 
boards of these 14 large, nonprofit health systems are 
more diverse, both in racial and gender composition. In 
2011, only 14% of Fortune 500 board members were 
non-Caucasians and only 16% were women.35  It is 
notable that 12% of Fortune 500 boards still included 
no women.36  The boards of all 14 systems in this study 
include several (two to 10) women.
Study Findings
TABLE 5
Gender Composition of Large System Boards
Women
Men
P < .01*
40%
60%
100%
33%
67%
100%
Board Composition in 
Faith-Based Systems 
(n = 179)
Board Composition 
in all Systems 
(n=274)
21%
79%
100%
Board Composition in 
Secular Systems
 (n = 95)
*The chi-square test demonstrates significantly different proportions of women board members in faith-based vs. secular systems.
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Table 6 shows that, in combination, 14% of the study 
populations’ board members are physicians and 6% are 
nurses.  Physicians are somewhat more prominent on the 
boards of secular systems (18%) as compared to faith-
based systems (11%); nurses comprise a larger proportion 
of the faith-based system boards (9%) than the secular 
system boards (2%).  In both groups, clinicians collectively 
constitute 20% of the systems’ voting board membership. 
The finding that 6% of large system board members are 
nurses is exactly consistent with the results of the AHA’s 
2011 survey of American hospitals.44 These findings 
appear to represent a shift in the direction that Dr. John 
Combes, Dr. Susan Hassmiller, and others believe is “…
long overdue.”45   The finding that the overall proportion of 
physician membership on these boards (14%) is somewhat 
lower than the proportion on the boards of America’s 
hospitals and community-based systems (approximately 
20%) may be due, at least in part, to the more direct 
responsibilities of local healthcare organization boards for 
oversight of patient care quality and safety.
Board Member and CEO Views on the Current 
Composition of Their System’s Board Composition.  In 
the one-on-one interviews with senior board members 
and CEOs, all were asked to identify their principal 
viewpoint regarding their board’s current composition 
from among the four options shown in Table 7.
Thirteen percent of the CEOs and trustees felt the current 
composition of their board was “just about right.”  One in 
five expressed the opinion that their board’s deliberations 
would benefit from more racial and ethnic diversity around 
the board table and at the committee level.
Study Findings
Clinician Engagement.  The National Quality Forum, 
the Institute for Quality Improvement, and many other 
prominent healthcare organizations have urged hospital 
and health system boards to engage clinical leaders in 
developing goals and strategies for improving patient care 
quality and safety.  For this and other reasons, involving 
highly-qualified physicians who are committed to the 
organization’s mission has become accepted as necessary 
and effective governance practice.39  As stated by Barry 
Bader et al:
“…a board’s membership should include independent, 
creative, strategic thinkers who bring a broad range of 
relevant skills to the table.  It is difficult to imagine those 
skills excluding medicine.”40 
Recognition of the importance of physicians’ involvement 
in healthcare governance is reflected in the results of several 
national studies showing that they constitute approximately 
20% of hospital and health system board membership.41  In 
contrast, engaging leaders in the nursing profession in the 
governance of healthcare organizations traditionally has not 
been a common practice.  Studies conducted in 2004-2005 
and 2008-2009 found that nurses comprised only about 
2% of nonprofit hospital and community health system 
boards.42  Recognizing the vital role of nursing in providing 
patient care and in determining the quality and cost of care, 
a growing number of respected organizations including the 
Robert Wood Johnson Foundation have urged hospital 
and health system officials to consider the appointment of 
highly-qualified nurse leaders to their boards.  As Donald 
Berwick has stated:
“It is key that nurses be as involved as physicians, and 
I think boards should understand that the performance 
of the organization depends as much on the well-being, 
engagement, and capabilities of nursing and nursing leaders 
as it does on physicians.  I would encourage much closer 
relationships between nursing and the board.”43 
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in working with the executive and legislative branches 
of the federal government; that is, as one senior trustee 
expressed it, “persons who know how Washington DC 
really works in today’s world.”  Later sections of this 
report will address, in more detail, the systems’ current 
status and plans with respect to succession planning for 
board members and senior management.
In combination, 59% of the CEOs and board members 
expressed the view that their board composition and 
dialog would benefit from additional expertise in one or 
more areas.  Two needs emerged as especially prominent: 
20 of 71 CEOs and board members identified and 
discussed the importance of adding more clinical 
expertise.  Eight spoke to the potential benefits of 
adding one or more persons with extensive experience 
Study Findings
TABLE 6
Clinician Composition of Large System Boards
Nurses
Physicians
Other
P < .05*
9%
11%
80%
100%
6%
14%
80%
100%
Board Composition in 
Faith-Based Systems
(n = 179)
Board Composition 
in all Systems
(n = 274)
2%
18%
80%
100%
Board Composition 
in Secular Systems
(n = 95)
*The chi-square test demonstrates significantly different proportions of nurses in the board compositions of faith-based vs. secular systems.
TABLE 7
“What is your overall opinion about the current composition of your Board?”*
The Board’s deliberations would benefit from 
additional expertise.
The Board’s deliberations would benefit from 
greater diversity in perspectives.
The Board’s deliberations would benefit from having 
more independent directors around the table.
The present composition is just about right.
50%
29%
7%
14%
100%
59%
21%
7%
13%
100%
CEOs
(n = 14)
Total Responses
(n = 71)
61%
20%
7%
12%
100%
Board Members
(n = 57)
*Test results are shown only when the observed differences were found to be statistically significant.
14  
research team realized the specific names of committees 
would vary from system to system.  Therefore, in 
reviewing system documents and interviewing board 
members and CEOs, the team focused on identifying 
and learning about the standing committees to whom 
oversight responsibility was assigned.
Based on information obtained from system documents 
and interviews with board members and CEOs, Table 8 
shows the number and proportion of boards in this study 
population that assigned oversight responsibility for seven 
core governance functions to standing board committees.  
The table also provides comparable information from the 
AHA’s 2011 national survey of hospitals and systems.51 
Given their complexity and importance, there is 
general accord that — in the contemporary healthcare 
environment — the audit and compliance,52 executive 
compensation,53 and financial functions54 warrant close 
oversight by standing board committees.  This has 
become a basic indicator of effective governance, and all 
14 of the study population’s boards meet this standard.
Study Findings
Board Committee Oversight of Specific 
Governance Functions
The basic functions of the boards of nonprofit hospitals 
and health systems are well-codified and widely  
accepted.46,47 However, as stated in Section I, of 
this report, there is considerable concern about the 
effectiveness with which governing boards in nonprofit 
(and investor-owned) organizations are performing those 
functions.  Numerous studies and expert panels suggest 
boards that adopt a proactive role are more likely to 
demonstrate effective performance than boards that are 
less involved.48 
It is widely agreed that a well-organized committee 
structure with knowledgeable, engaged members is one 
of the keys to effective governance.49  As Barry Bader and 
Elaine Zablocki have stated, “Working committees are 
the engine that powers effective boards.”50 
Based on their experience in serving on and studying 
boards in a broad array of healthcare organizations, the 
TABLE 8
Boards that have Assigned Oversight Responsibility for Selected Governance Functions 
to Standing Board Committees
100%
100%
100%
93%
86%
79%
43%
51%
36%
83%
75%
60%
44%
14%
Large Systems in this 
Study Population
 (n = 14)
All Hospitals Included 
in AHA 2011 Survey
( n = 1,052)*
*2011 AHA Health Care Governance Survey Report, op. cit., pp. 14-15.
**The P-value for the two-sample test of binomial proportions demonstrates significantly higher proportions of committees with oversight responsibility for these 
governance functions in large systems vs. hospitals. 
Governance Function
Audit and Compliance**
Executive Compensation**
Finance and Investments
Patient Care Quality and Safety
Board Education and Development
System Strategy and Planning**
Community Benefit**
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Written, Board-Approved Definitions of 
Committee Responsibilities
Assigning oversight responsibility for specific governance 
functions to standing committees in lieu of explicitly 
deciding to perform those functions by the board as a 
whole, is commonly accepted as a standard practice, 
both in the healthcare field and other sectors.  However, 
when oversight responsibility is delegated to a board 
committee, the committee’s role and duties should be 
spelled out by the board in a written form that will be 
clear to all parties.  This is a fundamental indicator of 
effective governance.59 
Based on system documents and interviews with 
CEOs and board members, Table 9 shows that the 
standing board committees of all 14 systems in the 
study population have clearly-defined responsibilities 
that are spelled out in a written document (i.e., a bylaws 
provision, a policy statement, or a formal committee 
charter) that has been formally adopted by the system’s 
board of directors.  As shown in Table 9, a recent study 
of governance in a group of 114 nonprofit community 
health systems found that only 72% of their boards met 
this standard.60 
Similarly, strong governance oversight of patient care 
quality and safety programs,55 board education and 
development,56 and system-wide strategy and planning 
functions57 are widely recognized as fundamental duties 
of healthcare organization boards in the contemporary 
environment.  Nearly all of the study population’s boards 
have assigned clear oversight responsibilities for these key 
functions to standing board committees; the other boards, 
up to the present time, have chosen to perform these 
governance functions as a “committee of the whole.”  The 
board of the sole system which, at the time of the research 
team’s site visit, did not have a standing committee 
with assigned responsibility for oversight of patient care 
quality and safety was in the process of establishing a new 
committee devoted to this governance function.
In contrast, only six of the 14 system boards (43%) have 
standing committees with clear oversight responsibility for 
system-wide community benefit policies, programs, and 
services.  Given growing concerns at national, state, and 
local levels about the extent to which nonprofit healthcare 
organizations provide community benefit, meet community 
health needs, and deserve tax-exempt status, concerted 
board-level attention to this area clearly is necessary and 
important for governance and management leaders, both 
at the local and system levels.58  The study population’s 
governance policies and processes with respect to community 
benefit programs are discussed in a later section of this report.
Study Findings
TABLE 9
Proportion of Health Systems Whose Standing Committees’ Responsibilities have been 
Spelled Out in a Written Document and Formally Approved by the System Board
100%
0%
0%
100%
72%
21%
7%
100%
Large Systems in this 
Study Population
 (n = 14)
Nonprofit Community 
Health Systems
 (n = 114)*
*L. Prybil, et al, Governance in High-Performing Community Health Systems, pp. 12-13.
**The Fisher’s exact test demonstrates a significantly larger proportion of committees with responsibilities spelled out in a written document in 
large vs. community-based systems.
Response
Yes, there are such documents for all standing Board committees.
Some, but not all, committees have such documents.
Other
P < .05** 
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Table 10 shows the responses of CEOs and board members 
in the 13 systems whose boards presently have executive 
committees. Eighty-two percent of these CEOs and 
board members think their board’s executive committee is 
“Somewhat Important”; none believes it is “Unimportant.”  
From the perspectives of these CEOs and board members, 
their board executive committees have a limited and clearly-
defined role which principally involves two basic functions:  
first, to act on routine, non-strategic matters that require 
formal board action between meetings of the full board, 
and, second, to serve as a “sounding board” for the CEO 
regarding topics on which he or she wishes to have informal 
governance input and counsel, e.g., board meeting agenda 
priorities. These CEOs and board members do not view 
the executive committee as a decision-making body on 
substantive issues.
Not surprisingly, two of the three CEOs and nearly all 
of the board members who believe their board’s executive 
committee plays a “Very Important” role are affiliated 
with the two largest boards in the study population, 
one with 60 members and one with 28 members.  
Examination of the corporate bylaws and committee 
“charters” for these two systems support these CEO and 
board member assessments.  In these two instances, the 
boards’ executive committees operate with substantial 
responsibility, and thus their performance clearly has 
considerable impact on the overall effectiveness of the 
systems’ boards.
Study Findings
Board Executive Committees
In both nonprofit and investor-owned organizations, it 
is quite common for governing boards to have “executive 
committees” as part of their governance structure.  
For example, a 2009 survey of nonprofit organizations 
(health related and non-health related) conducted by 
Grant Thornton LLP found that 88% of the boards 
had executive committees.61  A 2011 study of public 
companies by the National Association of Corporate 
Directors found that, in these organizations, board 
executive committees now are “nearly universal.”62
The specific role and responsibilities of board “executive 
committees” vary widely. Some meet often and perform 
substantial functions; others meet on rare occasions and 
have very limited duties.  If a board decides to establish 
an executive committee, it is imperative to define clearly 
the committee’s role and authority in board bylaws 
and monitor the committee’s actions to ensure those 
parameters are honored.63 
The boards of 13 of the 14 large systems in this study 
population have executive committees in place. As part 
of the interview process during on-site visits, the CEOs 
and board members of the 13 systems that have board 
executive committees were asked “In your opinion, how 
important is the Executive Committee to the overall 
effectiveness of your Board?”
TABLE 10
“In your opinion, how important is the Executive Committee to the overall effectiveness 
of your Board?”*
23%
77%
0%
100%
18%
82%
0%
100%
CEOs
(n = 13)
Total Responses 
(n = 66)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Very Important
Somewhat Important
Not Important
17%
83%
0%
100%
Board Members
(n = 53)
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Perceived Effectiveness of Board Committees
As part of the interview process, all CEOs and board 
members were asked to share their personal assessment 
of the overall effectiveness of their respective board’s 
committees.  As shown in Table 11, a majority of both the 
CEOs and board members believe that, on the whole, their 
board committees are well-organized and effective.  As a 
group, the CEOs’ views about the committees are more 
sanguine than the trustees’ assessment.
In four of the 14 systems, 60% or more board members 
believe the effectiveness of their committees’ performance 
varies considerably, and that “…there is plenty of room 
for improvement.”  In two of these four systems, the 
CEOs agree with this assessment.  It is likely this will lead 
to a serious review of those systems’ board committees’ 
roles, composition, and practices in the near future.
Study Findings
TABLE 11
“Based on your personal involvement and experience, how would you assess the overall 
effectiveness of your Board’s committees?”*
86%
14%
0%
100%
63%
34%
3%
100%
CEOs
(n = 14)
Total Responses 
(n = 71)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
On the whole, our Board committees are highly organized and 
perform their duties very effectively.
For the most part, our Board committees do a good job, but this 
varies from committee-to-committee, and there is plenty of room 
for overall improvement.
I’m not sure.
58%
39%
3%
100%
Board Members
(n = 57)
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Board Accountability
In the USA, there is growing interest in the relationship 
between large-scale organizations and their stakeholders.  
Clarity in corporate responsibility and accountability is a 
fundamental component in the foundation for effective 
organizational governance. 
“Corporate responsibility sets the terms of an implicit 
contract between companies and society.  This contract … is 
enormously valuable to all parties.  It establishes the shared 
expectations on which people place their trust in companies, 
and sets the ground rules within which companies compete 
legitimately to provide the goods, services, jobs, and wealth on 
which modern economies depend.”64 
The state statutes under which both investor-owned 
and nonprofit corporations are chartered call for their 
governing boards to have overall responsibility for the 
organization and the services or products it provides.  
A large body of corporate law and several theories of 
corporate governance have developed over the years, all 
with the general intent of explaining how boards should 
carry out their duties.65  In recent years, how effectively 
governing boards perform those duties and fulfill their 
accountability to shareholders, corporate sponsors, and 
society at-large has become the subject of increasing 
scrutiny.66  In the nonprofit sector, the tradition of 
substantial autonomy is being reduced by increasing 
demands for more information by governmental bodies 
with oversight responsibility such as the IRS, public and 
private payors, the media, and other stakeholders.67 
In this context, it is imperative for the boards of all 
nonprofit organizations to have a clear sense of the 
parties to whom — as the stewards of the organization
— they are accountable and the ways in which their 
accountability is fulfilled.  As part of the interview 
process, all board members and CEOs were asked “To 
whom, in your opinion, is your Board accountable?”
Study Findings
With respect to board processes, this study focuses on 
five basic benchmarks of effective governance.  They are:
3. Effective boards have clear definitions of their 
authority and accountability and the decision-making 
responsibility they have allocated to local operating 
units in their system.
4. Effective boards require mutual understanding 
regarding the respective roles of governance vs. 
management, skillful board leadership, and excellent 
board-management relationships.  
5. Effective boards continuously improve board and CEO 
performance by setting clear expectations, conducting 
objective evaluation, and taking follow-up actions.
6. Effective boards are committed to establishing and 
continually updating succession plans for the board, 
board leadership positions, and, in concert with the 
CEO, senior management positions.
7. Effective boards insist on meetings that are well-
organized, focus principally on system-wide strategy 
and key priorities such as patient care quality and 
community benefit, and employ board members’ time 
and energy wisely.
Indicators that relate to these process-oriented 
benchmarks include:
BOARD PROCESSES 
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As a follow-up question, the board members and CEOs 
were asked if there is a formal document that specifies 
the powers that are reserved to the body or group to 
whom their system’s board is principally accountable.  
As would be expected, the board members and CEOs 
in the nine faith-based systems, all of which have direct 
accountability to a particular religious body or entity, are 
well-aware of that relationship and the corporate bylaws 
or other legal documents that codify it.  In the secular 
systems, four of which are independent entities that do 
not have a parent organization or sponsor, the responses 
were less uniform.  However, these discussions and 
subsequent review of corporate documents demonstrated 
that all but two of the 14 systems in this study population 
have formal statements of some nature that address their 
board’s basic duties and accountability to another party or 
parties (see Table 12).
In most instances, however, the boards’ accountability to 
the “people, communities, and populations the systems 
serve” — while easy to profess — is not spelled out in 
a detailed fashion.  The precise nature of the boards’ 
accountability in this realm and the specific mechanisms 
by which their accountability is fulfilled generally are not 
codified.  Many board members and CEOs agree this is 
a facet of their present governance model that requires 
more attention and development.
For the board members and CEOs of faith-based 
systems, the initial response to this question was prompt 
and consistent.  They believe their board’s principal 
accountability is to the system’s religious sponsors or 
the legal entity the sponsors have established to direct 
and control the system and its local organizations; e.g., 
a “sponsors council“ of some type or, for the several 
Catholic systems that have shifted to this organizational 
arrangement, a public juridic person.68  For those 
affiliated with secular systems, the most common view 
is that their board’s principal accountability is to the 
“patients and populations” their healthcare institutions, 
health plans, and other programs serve.  A substantial 
portion of the trustees and CEOs of faith-based systems 
also believe the organizations they govern are accountable 
to the communities they serve.
In addition, many board members and CEOs express 
the belief that — because a large and growing proportion 
of their system’s revenues are provided by Medicare, 
Medicaid, and other public programs — there is de facto 
accountability to federal and state government.  Nearly 
all of these persons express the view that this is very likely 
to become more pronounced in the coming years.
Study Findings
TABLE 12
“Is there a formal, written document that lists the specific powers that are reserved to 
the party or parties to whom your Board is accountable?”*
100%
0%
100%
86%
14%
100%
 Faith-Based Systems
(n = 9)
All Systems
 (n = 14)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Yes
No
60%
40%
100%
Secular Systems
 (n = 5)
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system and local governance and/or management 
leadership.  The form of these documents varies; some 
are incorporated in corporate bylaws, some are corporate 
policies, and some take the form of an “authority matrix.” 
Only one system, at this time, has not formulated its 
practices into a formal board-approved document.
As part of the interview process, all board members 
and CEOs were asked to characterize their views 
on how their system’s current allocation of authority 
between system and local leadership is viewed within the 
organization.  Table 13 shows their responses.
Their perceptions vary slightly, but most CEOs 
and trustees felt their systems’ current policies and 
practices on allocation of authority are reasonably 
well (not perfectly) understood and accepted by board 
and management leaders throughout the system; very 
few believe there is substantive discord or problems 
in this area.  However, nearly all of these trustees and 
CEOs are in accord that the allocation of responsibility 
and authority within large, geographically-dispersed 
organizations requires continuous efforts to build 
understanding and on-going evaluation to identify 
opportunities for improvement.
Study Findings
Allocation of Responsibility and Authority to 
Local Organizations
In all complex, multi-level organizations, clarity in the 
allocation of responsibility and decision-making authority 
is imperative.  A lack of clarity, misunderstanding, and/
or uncertainty will create operational problems and 
adversely affect organizational performance.  In the world 
of health systems, especially those whose hospitals and 
other delivery organizations are geographically dispersed, 
a clear definition of the respective roles, responsibilities, 
and authority between system-level and local leadership 
is a fundamental indicator of effective governance.69 
Twelve of the 14 health systems in this study population 
presently have an organizational model that includes a 
system-level board with overall governance authority and, 
for their major community-based or regional organizations, 
“local” boards that function with some degree of decision-
making authority.  In two instances, there are no local 
boards, and the system-level boards directly exercise 
governance authority over operating units. 70
In 13 of the 14 systems, there is a written, board-
approved document that specifies the allocation of 
responsibility and decision-making authority between 
TABLE 13
“Which of the following, in your opinion, most accurately characterizes the present allocation 
of authority between system-level and local leadership within your organization?”*
57%
43%
0%
0%
100%
42%
52%
4%
2%
100%
CEOs
 (n = 14)
Total Responses 
(n = 71)
*Test results are shown only when the observed differences were found to be statistically significant. 
Response
The current allocation of authority is widely accepted by both 
local and system level leadership.
The level of acceptance is generally good, but it can and 
should be improved.
The level of acceptance is uneven and warrants system-wide 
attention.
Not sure.
39%
54%
5%
2%
100%
Board Members
 (n = 57)
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All of the 14 large systems in this study population have 
formal, written descriptions of the CEO’s position that 
have been adopted by the board.  Twelve of the 14 boards 
have adopted formal position descriptions for the board 
chair; in one system (Kaiser Foundation Hospitals and 
Health Plan), the CEO also chairs the board of directors.
This level of compliance compares very favorably with 
the findings of other studies.72 Naturally the position 
descriptions vary substantially, both in form and content.  
Some are incorporated into corporate bylaws or policy 
statements; others are free-standing documents.  Some 
are quite thorough and comprehensive; others are more 
succinct with less detail.  All, however, have been reviewed 
and formally approved by the system’s board of directors.
As one way to gauge role clarity, all CEOs and board 
members were asked to express their opinion on the 
extent to which there is agreement among their board 
colleagues on distinctions between the CEO’s and board 
chair’s respective roles.  As shown in Table 14, a large 
majority of both CEOs and board members concur that 
those distinctions are well-understood with their boards.
Board Chair - CEO Relationships
Creating and maintaining strong, trust-based 
relationships among the CEO, the board chair, and the 
board as a whole is universally recognized as a critical 
factor in organizational performance and success.  Clear, 
distinct, and mutually-understood definitions of roles 
and responsibilities are foundational to developing such 
relationships.71 
As a key ingredient in creating clear definitions and 
mutual understanding, having formal descriptions of 
the CEO’s and board chair’s duties has become a basic 
hallmark of effective governance.  Well-constructed 
position statements that are approved by the board — 
and reviewed and updated periodically — are a helpful 
tool for all parties.  Vague and/or out-dated position 
descriptions are useless and potentially troublesome.
Study Findings
TABLE 14
“In your opinion, is there solid agreement among board members on the distinctions 
between your CEO’s role and the Board Chair’s role?”*
86%
7%
7%
100%
90%
3%
7%
100%
CEOs
(n = 14)
Total Responses 
(n = 71)
*Test results are shown only when the observed differences were found to be statistically significant.
**In one system, the CEO also chairs the board of directors. 
Response
Yes
No
Not Applicable**
91%
2%
7%
100%
Board Members
(n = 57)
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Board Evaluation Process
On-going assessment of its structure, processes, and 
culture is a fundamental duty of every board of directors.  
Numerous bodies with regulatory or quasi-regulatory 
responsibilities in the healthcare field and other sectors 
(e.g., the Joint Commission and the New York Stock 
Exchange) have called for boards to conduct self-
assessments on a regular basis.  Accordingly, engaging in 
some type of formal board evaluation — with or without 
assistance by an external, independent party — has 
become the norm.  A 2011 study of public companies 
by the National Association of Corporate Directors 
found that nearly all companies (91%) regularly conduct 
full board evaluations and a very large proportion 
perform committee evaluations (83%).73  A 2011 survey 
conducted by the Governance Institute found that 92% 
of health system boards “…engage in a formal process to 
evaluate its own performance at least every two years.”74  
However, board evaluation processes vary greatly in rigor 
and value.  As stated by Beverly Behan:
Study Findings
As a way to get a sense of how systems’ CEOs and 
board chairs work together, interviewees were asked to 
express their views on their CEO-board relationship.  As 
shown in Table 15, the predominant view among both 
board members and CEOs is that these relationships are 
“consistently excellent.”
TABLE 15
“How would you describe the working relationship between your CEO and Board Chair?  
That is, how does it work?”*
86%
7%
0%
7%
100%
90%
4%
0%
6%
100%
CEOs
 (n = 14)
Total Responses 
(n = 71)
*Test results are shown only when the observed differences were found to be statistically significant.
**In one system, the CEO also chairs the board of directors.
Response
Our CEO-Board Chair relationship is consistently excellent.
Our CEO and Board Chair generally work together, but the 
relationship could be better.
Our CEO and Board Chair relationship can and should be improved.
Not Applicable**
91%
4%
0%
5%
100%
Board Members
 (n = 57)
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Two of the 14 large systems in this study population do 
not, at this time, perform formal, overall board evaluation 
on a regular basis.  However, these two systems — and 
most of the other 12 — do employ other, less formal 
types of “board evaluation” activities such as post-board 
meeting reviews in executive sessions.  One of these two 
boards presently is considering the establishment of a 
more formal board evaluation protocol.
The second part of the benchmark — actually making 
changes based on findings from the board evaluation 
process — is a more stringent test.  The information 
displayed in Table 17 represents one probe into the 
willingness of boards in large, geographically-dispersed 
health systems and the boards of smaller, community 
health systems to take such actions.
In both groups, slightly over half of the board members 
and CEOs believe their board evaluation processes have 
resulted in substantive changes in board composition, 
practices, and/or dynamics.  Most of these leaders 
were able to give specific examples of actions taken by 
their boards as a direct or indirect outcome of board 
assessment efforts during the past two years; e.g., re-
allocating some board meeting time from routine reports 
to long-range strategic issues; upgrading board education 
programs; and modifying board committee structures 
through adding, deleting, or consolidating committees.
“Rather than a robust and rigorous process that helps boards 
figure out whether they’re doing the right work in the right 
way, we too often see a mechanical exercise in ticking off the 
boxes on a formulaic checklist often borrowed from another 
company.  A board can get away with that and confidently 
report one more area where it complies with New York Stock 
Exchange rules.  However, it will waste an opportunity if 
it does nothing to increase the effectiveness or value to the 
company and its stakeholders … almost every board could 
find ways to do its job better.” 75  
 
In short, there are two basic indicators of effective 
board evaluation in all organizations:  serious, on-going 
examination of the board and its performance and 
demonstrated commitment to make actual changes as 
a result of the evaluation process.76 Studies have found 
that objective evaluation together with follow-up board 
development steps can improve board performance.77  
The 14 systems’ board members and CEOs were asked 
if, in their opinion, their boards engage in formal board 
evaluation activities.  Table 16 presents their responses 
compared to findings from a 2009 study of governance 
in 114 nonprofit community health systems.  Consistent 
with other recent studies, these data affirm that around 
90% of the boards in both groups conduct some type of 
formal board evaluation on an annual or biennial basis.  
Study Findings
TABLE 16
“Does your system Board regularly engage in formal evaluation of how well it carries out 
its duties?”*
86%
14%
100%
90%
10%
100%
Directors and CEOs of 
14 Large Systems
 (n = 71)
CEOs of 114 Community 
Health Systems
 (n = 114)**
*Test results are shown only when the observed differences were found to be statistically significant.
**L. Prybil, et al, Governance in High-Performing Community Health Systems, op. cit., pp. 17-18.
Response
Yes, either annually or biennially
No
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Each of the board members and CEOs in the 14 large 
systems also were asked to share their personal viewpoint 
on the effectiveness of their board’s formal board 
evaluation process.  Their responses, shown in Table 18, 
suggest that a large proportion of both board members 
and CEOs have reservations about their current board 
evaluation processes.  In combination, only 30% of these 
system leaders believe their current board evaluation 
processes are “thorough” and have produced “substantial 
improvements in board performance.”  Their responses to 
this question reinforce concerns about the present state of 
board evaluation in these systems surfaced by the findings 
presented in Table 17.  (As previously stated, at the time 
the site visits were conducted, two of the 14 systems did 
not have a formal, overall board evaluation program in 
place; one of the boards is engaged in considering the 
possibility of establishing one.)
Study Findings
However, about a third of these board members and 
CEOs clearly believe their investment of time and other 
resources in board evaluation exercises during the past 
two years did not result in substantial changes; several 
others “were not sure.”  It is possible that, in some 
instances, the evaluation processes simply concluded 
there was no need for changes in the board’s structure, 
processes, or practices; that is, everything was fine as is.  
However, these data do raise serious questions about the 
extent to which the current board evaluation practices 
actually are improving governance, at least in a large 
segment of these health systems.
TABLE 17
“Over the past two years, has the Board evaluation process resulted in actions that have 
substantially changed the Board’s size, composition, or practices.”*
52%
32%
16%
100%
56%
42%
2%
100%
Directors and CEOs of 14 
Large Systems (n = 71)
CEOs of 114 Community 
Health Systems 
(n = 114)**
*Test results are shown only when the observed differences were found to be statistically significant.
**L. Prybil, et al, Governance in High Performing Community Health Systems, op. cit., pp. 18-19.
Response
Yes
No
Not Sure or Did Not Answer
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National studies in the healthcare field and other 
sectors indicate that a large majority of boards formally 
evaluate their CEOs’ performance in some fashion.  
For example, a 2011 survey of public companies by the 
National Association of Corporate Directors found 
that approximately 70% of boards collaborate with their 
CEOs in setting financial and non-financial goals.79  
A 2011 Governance Institute study showed that 91% of 
the participating hospital and health system boards have 
adopted and utilize “…a formal process for evaluating 
their CEOs’ performance.”80 
CEO Evaluation Process
For all corporate organizations, appointing the CEO, 
establishing performance expectations and evaluating his 
or her success in meeting those expectations are among 
a governing board’s most essential duties.  Numerous 
studies have shown that — for organizations, teams, 
and individuals — having clearly-defined goals tends 
to enhance performance.78  For the CEOs of any 
organization, large or small, evaluating their performance 
against pre-established expectations in a fair, objective 
fashion is beneficial for the CEO, the board, and the 
organization as a whole.  Doing this well is widely 
accepted as a basic hallmark of effective governance.
Study Findings
TABLE 18
“Which of the following statements most accurately represents your view regarding the 
overall effectiveness of your Board’s current evaluation process?”*
36%
50%
0%
14%
100%
30%
54%
1%
15%
100%
CEOs
 (n = 14)
Total Responses 
(n = 71)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Our Board evaluation process is excellent and has resulted in 
substantial improvements in Board performance.
A process is in place and has been somewhat beneficial.
The process is not well-organized and not very productive.
We do not have a formal board evaluation process in place at this time.
28%
54%
2%
16%
100%
Board Members
 (n = 57)
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All of the board members and CEOs also were asked to 
express their opinion on the overall effectiveness of their 
system’s current CEO performance evaluation process.  
As shown in Table 20, a strong majority of both the 
CEOs and board members believe the current process 
“…produces clear performance expectations and assesses 
actual performance fairly.”  
Unfortunately, this is not the case in many organizations 
in the healthcare field and other sectors.  A recent study 
by the American College of Healthcare Executives 
found that 82% of CEOs were not given performance 
expectations when they initially were employed, and 66% 
reported that no formal evaluation process was conducted 
at the end of their first year in the position.81 Numerous 
experts have expressed serious questions and concerns 
about the rigor and efficacy of CEO evaluation in both 
nonprofit and investor-owned organizations.82  
Study Findings
On-site interviews with the CEOs and board members 
in the 14 large systems found that all of the boards 
regularly evaluate their CEOs’ performance in relation 
to pre-established expectations or criteria on a regular 
basis.  As shown in Table 19, in seven of the 14 systems, 
the boards’ compensation committees are charged with 
leading the evaluation process; in all seven instances, the 
board chair either serves on the compensation committee 
or works closely with it in the evaluation process.  In four 
systems, the current CEO evaluation protocol calls for 
the board chair personally to lead the CEO evaluation 
process; in all four of these systems, the board chair 
engages other board members in the process.
TABLE 19
“Who has lead responsibility for leading the CEO evaluation process?”*
3
0
5
1
9
4
1
7
2
14
Faith-Based Systems
(n = 9)
All Systems
(n = 14)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Board Chair
Board Executive Committee
Board Compensation Committee
Ad hoc group appointed by the Board Chair
Total
1
1
2
1
5
Secular Systems
(n = 5)
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The concept is straight-forward, and the potential 
benefits for the organizations which embrace and execute 
it effectively are clear.  This is why organizations such as 
the Securities Exchange Commission, rating agencies, 
and other bodies with oversight responsibilities in 
many sectors are devoting more scrutiny to leadership 
succession planning.83  Ensuring that well-designed 
leadership succession programs are in place and 
functioning well has become a fundamental indicator of 
effective governance.
Unfortunately, the evidence suggests that many boards, 
both in the healthcare field and other sectors, fall 
short.  To illustrate, a 2011 survey by the National 
Association of Corporate Directors found that only one 
third of America’s public companies had a formal CEO 
succession plan in place.84  A 2010 study by the American 
College of Healthcare Executives found that only 44% 
of hospitals had succession plans for their CEO, 39% for 
their chief nursing officer, and 36% for the chief financial 
officer.85  A 2011 Governance Institute study showed 
that only 41% of the participating hospitals and health 
systems employ “…an explicit process of board leadership 
succession planning to recruit, develop, and choose future 
board officers and committee chairs.”86 
Succession Planning Processes
In the organizational context, “leadership succession 
planning” should address the needs for clinical, 
governance, and management leadership talent.  Having 
highly-dedicated and skillful leaders in key roles in all 
three realms with capable persons in line to succeed them 
when needed is essential to sustain organizational success 
in our rapidly changing and increasingly challenging 
societal environment.
The concept of “leadership succession planning” includes 
several basic components:  on-going efforts to define 
leadership needs and how those needs are evolving as the 
organization’s internal and external environment changes; 
assessing existing talent in relation to the organization’s 
current and projected needs; building a strong leadership 
development program to enhance the existing talent base 
and recruit additional talent where required; and systematic 
planning to identify well-prepared individuals who have the 
competencies and motivation to step into key positions and 
perform effectively when they are called upon.
Study Findings
TABLE 20
“Which of the following statements most accurately describe your overall view of the 
effectiveness of your Board’s current CEO evaluation process?”*
79%
21%
0%
0%
100%
75%
24%
0%
1%
100%
CEOs
 (n = 14)
Total Responses 
(n = 71)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
The process produces clear performance expectations for the CEO 
and assesses actual performance fairly.
A process is in place and has been somewhat beneficial for the 
CEO and our organization.
The process is not well-organized and not very productive.
Has not yet participated in our CEO evaluation process
Total
74%
24%
0%
2%
100%
Board Members
 (n = 57)
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Board Oversight of Patient Care Quality 
and Safety
Extensive efforts to improve patient care quality and safety 
are being made by national organizations such as the 
Institute for Healthcare Improvement, the Hospital Quality 
Alliance, and the National Quality Forum as well as by 
health system leaders at the local level.  There is evidence 
that improvements in some areas are being made.87
However, a series of studies by the Institute of Medicine, 
the Commonwealth Fund, and other authorities show 
that the overall quality of clinical services provided by 
healthcare institutions continues to be uneven and needs 
to be improved.88  In March 2011, the U.S. Department 
of Health and Human Services promulgated a National 
Quality Strategy intended to “… promote quality 
health care in which the needs of patients, families, and 
communities guide the actions of all those who deliver 
and pay for care.”
Study Findings
In the on-site interviews, all board members and CEOs 
were asked about the current status of succession planning 
for board and senior management positions within their 
systems.  As shown in Table 21, these interviews and 
subsequent conversations with system staff indicate that 
six of the 14 systems (43%) have some form of succession 
plans in place, both for board leadership and senior 
management positions, including the system CEO.  
Another four systems (29%) have succession plans in place 
for the CEO and other senior management positions, but 
not for board leadership.  In general, the development of 
succession planning is somewhat more advanced in the 
secular systems than in faith-based systems.  However, 
virtually all of the board members and CEOs in systems 
that have initiated board and/or management succession 
planning programs express the view that their current 
programs are in “early stages of development” and will 
require much more work during the coming months and 
years.  They also are in accord that leadership succession 
planning is critically important to the long-term success of 
their systems.  
TABLE 21
“Has your board adopted formal succession plans for Board and senior management positions?”*
33%
11%
23%
33%
100%
43%
7%
29%
21%
100%
Faith-Based Systems
 (n = 9)
All Systems
 (n = 14)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Yes, for Board chair, for Board committee chairs, for the CEO, 
and for other senior management positions.
For Board leadership positions but not for senior 
management positions.
For the CEO and other senior management positions but not for 
Board positions. 
We have not yet adopted any formal succession plans.
60%
0%
40%
0%
100%
Secular Systems
 (n = 5)
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and the board “…knew or should have known about it, 
yet did nothing while the institution continued to submit 
claims to Medicare and other payers …”91   However, some 
studies have raised concerns about the extent to which 
hospital and health system boards are focused on patient 
care quality and safety.  For example, a study conducted by 
Ashish Jha and Arnold Epstein in 2007-2008 found that 
only half of the board chairs in a nationally representative 
sample of nonprofit hospitals identified clinical quality 
as one of their board’s two top priorities for governance 
oversight.92  A 2011 Governance Institute survey found 
that only 74% of health system boards have standing 
committees on quality and/or safety.93 
This study of governance in 14 large systems examined 
several aspects of the board’s oversight of patient care 
quality and safety and found evidence of substantive 
engagement.  As shown in Table 8 and discussed 
earlier in this report, nearly all of the boards (93%) 
have established a standing committee with oversight 
responsibility for patient care quality and safety.  Through 
interviews with senior board members and CEOs and 
review of system documents, this study examined the 
boards’ current role with respect to setting the system core 
measures and standards for patient care quality.  Table 22 
shows the findings.  In 11 of the 14 systems, the board 
of directors formally adopts system-wide measures and 
standards.  In two cases, the board’s standing committee 
on quality has been delegated responsibility to adopt 
the measures and standards and present them to the full 
board.  During the period of time when this study was 
being conducted, the remaining board was engaged in  
re-examining its role and practices with respect to 
oversight of patient care quality and safety.
The governing boards of America’s hospitals and health 
systems have a special role in meeting these challenges.  
Ensuring that organizational standards for patient care 
quality and safety are adopted and that processes for 
monitoring and improving clinical services are in place 
clearly are among the boards’ most fundamental duties.89   
It is imperative for boards to understand their legal and 
moral responsibility in this realm; engage with clinical 
and management leadership in establishing policies, 
standards, and metrics for patient care quality and safety; 
and monitor the organization’s performance in relation to 
them.  Boards also must ensure that appropriate actions 
are taken by clinical and management leadership when 
performance does not meet the established standards.
In the contemporary healthcare environment, meeting 
these obligations has become a basic expectation for 
hospital and health system boards.  This has been 
reinforced by new leadership standards set forth by the 
Joint Commission in January, 2009, and by provisions of 
the Affordable Care Act of 2010.
“The [Affordable Care Act’s] aim is to achieve optimal results 
in terms of the overall quality of care as well as its efficiency, 
cost, safety, and timeliness … boards, which are legally 
accountable for the quality of care their institutions provide, 
need to develop and implement effective quality oversight 
processes to achieve these objectives …90 
It seems likely that the  Centers for Medicare and 
Medicaid Services (CMS), the Department of Justice, and 
other regulatory bodies will hold the board of directors 
accountable if a healthcare institution is not providing 
patient care services that meet established quality standards 
Study Findings
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Study Findings
TABLE 22
The System Board’s Role with Respect to System-Wide Measures and Standards for 
Patient Care Quality*
78%
11%
11%
100%
79%
14%
7%
100%
Faith-Based Systems
 (n = 9)
All Systems
 (n = 14)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
The Board formally adopts core measures and standards for quality 
of patient care.
A Board committee adopts the core measures and standards and shares 
them with the Board, but the Board does not formally adopt them.
Measures and Standards for quality of patient care are not 
established at the system level; this function is handled by local 
organizations in our system.
80%
20%
0%
100%
Secular Systems
 (n = 5)
TABLE 23
“Has your system’s Board adopted specific action plans in the past 12 months directed at 
improving system performance with respect to patient care quality and safety?”*
79%
14%
7%
100%
80%
17%
3%
100%
CEOs 
(n = 14)
Total
 (n = 71)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Yes
No
I’m not sure
80%
 
18%
2%
100%
Board Members
 (n = 57)
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Board Oversight of Community Benefit 
Policies and Programs95 
The landmark work of the Commission on Hospital Care 
during and after World War II led to enactment of the 
Hospital Survey and Construction Act of 1946 (Public Law 
79-725).  This legislation, commonly termed the “Hill-
Burton Act,” became Title VI of the Public Health Service 
Act.  It represented the first major policy instrument for 
shaping hospital and health services planning in the United 
States.  To become eligible for federal grants for hospital 
construction projects, states were required to establish 
hospital planning agencies, assess existing facilities in relation 
to current and projected community needs, and set priorities 
on a statewide basis.  In the decades that followed, the Hill-
Burton Act enabled thousands of hospital construction 
and renovation projects, reshaped America’s health services 
delivery system, and introduced the concept that nonprofit, 
tax-exempt healthcare facilities should serve defined 
community needs.96 
Historically, nonprofit hospitals and health systems were 
accorded tax-exempt status on the premise that a fundamental 
reason for their existence was providing charity care to persons 
who required healthcare services but were unable to pay for 
them.  The original (1946) Hill-Burton legislation required 
facilities receiving grants to provide charity care for 20 years 
to eligible individuals unable to pay for their services; facilities 
funded with grants under Title XVI in later years were 
required to provide uncompensated care in perpetuity.97 
In 1965, Congress enacted Public Law 89-97 which 
established the Medicare and Medicaid programs and 
significantly expanded health insurance coverage for 
elderly and poor Americans.  In 1969, the IRS issued 
Revenue Ruling 69-545 which shifted the rationale 
for granting tax-exempt status to nonprofit healthcare 
institutions from providing charity care to providing 
“community benefits.”  In Revenue Ruling 69-545, the 
IRS reasoned that providing healthcare services for the 
general benefit of the community inherently is a charitable 
purpose, outlined the factors that would be considered in 
granting tax-exempt status, and, in doing so, created the 
so-called “Community Benefit Standard.”98 
In the one-on-one interview process, all board members 
and CEOs were asked if their system board “…regularly 
receives written reports on system-wide and hospital-
specific performance in relation to established measures 
and standards for the quality of care.”  All 14 CEOs 
and all 57 board members independently responded 
affirmatively.  Their opinions were verified by examining 
“scorecard” reports and other system documents that are 
prepared for and presented to these boards.
 
Finally, as a test of the boards’ willingness to address issues 
or problems that are surfaced by reports they receive, the 
board members were asked if, in the past 12 months, their 
system’s board had “…adopted specific action plans directed 
at improving system performance in patient care quality and 
safety.”  Table 23 presents their responses to this question.  
The congruence between the views of board members and 
CEOs on this important issue is striking:  among both 
groups, four out of five respondents stated that their boards 
had adopted one or more “action plans” within the past 
year.  Many were willing and able to give concrete examples.  
Predictably, these “action plans” varied widely.  They ranged 
from asking the CEO and system staff to address a specific 
quality of care issue at an institution in their system and 
prepare a special report for consideration at an upcoming 
board meeting to directing the board’s quality committee  
and staff to “take a fresh look” at certain quality measures  
and targets adopted in the past.
Contrary to some other studies, the input provided directly 
by these board members and CEOs — in combination with 
system documents such as quality committee charters and 
board scorecard reports — suggest high levels of interest and 
engagement in addressing their responsibilities for oversight 
of patient care quality and safety.  Nearly all of the board 
members and CEOs readily acknowledge the complexity 
of these responsibilities and the shortfalls they perceive 
in their current policies and practices.  They view these 
policies and practices as “work-in-process” and recognize 
the need for continuous assessment and improvement in 
them.  However, based on these findings, it certainly appears 
that the boards of these large nonprofit systems are heeding 
Donald Berwick’s call to embrace “stewardship of quality” as 
a fundamental board duty.94 
Study Findings
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hospitals and systems led, in 2007, to substantial 
revisions to the IRS Form 990, “Return of Organization 
Exempt from Income Tax,” and corresponding 
instructions.  The redesigned form consists of a common 
document that must be completed by all applicable 
tax-exempt organizations and a series of schedules that 
organizations may need to complete depending upon 
their particular roles and activities.  Phased in beginning 
with the 2008 tax year, this was the first major revision to 
Form 990 since 1979.
For healthcare institutions, the revised Form 990 and the 
new Schedule H require significantly more details about 
charity care, other types of community benefits provided 
by the organization, the expenses related to these services, 
and other information than in the past.  According to the 
IRS, Schedule H was intended to “ … combat the lack 
of transparency surrounding the activities of tax-exempt 
organizations that provide hospital or medical care.”105 
Since its adoption in 2007, the Form 990 and related 
schedules have been refined somewhat but basically 
remained intact since then.  However, the Patient 
Protection and Accountable Care Act (the “Act”) 
adopted by Congress in 2010 amended the IRS code 
by adding Section 501(r)(3).  It requires every hospital 
facility operated by a 501(c)(3) organization to conduct 
a “community health needs assessment” with input from 
interested parties in the community at least once every 
three years, develop an implementation strategy to address 
community needs identified through that process, and 
make the results widely available to the public.  Hospitals 
with a July 1- June 30 fiscal year are required to complete 
a community health needs assessment, set priorities, and 
adopt implementation plans by June 30, 2013.106 Details 
remain to be worked out, but if the Patient Protection 
and Affordable Care Act and IRS Code Section 501(r)(3) 
remain in place, they will have substantial impact on the 
nation’s nonprofit hospitals and systems.
Study Findings
As time passed and the healthcare field and society as 
a whole experienced major economic, demographic, 
and political changes, many parties in both the public 
and private sectors began to raise questions about the 
adequacy and appropriateness of the Community Benefit 
Standard as the basis for providing tax-exempt status for 
nonprofit healthcare institutions.99  A number of voluntary 
healthcare organizations including the American Hospital 
Association, the Catholic Health Association, the 
Health Research and Education Trust, the Public Health 
Institute, and the VHA have encouraged hospitals and 
health systems to document the services they provide 
and how those services benefit the communities they 
serve.100  However, several studies by the IRS, the 
General Accounting Office, and other organizations 
documented wide variability in definitions and amounts 
of “uncompensated care” and other forms of community 
benefit provided by nonprofit healthcare institutions.101,102 
These studies — in combination with a series of hearings 
by legislative bodies including the House Ways and 
Means Committee and the Senate Finance Committee 
at the federal level and growing need for revenues at the 
state and local levels — generated serious questions about 
nonprofit hospitals’ exemptions from income, property, 
and other taxes.
These issues have contributed to the adoption of various 
forms of community benefit requirements (such as a specific 
level of charity care and/or standard reporting rules) for 
nonprofit healthcare institutions in about half of the states.103 
In some locales, hospitals’ traditional exemptions from 
property taxes are being challenged on the basis of their levels 
of charity care.104 
At the federal level, continuing concerns about the utility 
of the IRS Community Benefit Standard, the absence 
of agreed-upon “community benefit” definitions, and 
wide variation in the amounts of uncompensated care 
and other community benefits provided by nonprofit 
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Among the basic aims of the Act are improving patient 
care quality and safety, reducing the growth in healthcare 
costs, and improving coordination among providers of 
healthcare services.  As one strategy for achieving these 
aims, the Act promotes the development of “accountable 
care organizations” (“ACOs”) which, as a general construct, 
can be defined as “ … groups of providers who are willing 
and able to take responsibility for improving the overall 
health status, care efficiency, and health care experience 
for a defined population.”107 Implicit in the ACO and 
other provisions of the Act is encouragement to improve 
communication and coordination between healthcare 
providers in the private sector and public health agencies.  
This theme also has been affirmed by the Institute of 
Medicine’s 2012 report, “Primary Care and Public Health:  
Exploring Integration to Improve Population Health” and 
a recent report by the Urban Institute.108 
While recognizing the Act was new and federal guidance 
regarding Code Section 501(r)(3) would not be available 
for some time, the interviews with system board members 
and CEOs did include several questions regarding their 
particular system’s community benefit programs as they 
exist at this time.  The first was “Has your board adopted 
a formal, written statement that defines overall goals 
and guidelines for your system’s community benefit 
program?” In combination, 61% of the trustees and CEOs 
answered affirmatively; many were able to discuss the 
genesis and content of their system’s policy and position 
in some detail.  A review of system documents support 
these finding and indicate that, at this time, nine of the 
14 systems (64%) have board-approved policy statements 
regarding their community benefit programs in place.  
CEOs and board leaders in several of the remaining 
systems are giving consideration to developing and 
adopting policy statements of this type.
Study Findings
TABLE 24
“Has the Board adopted a formal, written statement that defines overall goals and guidelines 
for the system’s community benefit program?”*
78%
11%
11%
100%
64%
29%
7%
100%
  Faith-Based System 
 (n = 9)
All Systems
(n = 14)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Yes
No
Not Clear
40%
60%
0%
100%
Secular Systems
(n = 5)
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In the contemporary environment, organizations in virtually 
all sectors of society face resource constraints and must 
set resource allocation priorities carefully.  As stated by 
Michael Porter and Mark Kramer, “No business can solve 
all of society’s problems or bear the cost of doing so.”109  For 
America’s hospitals as a whole, uncompensated care (charity 
care and bad debt) increased from $21.6 billion in 2000 to 
$39.3 billion in 2010, an increase of 82% in that decade.  
This trend clearly has affected the availability of resources 
for other categories of community benefit activities.110 For 
this and other reasons, developing and adopting formal plans 
and setting clear priorities for community benefit programs 
has emerged as a basic indicator of effective governance in 
healthcare organizations.111 
Study Findings
As one way to gauge the participating systems’ current 
policy positions on coordination between their local delivery 
organizations and public health agencies, the board members 
and CEOs were asked if their system’s board requires (not 
just “encourages”) their local organization to collaborate with 
local public health agencies in their vicinities.  The information 
presented in Table 25 shows that, at this time, such 
requirements are not common.  Only four board members 
and one CEO, all affiliated with a single secular system, 
indicated that collaboration with local public health agencies 
in assessing community health needs and setting community 
benefit priorities is a system-wide requirement for their local 
organizations.  However, in recognition of the nationwide 
need for greater focus on prevention and population health, 
many board members and CEOs expressed support for the 
idea of promoting stronger communication and coordination 
between their local institutions’ leadership teams and local 
public health agencies.
TABLE 25
“Does your Board require your local organizations to collaborate with local public health 
agencies in assessing community needs and setting community benefit program priorities?”*
7%
93%
0%
100%
6%
93%
1%
100%
CEOs
(n = 14)
Total
(n = 71)
 *Test results are shown only when the observed differences were found to be statistically significant.
Response
Yes
No
Not Sure
5%
93%
2%
100%
Board Members
 (n = 57)
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Allocation of Board Time and Effort
The time its board members are able and willing to devote 
to governance functions is one of an organization’s most 
important assets.  The manner in which board meetings are 
organized and how time is allocated is a key determinant of 
board effectiveness in all types of organizations.112 
The board members and CEOs who were interviewed as 
part of this study were asked to estimate the proportion of 
board (not board committee) time allocated to two critical 
topics in meetings of their system board during the past 
twelve months.  Those topics were, first, patient care quality 
and safety and, second, strategic thinking and planning.
In this study of governance in large nonprofit systems, all 
board members and CEOs were asked if, in their opinion, 
their system’s board has required their local organizations 
to develop and adopt a formal community benefit plan 
that identifies specific priorities for its community benefit 
program.  Nearly half of the board members and CEOs 
responded affirmatively.  A review of system documents 
supports their opinions and, as shown in Table 26, seven of 
the 14 systems (50%) in this study population — principally 
but not exclusively faith-based systems — have directed 
their local leadership teams to develop formal plans with 
priorities, strategies, and metrics for their community 
benefit programs.  In several instances, these expectations 
specify that the process of developing local plans must 
consider and address certain system-wide priorities.  If the 
provisions of IRS Code Section 501(r)(3) go into effect 
and resources become further constrained, the development 
and adoption of formal community benefit plans at both 
the system and local levels of nonprofit health systems will 
become increasingly prevalent.
Study Findings
TABLE 26
“Does your Board require your local organizations to adopt a formal community benefit plan 
that identifies specific priorities and strategies for its community benefit program?”*
67%
33%
0%
100%
50%
43%
7%
100%
  Faith-Based System 
 (n = 9)
All Systems
(n = 14)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Yes
No
Not Clear
20%
60%
20%
100%
Secular Systems
(n = 5)
36  
Perhaps the most striking insight from these discussions with 
board members and CEOs was the consistent expressions 
of interest and commitment by both board members and 
CEOs to increase their boards’ focus on strategic thinking 
and deliberations.  Virtually all recognize the importance 
of this governance responsibility in our increasingly volatile 
healthcare environment; many discussed steps their boards 
already have taken and/or are planning to take to re-align 
their traditional board meeting agendas and practices to 
create more time for various forms of strategic assessment 
and deliberations.  These include, for example, adopting a 
formal board policy to commit at least half of every board 
meeting to long-term strategic thinking and planning.  
Another board now blocks at least two hours of every board 
meeting to focus on a particular strategic issue or opportunity 
their system needs to address.
It must be recognized that the data regarding allocation of 
board meeting time simply represent the “best estimates” of 
board members and CEOs, not actual measurements, and 
longitudinal data are not available for comparison.  However, 
these estimates in combination with narrative comments 
provided by the board members, CEOs, and system staff 
members are congruent and clearly suggest two conclusions:  
first, on the overall basis, these 14 system boards over the 
past year have devoted approximately half of their board (not 
committee) meeting time to deliberations regarding quality 
and safety and to strategic thinking and planning.  Second, 
virtually all of these boards and their CEOs are making 
intentional efforts to re-balance their board meetings to 
provide more time for engagement in active deliberations 
with less time devoted to routine reports and presentations.
Study Findings
As reported earlier in this report, 13 of the 14 boards in 
this study population have established standing committees 
on patient care quality and safety; virtually all of the 
board members and CEOs interviewed in this study view 
setting direction and providing oversight of their systems’ 
performance in this area as one of their most important 
duties.  With respect to allocation of board meeting time to 
reports and deliberations regarding patient care quality and 
safety during the past year, the combined estimates by board 
members and CEOs of the 14 boards ranged from a low 
of 10% to a high of 35%.  The median estimate for the 14 
boards was 23%; the mean estimate was 22%.
Governing boards in all types of organizations frequently 
are criticized for focusing on current operating performance 
and short-term issues as compared to the major strategic 
problems and opportunities that confront the organization.113 
In surveys of boards in both public companies and nonprofit 
organizations, directors often rank “strategic planning 
and oversight” as one of their boards’ top priorities.114 
Many authorities have urged boards to devote more time 
and attention to strategic or “generative” thinking and 
deliberations; however, recent studies do not demonstrate 
that this shift is occurring.115  
In this study, board members and CEOs were asked to  
give their best estimates of board meeting time devoted  
to strategic thinking and planning during the past year.  
The combined estimates by board members and CEOs of 
the 14 boards ranged from a low of 15% to a high of 53%.  
The median estimate for the 14 boards was 32%; the mean 
estimate was 30%.
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Healthy Board Culture 
Examining and trying to understand the culture of any 
organization or group is quite challenging.   Based on the 
work of a panel including senior board leaders, CEOs, 
governance consultants, and university faculty members with 
experience in board service and research convened by HRET 
in 2007 and other studies, the research team selected seven 
features that, if present, indicate the existence of a healthy, 
effective board culture.119  Board members and CEOs of the 
14 large systems who participated in this study were asked 
to express their views on the extent to which their system’s 
board demonstrates these seven characteristics.120  Table 27 
displays their responses in comparison to the views of CEOs 
who participated in a recent study of governance in 114 
nonprofit community health systems.
These data suggest that nearly all trustees and CEOs in 
these 14 large systems believe their boards consistently 
demonstrate commitment to their system’s mission and 
honor their conflict of interest and confidentiality policies.  
However, less than 60% of them feel their board leaders 
“hold board members to high standards of performance” 
or that “robust engagement and respectful disagreement 
consistently are encouraged.”  In combination, only one-
third of the trustees and CEOs feel their systems’ board 
meetings consistently are “well-organized and focus 
principally on strategic deliberations rather than receiving 
information.”  This finding is consistent with Section III (B) 
of this report which documents the commitment by many 
board members and CEOs to shift a larger proportion of 
board time and effort from reports on routine operations to 
strategic thinking and deliberations.  In general, the views of 
the CEOs of these 14 large systems on these indicators of 
effective board culture are similar to the view of community 
health system CEOs.  None of the observed differences are 
statistically significant.
With respect to board culture, this study focuses on two basic 
benchmarks of effective governance.  They are:
8. Effective boards intentionally create a culture that 
nurtures enlivened engagement, mutual trust, 
willingness to act, and high standards of performance.
9. Effective boards expect their CEOs to demonstrate 
exceptional leadership and management skills, high 
personal and professional standards, and strong  
support for the role of governance.
Over time, either deliberately or not, every board of 
directors creates a governance culture — a pattern of 
beliefs, traditions, and practices that come to prevail 
when the board meets to perform its duties.  As stated 
by Barry Bader:
“Like their organizations, governing boards have a culture too. 
The pivotal importance of culture in distinguishing the effective 
from the ineffectual board has been apparent at least since the 
downfall of the Enron Corporation.  Observers attributed Enron’s 
collapse in part to a passive, management-driven board of 
directors.  Despite talented members and a well-defined structure, 
directors failed to ask hard questions or display the independence 
needed to detect egregious accounting irregularities and unethical 
conduct by senior executives.”116 
Some boards, like Enron’s and many others, are 
insufficiently dedicated with a passive culture and low 
performance standards. This combination generally 
results in ineffective governance.117  In both the healthcare 
field and other sectors, there is growing conviction that 
effective governance requires a healthy board culture with 
commitment to proactive engagement, high performance 
standards, and rapt attention to making and executing 
decisions.118  
Study Findings
BOARD CULTURE
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As one way to probe this dimension of the boards’ cultures, 
board members and CEOs were asked to characterize 
their board’s overall approach to “… making decisions on 
important issues over the past 12 months.”  Table 28 displays 
their opinions, again in comparison with the views of 114 
community health system CEOs who responded to the same 
question as part of a previous study.
Study Findings
Approach to Decision-Making
The role and responsibilities of a governing board requires it 
to make decisions that shape the organization and its future 
direction.  The manner in which a board approaches and 
conducts its decision-making processes is a fundamental 
indicator of its culture and has major impact on the 
organization’s performance.121 
TABLE 27
Board Member and CEO Opinions on Whether or Not their Boards Demonstrate Selected 
Indicators of Effective Board Culture*
93%
93%
75%
74%
58%
51%
32%
89%
n/a
70%
72%
42%
54%
n/a
Board Members of 
14 Large Systems 
(n = 57)                   
CEOs of 114 Community 
Health Systems
(n = 114)**
*Test results are shown only when the observed differences were found to be statistically significant.
**Prybil, et al, Governance in High-Performing Community Health Systems, pp. 28-29.
Indicators of Healthy, Effective Board Culture
The Board’s actions always demonstrate deep commitment to 
our organization’s mission.
There always is a strong focus on honoring Conflict of Interest 
and Confidentiality policies.
There always is an atmosphere of mutual trust among the 
Board members.
Our system’s performance (financial and clinical) always is 
tracked closely by the Board and actions are taken when 
performance does not meet our targets.
Board leadership always holds Board members to high 
standards of performance.
Robust engagement and respectful disagreement always 
is encouraged.
Board meetings are well-organized and focus principally on 
strategic deliberations, rather than receiving information.
93%
86%
71%
93%
57%
50%
43%
CEOs of 14 Large 
Health Systems 
(n = 14)
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These data show that a substantial majority of board 
members (63%) and CEOs (57%) view their respective 
board’s current approach to decision-making positively.  
On the whole, board members are slightly more sanguine 
about their approach than CEOs, but the difference is 
modest and not statistically significant.  The CEOs of 114 
community health systems studied in 2008-2009 view their 
boards’ approach to making major decisions somewhat more 
positively than the CEOs of the 14 large systems in this 
study population, but, again, the observed difference is not 
statistically significant.
Study Findings
TABLE 28
“Over the past 12 months, how would you characterize your system Board’s approach to 
making decisions on important issues?”*
63%
35%
0%
2%
100%
70%
29%
1%
0%
100%
Board Members of 
14 Large Systems 
(n = 57)                   
CEOs of 114 Community 
Health Systems
(n = 114)**
*Test results are shown only when the observed differences were found to be statistically significant.
**L. Prybil, et al, Governance in High-Performing Community Health Systems, op. cit., p. 30.
Overall Approaches to Decision-Making on Major Issues
The Board tends to be actively engaged in discourse and 
decision-making processes.  Most Board members are willing to 
express their views and constructively challenge each other and 
the management team.
The Board is involved in some issues, but its level of 
engagement is inconsistent.  The Board’s decision-making 
process would benefit from more dialog and debate.
The Board tends to be passive and reactive in its approach to 
decision-making.  We need to find ways to get the Board much 
more engaged.
Other
57%
43%
0%
0%
100%
CEOs of 14 Large 
Health Systems 
(n = 14)
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Senior Staff Support for the Board
Table 29 provides another indicator of CEO commitment to 
strong governance.  Because solid staff support for boards is 
a critical determinant of their effectiveness, board members 
were asked if all standing board committees are staffed by 
senior members of their system’s leadership team.  Ninety-
one percent of the board members replied affirmatively to 
this question.  Their opinions were verified by reviewing 
system documents and through discussions with the system 
CEOs and staff members.  In only one system did board 
members express the view that the overall caliber of staff 
support for board committees — and for the board as a 
whole — was somewhat less than satisfactory.    
In combination, these findings indicate that the CEOs 
of these 14 systems are strongly committed to effective 
governance and, on the whole, provide excellent support  
for their board and board committees.
Study Findings
CEO Commitment to Board Development
As part of the interview process, all board members were 
asked to describe their CEO’s level of commitment to 
developing a governing board whose culture has the 
characteristics shown in Table 27.  Virtually without 
exception, the board members’ responses to this question 
were positive and highly complimentary.  It is clear that 
this group of CEOs — and their commitment to assist in 
building a strong, healthy board culture — is recognized  
and greatly appreciated by their board members.
TABLE 29
“Are the standing committees staffed by senior members of your system’s leadership team?”*
100%
0%
0%
100%
91%
9%
0%
100%
CEOs
(n = 14)
Board Members
 (n = 57)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Yes, all standing committees have senior staff support.
Some, but not all, do.
No, they do not.
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Executive sessions of this nature provide an opportunity for 
board members to candidly exchange views on governance 
issues such as board succession planning while still ensuring 
solid communications and coordination between the board 
and the CEO.  Establishing the tradition of executive 
sessions of this nature as part of every board meeting with 
the understanding and support of the CEO is an effective 
governance practice.  It also becomes an important feature 
of the board culture and reflects mutual trust and respect 
between the board and the CEO.
Table 30 shows that nine of the 14 system boards in this 
study population (64%) hold executive sessions as part 
of every board meeting; the balance (36%) have such 
sessions sometimes, but not always.
Executive Sessions of the Board
Over the past twenty years, the practice of having 
“executive sessions” of the board has evolved from being 
rare to becoming commonplace, both in the healthcare 
field and other sectors.  Among public companies, this 
practice now is virtually universal.122  A 2011 survey 
conducted by the Governance Institute found 73% of the 
health systems that responded now schedule executive 
sessions before or after every board meeting.123  
Executive sessions organized into two segments, one part 
without the CEO or other management team members 
present and one part with the CEO present, have become 
widely accepted as a standard practice of effective boards.124   
Study Findings
TABLE 30
Does the Board Hold an Executive Session at the End of Board Meetings Without the CEO or 
Other Management Staff Present?*
67%
33%
0%
100%
64%
36%
0%
100%
  Faith-Based System 
 (n = 9)
All Systems
(n = 14)
*Test results are shown only when the observed differences were found to be statistically significant.
Response
Yes
Sometimes, but not always
No
60%
40%
0%
100%
Secular Systems
(n = 5)
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“The healthcare environment is changing dramatically and 
will continue to do so, but our system has been successful 
and comfortable with the status quo.  The question is, can 
our system change — really change — to better address the 
changing needs of an aging population and a much greater 
emphasis on prevention and health promotion?  Can we re-
invent ourselves as a system to focus on improving community 
health status as well as providing acute care services much 
more efficiently?” 
Healthcare in the USA is in the midst of turbulent 
change, and healthcare providers are facing difficult 
issues and great uncertainty.  All of these large systems 
are engaged in various forms of transformational 
change; e.g.: re-designing their corporate structures 
to facilitate large-scale diversification; aligning closely 
with physicians and other providers to create a more 
integrated continuum of care; investing in for-profit 
ventures; and partnering with insurers to form new 
“accountable care organizations.”  The boards and CEOs 
realize that making major changes is imperative; making 
those changes while preserving their system’s core values 
clearly is one of their fundamental challenges.
2. Increasing focus by boards on system-wide strategy 
and strategic issues
In all of the systems that participated in this study,  
the boards and CEOs are engaged in a distinct shift in 
governance focus and allocation of time.  The pattern 
that clearly is emerging involves a growing emphasis 
on strategic issues, deliberations, and decision-making.  
All of the systems are in the midst of reforming their 
board structures, processes, and practices to accelerate 
that shift.  In addition to now-standard practices such as 
board retreats and the use of a “consent agenda” format 
for board meetings, some examples of steps being taken  
by the systems’ boards to enable greater attention to 
system-wide strategy and strategic issues include:
Study Findings
This section of the report has two parts:  first, an overview 
of several  overall patterns or “themes” that emerged from 
this study of governance in 14 large, nonprofit health 
systems and, second, a synopsis of one particular feature 
of the governance model currently in place in each of 
these systems.
Emerging Governance Patterns
Each of the 14 health systems that participated in 
this study is unique in certain respects.  Their genesis, 
their evolution over the years, the particular set of 
communities and populations they presently serve, their 
current mission, and their vision and goals for their future 
all differ in various respects.  However, from this study 
of their governance structures, processes, and cultures 
including interviews with their senior board leaders and 
CEOs, several common patterns of governance emerge.  
These overall patterns appear consistently in all or most 
of the systems and in all parts of the country.  These 
emerging patterns include the following:
1. Our nation’s economic, political, and social 
environment is demanding major changes in all  
of these systems.
Virtually all of the systems’ board leaders and CEOs 
recognize that the rapidly changing environment 
will require fundamental changes in their system’s 
organizational structure, policies, programs, and, in  
many cases, their traditional mission and current vision.  
As one CEO stated during the interview process: 
 
EMERGING GOVERNANCE PATTERNS AND 
SELECTED FEATURES125 
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3. Patient care quality and safety has risen to become a 
principal board priority.
The board leaders in these 14 health systems clearly 
recognize their board’s fiduciary and moral responsibility 
for quality and safety.  Thirteen of the 14 boards now 
have standing committees to provide direction and 
oversight and all of the boards now routinely receive 
written reports on system-wide and hospital-specific 
performance in relation to quality measures.  The 
interviews with senior board members and CEOs as well 
as conversations with system staff associates consistently 
reflect that patient care quality and safety has become a 
high governance priority.  As stated by the CEO of one 
of these systems:
“Getting ready for ‘value-based purchasing’ which is emerging 
in many forms across the country is one of our system’s greatest 
challenges.  To be successful in the future, all providers of 
healthcare services must make dramatic advancements in 
improving quality and reducing costs.  Multi-state providers 
such as we are will have special challenges because private and 
governmental payors in different states will adopt a variety of 
approaches and requirements.”
The findings of this study suggest their oversight 
responsibility for patient care quality and safety has 
the boards’ attention.  However, many of the boards 
and CEOs are wrestling with the best approaches and 
methods for fulfilling this responsibility.  What are the 
proper quality and safety measures against which boards 
should set targets and monitor performance?  What is 
the most appropriate approach to articulate the respective 
roles of the board as a whole, the board committee 
on quality and safety, the system CEO and his or her 
management team, and local leadership?  These are 
among the questions that the boards of health systems 
and other providers of healthcare services throughout  
the country are addressing.
• A policy decision by one board to devote 50% of every 
board meeting to strategic issues and deliberations.
• Blocking at least two hours of every board meeting to 
a specific challenge or opportunity felt to have major 
implications for the organization’s future direction.
• Re-structuring the board agenda to place items 
requiring board decisions and strategic issues that 
call for board deliberations as the first segment 
of every board meeting.  Routine committee and 
management reports are distributed in advance of 
the board meetings, with the understanding that the 
information therein will not be replicated in verbal 
presentations.
• Requesting every board committee, as a standing 
agenda item at every committee meeting, to devote 
concerted time to identifying issues in their realm of 
responsibility (e.g., quality and safety) that could have 
major, long-term strategic impact on the system; then 
— with appropriate explanation and information — 
proposing such items for strategic deliberations at a 
future board meeting.
Proper board oversight of their system’s operations in 
relation to established goals and targets is obviously 
essential.  However, it is clear that — in the contemporary 
environment — it is increasingly important for boards to 
devote attention to strategic thinking and deliberations.  
In various ways and at differing speeds, the boards of all 
14 systems are in the process of making this shift.  As 
a board chair of one faith-based system stated in the 
interview process:
“As a system, what can and should we become in the future?  
What is the best direction for our health ministry?  What 
should be our vision for the future and what strategies should 
we adopt for getting there?  These are the issues our board and 
management colleagues must focus on.”
Study Findings
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For many faith-based and secular health systems, 
a fundamental question that emerges is this:  In an 
increasingly complex healthcare environment where 
public and private payors and the public at-large are 
demanding healthcare providers to enhance access to 
services, improve quality, and reduce costs, to whom are 
nonprofit health systems and their boards accountable for 
their performance, and what are the best mechanisms for 
fulfilling that accountability?  What are the best methods 
for ensuring proper accountability to the communities and 
populations these systems exist to serve?  These are among 
the questions that are emerging and which a growing 
number of boards and CEOs are now addressing.
5. Increasing board focus on system-wide community 
benefit programs and community health needs
The boards of nine of the 14 large systems in this study 
population have adopted policies or some other formal 
statement that define overall goals and guidelines for 
their systems’ community benefit programs; others are 
considering such action.  About half of the systems now 
require their local organizations to develop and adopt 
formal plans that identify specific priorities and strategies 
for their community benefit programs.  Moreover, 
discussions with the systems’ board members and CEOs 
reflect board awareness of the national spotlight on  
what nonprofit organizations are doing in this area.   
It is apparent their awareness has been heightened by 
passage of the Patient Protection and Affordable Care 
Act which, among its many provisions, places several 
new requirements on tax-exempt hospitals related to 
their community benefit plans and programs.  As stated 
in Section III (B) of this report, these new requirements 
include conducting community health needs assessments 
in concert with public health and other interested parties 
in the community, prioritizing these needs, developing 
implementation strategies, and making these strategies 
and results available to the public.
Study Findings
The array of quality and safety measures being 
disseminated by CMS, the National Quality Forum,  
and other parties is large and growing constantly.  As 
stated recently by Michael Wagner:  
“Current health care leaders are finding it increasingly 
difficult to make progress in the quality terrain as the answer 
to the question, ‘What is quality?’ is an expanding and 
moving target.”126 
It seems apparent that the leadership of many health 
systems, large and small, would benefit from clear, 
pragmatic guidance in this complex realm.
4. Defining or re-defining the systems’ key stakeholders 
and accountability protocols
As these systems become larger and more complex, many 
board leaders have identified the need to revise their 
organizational models and re-think their definitions 
of key “stakeholders” and traditional mechanisms for 
accountability.  For example, as discussed earlier in this 
report, several Roman Catholic systems have adopted 
the Public Juridic Person model which enables religious 
congregations to transfer control to a new Catholic entity 
with substantial laity leadership.  This has involved major 
changes in their traditional accountability to former 
religious sponsors and new forms of accountability 
to the Vatican.  Other systems, both faith-based and 
secular, have made or are contemplating organizational 
changes that alter their traditional forms and practices 
with respect to accountability.  For example, one 
large secular system recently eliminated hospital-level 
boards and replaced them with “regional” boards that 
now have defined levels of responsibility and decision-
making authority for the system’s hospitals and other 
healthcare programs in their geographic area.  Among 
the implications of this organizational change is that the 
system no longer can expect its hospital boards to be a 
primary link for communications with and accountability 
to the particular communities and populations those 
hospitals serve.
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to carry-out its duties.  Each board is responsible for 
shaping its own culture, and the culture that exists will 
have a major impact on the board’s performance.
Among the large health systems included in this study, 
the board cultures are varied and, in all cases, there 
are some gaps between the cultures that presently 
prevail and key indicators of effective board culture.  
However, among the board leaders and CEOs of all 
14 systems, there is substantial agreement that healthy, 
high-performing boards are characterized by clear 
understanding of their role and responsibilities, active 
engagement in their governance duties, mutual trust, 
and willingness to take decisive actions.  Further, as a 
whole, these board leaders and CEOs express strong 
commitment to board evaluation and development, 
including on-going attention to cultural characteristics.
8. High level of CEO support for the role of governance 
and solid, trust-based board-CEO relationships
When asked to describe their respective CEO’s 
commitment to developing strong system-level 
governing boards with a healthy culture, nearly all 
board members expressed the view that their CEO’s 
support is consistently high and greatly appreciated 
by them and their board colleagues.  All of the boards 
have adopted a formal description of their CEO’s and 
board chair’s duties and believe that, at this time, their 
respective roles are well-understood, both by the board 
and the management team.  With very few exceptions, 
the members believe their board of directors and board 
committees receive solid staff support from senior 
members of the management team.  Ninety percent of 
the board members characterize the working relationship 
between their board and CEO as “consistently excellent.”
In brief, the prevailing pattern is clear:  the CEOs of these 
14 large health systems understand and respect the role of 
governance, provide strong support for their board and board 
committees, and enjoy excellent, trust-based respect in their 
board-CEO relationships.  These ingredients are vitally 
important in building and maintaining effective governance.
While the regulatory details remain to be developed, it 
seems clear these new requirements will have considerable 
effects on tax-exempt hospitals and their parent systems.  As 
Richard Umbdenstock, President and CEO of the American 
Hospital Association, stated recently “… it’s important to 
identify critical interfaces between public health and acute 
care and open a new, mutually-beneficial chapter in dialog 
and collaboration between the hospital and public health 
communities.”127   The boards and CEOs of America’s  
health systems will serve a key role building these linkages.
6. Succession planning for board and senior management 
is becoming a governance priority
Identifying and developing future leaders for the board of 
directors and the management team in a systematic fashion is 
critically important in all organizations.  Unfortunately, there 
is abundant evidence that leadership succession planning in 
the healthcare field as well as other sectors traditionally has 
been — and continues to be — spotty at best.
This study provides evidence that leaders of many health 
systems in this study population have recognized the 
importance of succession planning and now are devoting 
attention and resources to it.  Six of the 14 systems now have 
some form of succession plans in place, both for board and 
senior management positions; five others have instituted 
succession planning processes for either management or 
board leadership positions but not both.  Most of the CEOs 
and board leaders who were interviewed acknowledge that 
developing and sustaining solid succession plans is essential, 
that the programs they presently have in place need a lot 
of improvement, and express commitment to ensuring this 
happens in the near future.
7. Boards and CEOs in most of these large systems 
are giving priority attention to board development 
and culture
Every board of directors, over time, develops a 
governance culture — a pattern of beliefs, traditions,  
and practices that prevail when the board convenes 
Study Findings
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Those descriptions are presented in Appendix B:   
In alphabetical order by system they include: 
Study Findings
Selected Governance Features
Early in the process of conducting site visits to the 
corporate offices of systems in this study population 
and visiting with senior board leaders, CEOs and staff 
associates, it became clear to the research team that all of 
their governance models were distinctive in various ways.  
In addition, the systems’ board and management leaders 
demonstrated clear understanding of particular strengths 
of their current governance model, as well as areas where 
they believe improvements are needed.
These conversations prompted the following question 
to each system’s leadership team:  “Would you please 
identify and describe one feature of your system’s current 
governance model — its structure, policies, practices, 
or culture — that you believe has proven, over time, 
to be particularly beneficial?”  All agreed to do so.  
Subsequently, guidelines with respect to length and 
format were provided to the systems and, during the fall 
of 2011, all of the systems prepared concise descriptions 
of the governance features they selected to showcase.
The research team greatly appreciates the support of the 
systems’ CEOs and leadership teams in selecting and 
describing these features of their governance models.  All 
have proved to be valuable for their particular organizations; 
the system leaders and our research team hope the readers  
of this report also will find them to be useful.
System Compensation 
Philosophy
Integrated Strategic, 
Operational, and Financial Plan
Board Culture
Competency-Based Board 
Selection
Development of Lay Leaders
CHI Discernment Process
System Scoreboard and 
Executive Evaluation
Generative Governance
Board Committee for 
Community Benefit
Building Mayo Clinic’s Vision 
for 2020
Physician Integration Policy 
and Strategy
Board “Checking In and 
Checking Out” Practice
Restructuring Governance to 
Enable Strategic Alignment
Founding Principles
The Governance Feature 
They Selected to DescribeHealth System
Adventist Health System 
Sunbelt,
Altamonte Springs, Florida 
Ascension Health,
St. Louis, Missouri
Banner Health, 
Phoenix, Arizona
Carolinas HealthCare System,
Charlotte, North Carolina
Catholic Health East,
Newtown Square, 
Pennsylvania
Catholic Health Initiatives,
Englewood, Colorado
Catholic Health Partners,
Cincinnati, Ohio
Christus Health,
Irving, Texas
Kaiser Foundation Hospitals 
and Health Plan,
Oakland, California
Mayo Clinic,
Rochester, Minnesota
Mercy Health,
Chesterfield, Missouri
Providence Health & 
Services,
Renton, Washington
Sutter Health,
Sacramento, California
Trinity Health,
Novi, Michigan
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Governance Scores
This study examines board structures, processes, and 
cultures in a set of large, nonprofit health systems in 
relation to basic benchmarks of effective governance 
and related indicators.  Table 31 displays the nine 
benchmarks, 34 indicators which the research team 
considered to be reasonably well-established and 
measurable, and the manner in which those indicators 
were scored.  By meeting all of these indicators, a system 
could receive a maximum score of 48. 
This section of the report addresses two dimensions 
of the health systems’ performance:  First, their scores 
in relation to the indicators of effective governance 
addressed in this study; and second, their operating 
performance using a Thomson Reuters assessment 
protocol that uses a blend of eight measures.
Study Findings
SYSTEM PERFORMANCE
TABLE 31
Benchmarks and Related Indicators of Effective Governance Against Which the Health 
Systems were Scored 
1
1
1
1
7
1
1
1
Possible ScoreBenchmarks and Related Indicators
Yes
Yes
Yes
Yes
(one point for each 
function for which 
there is a standing 
oversight committee)
Yes
Yes
Yes  
Scoring Basis*
Effective boards insist on governance policies and structures that facilitate their 
efforts to perform the board’s functions and fulfill its responsibilities
Board bylaws establish clear limits on the number of consecutive terms a voting 
member may serve
Board bylaws establish clear limits on the number of voting board members
Board size is consistent with Blue Ribbon Panel on Health Care Governance 
recommendations (9-17 members)
Standing board committees have clear oversight responsibilities for the following 
governance functions:
(a)  Audit and compliance
(b) Board education and development
(c)  Community benefit
(d) Executive compensation
(e) Finance and investment
(f)  Patient care quality and safety
(g)  System-wide strategy and planning
The responsibilities of all standing board committees (not just some) are spelled out 
in a written document or documents (“charters”) and formally adopted by the health 
system board
The board has an “executive committee” that is authorized to act on behalf of the 
full board between its meetings
Board members perceive their board’s committees to be highly organized and very 
effective
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
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TABLE 31 (continued)
Benchmarks and Related Indicators of Effective Governance Against Which the Health 
Systems were Scored 
1
1
1
−
1
1
−
1
1
1
1
1
Possible ScoreBenchmarks and Related Indicators
At least a majority of 
voting board members 
are independent 
At or above the median 
% of all 14 systems (17%)
No objective basis for 
scoring at this time
At or above the median 
% of all 14 systems (20%)
Yes
No objective basis for 
scoring at this time
Yes
Yes  
Yes
 (both questions)
Yes
Yes  
Scoring Basis*
Effective boards are comprised of highly-dedicated persons who collectively 
have the competencies, diversity, and independence that produce constructive, 
well-informed deliberations
Board composition includes at least a majority of voting board members who 
are “independent” (i.e., not a member of a sponsoring body such as a religious 
community, not a full- or part-time employee, and not directly affiliated with the 
system in any way other than serving as a board member)
Substantial racial diversity in board composition
Substantial gender diversity in board composition
Substantial engagement of voting members have clinical (medical and nursing) 
education and experience
Effective boards have clear definitions of their authority and accountability and 
the decision-making responsibility they have allocated to local operating units in 
their system
Where the board is accountable to a higher body, there is a formal, written 
document that specifies the powers reserved to that body
Where the board is accountable to a higher body, there are specific, well-established 
mechanisms through which the board fulfills its accountability to that body
There is a board-approved document that specifies the allocation of responsibility 
and authority between the system and local organizations
The association of responsibility and authority is widely understood and accepted 
both by local and system-level leaders
Effective boards require mutual understanding regarding the respective roles 
of governance vs. management, skillful board leadership, and excellent 
board-management relationships
The board has adopted written descriptions of both the board chair’s and the CEO’s 
role and duties
There is solid agreement among board members and the CEO on the distinctions 
between the chair’s and CEO’s role
The working relationship between the board and the CEO is consistently excellent**
2
2.1
2.2
2.3
2.4
3
3.1
3.2
3.3
3.4
4
4.1
4.2
4.3
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TABLE 31 (continued)
Benchmarks and Related Indicators of Effective Governance Against Which the Health 
Systems were Scored 
1
1
1
1
1
1
2
1
1
1
1
1
Possible ScoreBenchmarks and Related Indicators
Yes, annually or every 
other year  
Yes  
Yes  
Yes
Yes
Yes, for board and 
management positions
Yes, for board or 
management positions
Yes
Yes
Yes  
Yes
Scoring Basis*
Effective boards continuously improve board and CEO performance by setting 
clear expectations, conducting objective evaluation, and taking follow-up actions
The board formally evaluates how well it is fulfilling its responsibilities annually or 
every other year
During the past two years, the board evaluation process resulted in specific actions 
that substantially changed board size, composition, or practices
Board members believe their board’s current board evaluation process is excellent 
and has resulted in substantial improvements in board performance
CEO’s performance is evaluated in relation to established expectations annually
CEO evaluation process produces clear performance expectations for the CEO and 
assesses their actual performance fairly
Effective boards have clear definitions of their authority and accountability and 
the decision-making responsibility they have allocated to local operating units in 
their system
The board has adopted formal succession plans for board and senior 
management positions
Effective boards insist on meetings that are well-organized, focus principally 
on system-level strategy and key priorities such as patient care quality and 
community benefit, and employ board members’ time and energy wisely
The board formally adopts system-wide core measures and standards for quality 
of patient care
The system board regularly receives written reports on system-wide and hospital-
specific performance in relation to established measures and standards for the 
quality of patient care
Within the past 12 months, the board has adopted specific action plans 
directed at improving the system’s performance in patient care quality 
and safety
The board has adopted a formal written statement that defines overall goals and 
guidelines for the system’s community benefit program
5
5.1
5.2
5.3
5.4
5.5
6
6.1
7
7.1
7.2
7.3
7.4
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TABLE 31 (continued)
Benchmarks and Related Indicators of Effective Governance Against Which the Health 
Systems were Scored 
1
1
1
1
7
1
1
1
1
1
48
Possible ScoreBenchmarks and Related Indicators
Yes
Yes
Yes
Always
Yes  
Consensus of the 
system’s board members
Yes
Yes  
Yes
Scoring Basis*
The board requires its local organizations to collaborate with local public health agencies in 
their vicinity in assessing community needs and setting community benefit program priorities
The board requires its local organizations to develop and adopt a formal community benefit 
plan that identifies specific strategies and priorities for its community benefit activities
Well-organized board meetings focused principally on strategic deliberations, rather 
than “receiving information”***
Effective boards intentionally create a culture that nurtures enlivened 
engagement, mutual trust, willingness to act, and high standards of performance
The board consistently demonstrates a healthy and proactive culture including:
(a)   Deep commitment to the system’s mission
(b)   Well-organized board meetings focus principally on strategic deliberations, 
       rather than “receiving information”***
(c)   Tracking system’s performance (clinical and financial) and taking action when 
       performance doesn’t meet targets
(d)   Encouraging robust engagement and respectful disagreement at board meetings
(e)   Atmosphere of mutual trust among board members
(f)   Holding board members to high standards of behavior and performance
(g)   Strong focus on honoring Conflict of Interest and Confidentiality policies 
The board is actively engaged in discourse and decision-making, with most board 
members willing to express their views and constructively challenge each other and 
the management team
Effective boards expect their CEOs to demonstrate exceptional leadership and 
management skills, high personal and professional standards, and strong support 
for the role of governance
The CEO demonstrates strong commitment to board development and on-going 
improvement in governance effectiveness
The working relationship between the board and the CEO is consistently excellent**
All standing board committees (not just some) are staffed by senior members of 
system leadership team
The board routinely holds an executive session at the end of board meetings without 
the CEO and other management staff present
Total Possible Score
7.5
7.6
7.7
8
8.1
8.2
9
9.1
9.2
9.3
9.4
*For items where the scoring is based on the opinions of board members and the CEO, there must be at least 80% agreement on a particular response to identify 
it as the “system position” on that item.  Where only outside board member data is applicable (i.e., excluding the CEO), there must be at least 75% agreement on 
a particular response to identify it as the “system position.”  To obtain a copy of the Data Collection Guide, send a request to Lawrence Prybil at Lpr224@uky.edu
**This indicator relates to Benchmarks #4 and #9
***This indicator relate to Benchmarks #7 and #8
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• Benchmark #4:  “Effective boards require mutual 
understanding regarding the respective roles of 
governance vs. management, skillful board leadership, 
and excellent board-management relationships.”
• Benchmark #9:  “Effective boards expect their 
CEOs to demonstrate exceptional leadership and 
management skills, high personal and professional 
standards, and strong support for the role of 
governance.”
As a group, the systems scores were relatively low (60% 
or less of total possible score) on three benchmarks:
• Benchmark #6:  “Effective boards are committed 
to establishing and continually updating succession 
plans for the board, board leadership positions, 
and, in concert with the CEO, senior management 
positions.”
• Benchmark #7:  “Effective boards insist on meetings 
that are well-organized, focus principally on system-
wide strategy and key priorities such as patient care 
quality and community benefit, and employ board 
members’ time and energy wisely.”
• Benchmark #8:  “Effective boards intentionally  
create a culture that nurtures enlivened engagement, 
mutual trust, willingness to act, and high standards  
of performance.”
Continuous evaluation and improvement is the pathway 
to great performance in all endeavors.  The system-
specific and consolidated information presented in Tables 
32 and 33 shows that all of these excellent health systems 
have opportunities to further improve their governance 
models and suggests some possible areas that warrant 
collective attention. 
Table 32 shows the governance scores for each health 
system. They ranged from a high of 42 to a low of 26; 
the mean score was 33.9, and the median score was 35.128
Table 33 displays consolidated information about all 14 
systems.  For each benchmark it shows the number of 
scorable indicators, the total possible score a system could 
receive, the range of the systems’ actual scores, and — for 
the 14 systems as a whole — their collective mean score.
As with each system’s individual scores, this information 
demonstrates there is considerable variation in the extent to 
which the systems’ board structures, processes, and cultures 
collectively meet contemporary benchmarks of effective 
governance.  On the whole, the systems score high (over 
80% of total possible score) on three benchmarks:
• Benchmark #1:  “Effective boards insist on 
governance policies and structures that facilitate their 
efforts to perform the board’s functions and fulfill its 
responsibilities.”
Study Findings
TABLE 32
Total Governance Scores for All 14 Systems
System A
System B
System C
System D
System E
System F
System G
System H
System I
System J
System K
System L
System M
System N
Score
 42
 40
 39
 38
 36
 36
 36
 34
 31
 31
 30
 28
 28
 26
% of Total Possible 
Points (48)
 88%
 83%
 81%
 79%
 75%
 75%
 75%
 71%
 65%
 65%
 63%
 58%
 58%
 54%
Rank
 1
 2
 3
 4
 5
 5
 5
 8
 9
 9
 11
 12
 12
 14
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TABLE 33 
The Systems’ Collective Scores for the Indicators Related to Each Benchmark
13
3
3
3
5
2
7
8
4
Total 
Possible 
Score
Benchmark
No. of Scorable 
Indicators  Related 
to this Benchmark
Effective boards insist on governance policies 
and structures that facilitate their efforts to 
perform the board’s functions and fulfill its 
responsibilities
Effective boards are comprised of highly-
dedicated persons who collectively have the 
competencies, diversity, and independence 
that produce constructive, well-informed 
deliberations
Effective boards have clear definitions of their 
authority and accountability and the decision-
making responsibility they have allocated to local 
operating units in their system
Effective boards require mutual understanding 
regarding the respective roles of governance 
vs. management, skillful board leadership, and 
excellent board-management relationships
Effective boards continuously improve board and 
CEO performance by setting clear expectations, 
conducting objective evaluation, and taking 
follow-up actions
Effective boards are committed to establishing 
and continually updating succession plans for 
the board, board leadership positions, and, 
in concert with the CEO, senior management 
positions
Effective boards insist on meetings that are 
well-organized, focus principally on system-level 
strategy and key priorities such as patient care 
quality and community benefit, and employ 
board members’ time and energy wisely
Effective boards intentionally create a culture 
that nurtures enlivened engagement, mutual 
trust, willingness to act, and high standards of 
performance
Effective boards expect their CEOs to 
demonstrate exceptional leadership and 
management skills, high personal and 
professional standards, and strong support for 
the role of governance
1
2
3
4
5
6
7
8
9
Range of the 
14 Systems’ 
Scores
The Systems’ 
Collective 
Mean Score
The Mean as
% of Total 
Possible Score
7
3
3
3
5
1
7
2
4
11.4
1.9
2.1
2.5
3.4
1.2
3.8
4.3
3.4
8-13
1-3
1-3
0-3
2-5
0-2
2-6
0-7
2-4
88%
63%
70%
83%
68%
60%
54%
54%
85%
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and many other parties to develop performance 
measurement systems that are fair, practical, and reliable.  
This is complex terrain.  Lots of time and effort already 
have been invested; much more work remains to be done.
Methodologies for measuring the overall performance 
of multi-unit health systems are even less developed 
than methodologies for measuring the performance 
of hospitals, and thoroughly examining the operating 
performance of the 14 large systems in this population 
is beyond the scope of this study.  However, as one 
indicator of the performance of the systems’ hospitals, 
the team obtained the results of a 2012 study conducted 
by Thomson Reuters.129 That study examined the 
performance of private and investor-owned health 
systems using a combination of eight patient care 
measures.  These measures and sources of data are  
shown in Table 34.130 
Operating Performance
As Peter Drucker and many other experts have noted 
over the years, hospitals and health systems are among 
the most complex organizations that exist.  A myriad 
of inputs contribute to determining the cost, quality 
and volume of services they provide for the patients, 
populations, and communities they serve.
Other than standard financial indicators, no universally-
accepted methods for assessing the overall performance 
of hospitals or multi-unit health systems exist.  As the 
Medicare Program and other payors move toward “value-
based payment systems” that provide incentives for 
excellence in patient care and efficiency in cost control, 
major efforts are being made by providers, voluntary 
organizations such as the National Quality Forum, the 
Centers for Medicare and Medicaid Services (CMS),  
Study Findings
TABLE 34
Performance Measures and Data Sources for 2012 Thomson Reuters Health System 
Performance Study
MedPAR FY2009 and 2010
MedPAR FY2009 and 2010
MedPAR FY 2009 and 2010
CMS Hospital Compare, second quarter 2011 release (October 1, 
2009-September 30, 2010 dataset)
CMS Hospital Compare, second quarter 2011 release (July 1, 2007-
June 30, 2010 dataset)
CMS Hospital Compare, second quarter 2011 release (July 1, 2007-
June 30, 2010 dataset)
MedPAR FY 2010
CMS Hospital Compare, second quarter 2011 release (October 1, 
2009-September 30, 2010 dataset)
Data Source and Time PeriodMeasure
Risk-adjusted mortality index
Risk-adjusted complications index
Risk-adjusted patient safety index
Core measures mean percent
30-day mortality rates (AMI, heart failure, pneumonia)
30-day readmission rates (AMI, heart failure, pneumonia)
Severity-adjusted average length of stay
HCAHPS score
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The historical evidence of governance impact on 
organizational performance in various sectors is mixed.133  
However, a growing body of empirical studies supports 
the general proposition that, in the long term, there is a 
positive relationship between the caliber of governance 
and organizational success.134 
This study of governance in large, nonprofit health 
systems was not designed to determine the impact of their 
boards’ structures, processes, and cultures on the systems’ 
operating performance.  The size of the population (14 
of the country’s 15 largest nonprofit health systems based 
on 2010 information) is not sufficient to enable robust 
analysis of this complex topic and, as stated earlier, there 
are no universally-accepted methods for measuring the 
overall performance of health systems including their 
financial, patient care, and community service results.
While recognizing and respecting these constraints, 
the research team did explore the relationships between 
the systems’ scores on the benchmarks of effective 
governance and related indicators shown in Tables 
31-33 and their performance scores on the performance 
measures listed in Table 34.  This analysis did not find a 
statistically significant correlation between the systems’ 
total governance scores displayed in Table 32 and their 
aggregate scores on the eight patient care measures 
included in the Thomson Reuters study.  Positive and 
statistically significant correlations between the systems’ 
total governance scores and some individual patient 
care measures were identified.  These data are not 
sufficiently meaningful or statistically robust to warrant 
solid conclusions; however, they underscore the need for 
further examination regarding the long-term effect of 
governance on organizational performance — and, thus, 
steps that can be taken to ensure that impact is positive.
Study Findings
Of the 83 health systems with over $1.5 billion in 
operating expenses in 2010, 71 were independent, 
nonprofit organizations.  Thomson Reuters was able 
to obtain data for 13 of the 14 systems in this study 
population.  Based on their composite scores on the eight 
measures outlined in Table 34, the rankings of these 13 
systems among the total group of 71 large, nonprofit 
systems ranged from a high of Number 2 to a low of 
Number 52.  The median rank of the 13 systems was 28.   
On this set of measures, the health systems in this study 
population on the whole perform well in comparison to 
other large nonprofit systems.
Governance Impact of Organizational 
Performance131 
In recent years there have been graphic illustrations 
of the adverse impact that ineffective governance can 
have on organizations.  Inadequate board direction 
and/or oversight have been factors in major problems 
encountered by numerous organizations such as 
Allegheny Health, Education, and Research Foundation 
(AHERF), Enron, HealthSouth, Merrill Lynch, British 
Petroleum, and, recently, J.P. Morgan Chase.132   
In these and other situations, poor governance has been 
shown to contribute substantially to poor organizational 
performance and, in some instances, abject failure.  
Common sense would suggest the inverse also should 
be true, i.e., that effective governance should contribute 
in some degree to organizational success.  Examining 
this thesis is complicated by many factors including 
the myriad of variables, both internal and external, that 
affect organizational operations and the difficulty of 
defining and measuring “organizational performance” 
in a consistent, meaningful, and valid manner.  This is 
especially difficult in nonprofit healthcare organizations 
for which classic financial performance measures are 
important but not sufficient and patient care outcomes 
and impact on community health are paramount.
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IV.  Concluding Remarks and Recommendations
As stated in Section I, the purpose of this study is to 
examine board structures, processes, and cultures in a set of 
our country’s largest nonprofit health systems and compare 
them to several benchmarks of effective governance and 
related indicators.  The objectives of the study are to:
• Increase our understanding of governance in large 
health systems;
• Identify and describe some examples of “exceptional 
governance features” that are in place in these systems;
• Identify areas where, on the whole, the governance of 
these systems could be improved; and
• Produce information that can assist CEOs and board 
leaders — in these systems and other healthcare 
organizations — to assess and enhance their boards’ 
effectiveness.
These are turbulent and challenging times for those with 
leadership roles in hospitals, health systems, and other 
healthcare organizations.  For many reasons, the need for 
healthcare services is growing and resource constraints 
are becoming more stringent.  Clinical, executive, and 
governance leaders are being asked by public and private 
payors and many stakeholders to improve access, quality, 
and operational efficiency in ways that can be measured and 
documented.  In the near future, “value-based” purchasing 
programs of various forms are likely to predominate, and 
payment methods will be evidence-based with increasingly 
stringent standards and requirements.  Hospitals and 
health systems increasingly will be expected to focus on 
preventing illness and injuries and improving the health of 
the communities and populations they serve.
In this environment, the duties of governing boards have 
become more complex and demanding.  In recent years, 
organizations with oversight responsibilities for nonprofit, 
tax-exempt hospitals and health systems — including 
bond rating agencies, the IRS, the Joint Commission, 
the Office of the Inspector General, and others — have 
focused increasing attention on governing boards.  
With varying degrees of rigor and specificity, they are 
expecting distinct improvements in board performance, 
transparency, and accountability.
The process of formulating the nine benchmarks of 
effective governance and related indicators addressed 
in this study considered these expectations as well 
as information from other sectors.  The findings of 
this study provide solid evidence that the boards and 
CEOs of the systems in this study population are 
highly committed to the organizations they lead and 
dedicated to improving governance and organizational 
performance.  However, the findings clearly show 
some gaps between current practices and contemporary 
benchmarks of effective governance.  A number of other 
studies regarding governance in hospitals and health 
systems cited in this report reach similar conclusions.  
To meet society’s increasing needs and rising expectations, 
it is apparent that substantial changes will be required 
in healthcare organizations and how they are governed.  
Therefore, the team recommends that board leaders and 
CEOs of nonprofit health systems and other healthcare 
organizations:
1. Conduct an overall review of their board’s role and 
responsibilities in the context of recent and anticipated 
changes in the healthcare environment and in the 
communities they serve.  They must ensure all board 
members clearly understand the impact of these changes 
on their individual and collective duties.
The 14 health systems that participated in this study are 
progressive and, as one illustration, their boards clearly have 
made deliberate efforts to increase the energy and time they 
devote to strategic deliberations and decision-making.  All 
of these boards are in the midst of reforming their board 
agendas and practices in this direction while still providing 
proper oversight of system operations and performance.
However, the findings indicate that even this group of 
boards and their CEOs believe they must continue and 
accelerate the shift toward a greater focus on system-
wide strategy and strategic thinking.  Evidence from 
other studies in the healthcare field and other sectors 
suggest many boards still spend large portions of board 
meetings listening to reports and discussing operational 
issues as compared to active engagement in constructive 
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Societal realities are demanding fundamental changes 
in the mission and goals of public and private health 
organizations and the services they provide to their 
communities.  Stakeholders want assurance that nonprofit 
hospitals and health systems deserve tax-exempt status 
and are meeting high-priority community needs and that 
public health agencies are performing essential functions 
efficiently and effectively.  Concurrently, the historic roles 
of hospitals and health systems and public health agencies 
are evolving as all parties recognize that prevention of 
illness and injuries, early detection and treatment, and 
intentional promotion of wellness in all sectors of the 
population are imperative.  Better communication and 
closer collaboration among health systems and public 
health agencies increasingly are essential.  Therefore, if 
they haven’t already done so, the team recommends that 
board leaders and CEOs of nonprofit health systems and 
other healthcare organizations: 
4. Charge a standing board committee with oversight 
responsibility for system-wide community benefit 
policies and programs and the organization’s role and 
priorities in the realm of population health.  It is time for 
a fresh look at traditional practices and relationships — 
and for new approaches that will serve our communities 
better and more efficiently.
The idea of building stronger, more durable linkages 
between the private and public sectors of the health field 
and instituting new models for promoting population 
health has important implications for traditional practices 
in both sectors.  Among them are the need to re-think 
the organizations’ fundamental roles and accountabilities. 
It has been customary for many nonprofit hospitals and 
health systems to declare a principal accountability to the 
“community or communities they serve.”  This clearly 
is appropriate; however, the mechanisms, methods, and 
metrics for fulfilling that accountability often are under-
developed and imprecise.  In an era where governmental 
bodies with regulatory and/or oversight responsibilities 
and society at-large are scrutinizing nonprofit 
organizations more closely than ever before, the question 
Concluding Remarks and Recommendations
dialogue about strategic challenges and opportunities.  
Therefore, the team recommends that board leaders and 
CEOs of nonprofit health systems and other healthcare 
organizations: 
2. Candidly re-examine their board and board committee 
agendas and practices, with a focus on how the meetings 
are structured, how topics are selected, expectations 
regarding the distribution and review of materials in 
advance of meetings, and pragmatic steps that can and 
should be taken to enable the board to devote more time 
and energy to strategic deliberations.  The effectiveness 
of changes that are made should be evaluated on an 
on-going basis with strong commitment to continual 
improvement. 
Achieving excellence in any endeavor requires 
commitment to on-going evaluation and improvement.  
Particularly in a dynamic environment, forthright 
assessment and timely changes are essential to 
organizational survival and success.  Evidence from many 
studies indicate that board evaluations often become a 
formality, a pro forma exercise that involves completing 
standard questionnaires and leads to reports that are 
accepted with little deliberation and produce little or no 
action.  This is an approach that wastes time, perpetuates 
the status quo, and does not improve board structures, 
practices, culture, or performance.  Therefore, the team 
recommends that board leaders and CEOs of nonprofit 
health systems and other healthcare organizations:
3. Engage in a thorough assessment of their existing 
“board evaluation” processes and practices with the 
intent of either improving them or, depending on 
the findings, totally replacing them with better, more 
progressive models.  The goal is to have vibrant, 
outcome-oriented evaluation processes — formal 
and informal — that consistently generate action and 
improve the effectiveness of boards, board committees, 
and board leadership.  Retaining expert, independent 
parties to facilitate the re-examination of current board 
evaluation protocols may be helpful in this initiative.
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Therefore, the team recommends that board leaders and 
CEOs of nonprofit health systems and other healthcare 
organizations:
6. Mount concerted initiatives — in partnership with 
their clinical leadership teams, other health systems, 
voluntary associations, and independent experts in 
this area — to define more clearly the roles that boards 
and board committees can and should play in today’s 
environment with respect to patient care quality and 
safety.  In that context, the information (volume, 
content, and format) that will facilitate board members’ 
understanding and ability to perform their duties 
effectively should be identified and provided.135 
A large proportion of the board leaders and CEOs in 
the health systems in this study population recognize the 
tremendous importance of thoughtful, well-organized 
leadership succession planning programs for boards, 
board leadership positions, and system management 
positions.  Most of these systems already have some 
type of succession planning programs in place — and, 
thus, appear to be somewhat ahead of most healthcare 
organizations.  However, nearly all of these board leaders 
and CEOs view their present programs as “work-in-
progress” that need further development.  Therefore, 
the team recommends that board leaders and CEOs 
of nonprofit health systems and other healthcare 
organizations:
7. Make the development of top-notch leadership 
succession planning programs for boards, board 
leadership, and senior management a system-
wide strategic priority.  The basic components of 
comprehensive succession planning programs are 
identified in Section III of this report.
of these organizations’ accountability — to whom, for 
what, and how it can be fulfilled effectively — warrants 
attention.  Therefore, the team recommends that board 
leaders and CEOs of nonprofit health systems and other 
healthcare organizations:
5. Collaborate with professional associations and legal 
experts in developing better methods and practices to 
enable their organizations to be properly accountable 
to the communities and populations they are chartered 
to serve.  This process can and should be open to 
new definitions and protocols that provide greater 
transparency and new metrics.   
Strong, effective oversight of patient care quality and 
safety is, without question, one of the most fundamental 
duties of hospital and health system boards.  Among 
clinical, governance, and management leaders, there now 
is broad recognition that the overall quality of services 
provided by our country’s hospitals and health systems is 
uneven and needs to be improved.  During recent years, 
this realization — coupled with the movement toward 
evidence-based medicine and value-based purchasing 
programs — has produced enormous growth in quality 
improvement programs and metrics.  This trend is 
important and necessary; however, one consequence 
is that hospital and health system boards often are 
presented with reports on patient care quality and safety 
that include an extensive array of highly-detailed metrics 
and data that, for many board members (including 
executives and clinicians) are too voluminous and difficult 
to comprehend.
The boards and CEOs of the large systems in this study 
population clearly are focused on meeting their oversight 
responsibilities with respect to patient care quality and 
safety.  However, along with their counterparts in other 
health systems, they would benefit from improvements 
in the content and form of information they receive 
as the basis for deliberation.  Too many boardrooms 
are awash in quality and safety “data”; what the boards 
need is more concise and understandable information.  
Concluding Remarks and Recommendations
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For these boards — and the boards of most other 
healthcare organizations — frank, objective appraisal 
of their existing boardroom culture is likely to identify 
practical steps that, if taken, will strengthen the culture 
and, in doing so, improve the board’s performance.  
Therefore, the team recommends that board leaders 
and CEOs of nonprofit health systems and other 
organizations:
8. Undertake an objective appraisal of the boardroom 
culture that currently prevails within their organization 
and determine steps that can be and should be taken to 
make it healthier and more effective.
It is the team’s belief that these eight recommendations 
are evidence-based and warrant consideration by the 
systems that participated in this study and by other 
healthcare organizations.  It is our view that devoting 
some time and energy to considering them will prove to 
be a good investment that will pay long-term dividends 
for each board, the organization it governs, and the 
population and communities it serves.
After some consideration and reflection, it is paramount 
for boards to identify and prioritize the particular issues 
they believe are most important, assign responsibility, 
and set a timetable for taking action.  Focusing on 
carefully-established priorities will enable prudent use of 
board and staff time and increase the likelihood of solid 
improvement in board practices and performance. 
Concluding Remarks and Recommendations
In the healthcare field and other sectors, there is growing 
evidence that boards with a culture that consistently 
demonstrates commitment to high standards, mutual trust 
among board members and management leadership, robust 
engagement in the work of the board, and willingness 
to take action are more likely to perform well than other 
boards.  As stated recently by Pamela Krecht and Karma 
Bass, “A healthy culture at the very top of an organization 
can create a spillover effect to the organization as a whole.  
With all the changes facing [healthcare] organizations 
today, a healthy culture can be a key differentiator in 
facilitating an organization’s success.”136 
The findings of this study show the system boards and 
CEOs are highly committed to their organization and 
its mission.  However, with respect to several other core 
characteristics of a healthy culture, many senior board 
leaders and CEOs perceive their boardroom cultures 
as uneven.
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Appendix A – Limitations of the Study
The methodology employed in this study has several 
limitations.  They include:
• The study population was limited to 14 of the 
country’s 15 largest private, nonprofit health systems 
in 2010 using AHA data and a blend of three 
measures of size:  total annual operating expenses for 
the system’s hospitals, the number of hospitals in the 
system, and the number of counties in which those 
facilities are located.  The findings and conclusions 
relate directly to exceptionally large, nonprofit 
systems; they cannot be generalized to systems of all 
types and sizes.
• The study has focused on comparing board structures, 
processes, and cultures in a set of very large health 
systems to nine benchmarks of effective governance and 
34 related indicators.  These benchmarks are pertinent 
to the governance of large systems, and the indicators 
are considered to be reasonably well-established and 
measurable.  There certainly are other benchmarks that 
merit attention by CEOs and board leaders but, due to 
constraints including the unavailability of measurable 
metrics and/or objective scoring techniques, these are not 
addressed in this study.
• This report presents the views of system CEOs and 
board members regarding their particular board’s 
structure, selected processes and practices, and 
cultures.  A structured interview guide was employed, 
and there were substantial follow-up communications 
after the site visits to clarify questions and obtain any 
missing data elements.  Also, information obtained 
from system documents and staff members were 
employed to supplement and, where possible, verify 
the interview data.  However, those data represent 
the participants’ perceptions and may or may not be 
factually correct in some instances.  Opinion data 
have inherent limitations, and there are bound to be 
some inaccuracies in the team’s interpretation and 
summarization of those data.
• The tests employed in this report to determine  
the statistical significance of observed differences  
(chi-square test, two-sample test of binomial 
proportions, and Fisher’s exact test) and correlations 
(Pearson’s product-moment and Spearman’s rank 
correlation coefficient) are appropriate for this data 
set.  However, due to the relatively small size of the 
study population, some of the testing procedures 
do not have sufficient power to detect and precisely 
estimate actual differences and correlations.
• This study examined certain aspects of board 
structures, processes, and cultures in a set of large 
nonprofit health systems and compared them 
to nine benchmarks of effective governance and 
related indicators.  Clearly there is great need 
and opportunity for more research regarding the 
governance of both nonprofit and investor-owned 
healthcare organizations.  As one example, we would 
encourage studies designed specifically to examine 
relationships between selected features of board 
structures, processes, and cultures and measures  
of organizational performance.
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Appendix B – Selected Features of the Participating Systems’ 
Governance Models
Adventist Health System
Altamonte Springs, Florida
Compensation Philosophy
The current philosophy of Adventist Health System in compensation dates from the mid 1990’s. Prior to that time, 
our system did not even use a market-based approach, but had an extremely conservative wage structure tied to some 
Church approved principles.  
When it was agreed the time had come to adopt a market-based approach, our System’s governance and management 
leadership team was determined to have a program that met all of the requirements that could be expected of a 
501(c)3 organization, but also wanted the philosophy, while market-based, to be conservative. Attachment A is a 
statement of our System’s Board-approved compensation philosophy.
Also, governance and management leadership decided the Compensation Committee should take actions that would 
generate confidence in and support for the compensation system by establishing processes and procedures that went 
beyond the IRS standards for obtaining the rebuttable presumption of reasonableness.
A governance practice we started at the time, and even up to the current day has never been required by external 
parties, is to have the System’s external auditor annually review the actual implementation of the compensation 
program to ensure management has carried out the instructions of the Compensation Committee without exception.  
That practice has now been in place for several years.  To date there has never been an instance where a compensation 
action has been out of line with the Committee’s instructions or a variance that was inconsistent with the authority 
given by the Committee to the CEO of the company.  
The fact that the actual administration of wage and benefit practices is independently audited, we believe is, a very 
beneficial practice that may not be employed by some health systems.  It gives our Board and its Compensation 
Committee additional comfort and protection and, in addition, protects management from any chance of being 
criticized for doing something which is not authorized by the Compensation Committee. 
Donald Jernigan, Ph.D.
President and CEO, Adventist Health System
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1. COMPENSATION PHILOSOPHY 
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executives believe themselves to be agents of the church’s medical ministry, wages are more 
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annual net revenue of the employing organization as well as a careful review of each executive’s core 
responsibilities. 
 
Salary maximums are established using the following principles: 
• The AHS CEO base salary shall not exceed the 40th percentile of comparable CEO positions 
nationwide. 
• Other leadership base salary shall relate to the 50th percentile of national market data. 
• Small hospitals may exceed the 50th percentile as necessary. 
• Geographic adjustments may be approved where necessary. 
Other compensation: 
• Flex Benefit percent at market median 
• Incentive bonus opportunity at market median for the respective position 
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• The committee will select their Advisor from qualified professionals who specialize in healthcare 
executive compensation. The Committee shall provide direction to the Advisor with regard to 
AHS compensation philosophy and practices which will form the basis for a compensation study 
and then commission the review of all executive wage ranges, benefit and bonus levels by their 
Advisor. 
• The compensation study for all AHS executive positions will be performed every other year. 
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• As necessary, the Committee will review and approve any changes to the executive Flex Benefit 
and Accountability plans. 
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Ascension Health
St. Louis
Integrated Strategic, Operational 
and Financial Plan
A key governance feature for Ascension Health is the annual Integrated Strategic, Operational and Financial 
Planning (ISOFP) process.  Ascension Health senior leaders and Board of Trustees utilize the ISOFP as a vehicle 
to ensure that the System is generating the resources required to sustain the national health ministry and its mission 
into the future and is implementing strategies that will ensure the accomplishment of Ascension Health’s Strategic 
Direction. The Strategic Direction (Figure 1) calls the national health ministry to fulfill its promise to those it serves 
by providing Healthcare That Works, Healthcare That Is Safe, and Healthcare That Leaves No One Behind, for 
Life through a clarified focus on a person-centered approach that fosters the potential for continuous, dynamic 
relationships with those served. This will be made possible by four Enabling Strengths: Inspired People, Trusted 
Partnerships, Empowering Knowledge and a Vital Presence in meeting the evolving needs of the communities served. 
In their annual Integrated Strategic, Operational and Financial Plans (ISOFP), each of Ascension Health’s Health 
Ministries describes their strategic, operational, financial and capital plans and highlights their current and planned 
participation in the components of Ascension Health’s Strategic Direction over a five-year period.  The ISOFP 
utilizes the seven components of Ascension Health’s Strategic Direction as the organizing construct.  Figure 1 
highlights how certain Health Ministry strategic initiatives fit with the components of Ascension Health’s Strategic 
Direction.  
As an integrated plan, the ISOFP connects Health Ministry strategic plans to capital requirements, operational plans, 
financial plans and budgets, and therefore is a collaborative effort among Health Ministry finance, operational and strategy 
leaders.  In addition, the ISOFP process incorporates a set of principles that create the foundation for Ministry stewardship, 
including strategic relevance, operational excellence and financial health.  
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Ascension	Health	
St.	Louis,	Missouri	
Integrated	Strategic,	Operational	and	
Financial	Plan	
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accomplishment of Asce sion Health’s Strategic Direction. The Strategic Direction (Figure 1) calls the 
national health ministry to fulfill its promise to those it serves by providing Healthcare That Works, 
Healthcare That Is Safe, and Healthcare That Leaves No One Behind, for Life through a clarified focus on 
a person‐centered approach that fosters the potential for continuous, dynamic relationships with those 
served. This will be made possible by four Enabling Strengths: Inspired People, Trusted Partnerships, 
Empowering Knowledge and a Vital Presence in meeting the evolving needs of the communities served.   
 
In their annual Integrated Strategic, Operational and Financial Plans (ISOFP), each of Ascension Health’s 
Health Ministries describes their strategic, operational, financial and capital plans and highlights their 
current and planned participation in the components of Ascension Health’s Strategic Direction over a 
five‐year period.  The ISOFP utilizes the seven components of Ascension Health’s Strategic Direction as 
the organizing construct.  Figure 1 highlights how certain Health Ministry strategic initiatives fit with the 
components of Ascension Health’s Strategic Direction.   
 
Figure 1 
Current Work / Initiative  Fit with Strategic Direction Component 
Create an Exceptional Patient Experience   Healthcare That Works 
Implement Physician Engagement Strategies  Healthcare That Is Safe 
Build Community Coalitions that Address Public Health 
Issues (e.g., childhood obesity) 
Healthcare That Leaves No One Behind 
Implement Initiatives to Optimize Associate Health   Model Community 
Forge Partnerships With Post‐Acute Care Providers  Trusted Partnerships 
Deploy Electronic Health Records  Empowering Knowledge 
Develop Unique Health Services for Seniors   Vital Presence 
 
As an integrated plan, the ISOFP connects Health Ministry strategic plans to capital requirements, 
op rational plans, financial plans and budgets, and ther fore is a c ll borative effort am ng Health 
Ministry finance, operational and strategy leaders.  In addition, the ISOFP process i orpora es a set of 
principles that create the foundation for Ministry stewardship, including strategic relevance, operation l 
excellence and financial health.   
 
Strategic relevance is the ability to pursue strategies that ensure accomplishment of the 
Strategic Direction, appropriate services are provided by the Health Ministry or in partnership 
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 Strategic relevance is the ability to pursue strategies that ensure accomplishment of the Strategic Direction, appropriate  
 services are provided by the Health Ministry or in partnership with others, programmatic development is relevant to the  
 current and future needs of the communities served and a vital presence is maintained in the community. 
 Stewardship of the Mission and its long-term preservation calls each Health Ministry to be operationally excellent and  
 ensure that high quality, safe clinical services are provided in the most efficient manner, productivity is maintained at or  
 better than benchmark levels and high-value support services are provided to operations.
 Financial health is the ability of leadership to optimize Health Ministry financial performance to fund care for  
 persons who are poor and vulnerable, short-term capital needs, replacement of the long-term assets, sufficient resources  
 for programmatic development, resources for investing in transformational opportunities and resources during economic 
 downturns.
Ascension Health’s Ministry Market Leaders1 assume shared accountability for assessing the strategies and quality of the 
ISOFPs and hold review meetings with each of the Health Ministries in their market prior to ISOFP submission to the 
System Office.  The objectives of these meetings are to: 
 1. Confirm that the ISOFP was developed with a high level of rigor.
 2. Assess the level of collaboration between finance, operations and strategy leaders.
 3. Validate that mechanisms are in place to monitor ISOFP progress and close gaps in performance.
 4. Ensure that Health Ministry leaders are committed to the achievement of the ISOFP.    
The consolidated System ISOFP is eventually presented to the Ascension Health Board Finance Committee and 
full Board of Trustees each June for approval and serves as a key input to Ascension Health’s Developmental Model 
(Attachment A) which supports the tracking of Strategic Direction initiatives from early development to full operations.  
Ascension Health’s senior leaders and Board of Trustees also utilize an Integrated Scorecard to set annual goals, align 
incentives and measure the progress that each Health Ministry is making in delivering on the System’s Strategic Direction 
commitments. 
Anthony R. Tersigni, Ed.D.
President and CEO, Ascension Health Alliance
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1Ascension Health’s Health Ministries are organized into eight regional Ministry Markets (e.g., New York/Connecticut, Gulf Coast/North 
Florida).  Each Ministry Market is led by an executive, the Ministry Market Leader.   
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Banner Health
Phoenix, Arizona
Culture Trumps All Other Variables 
for Success
The success of the Banner governance model really focuses on a few key behavioral approaches that have driven 
organizational success and demonstrate that culture supports behaviors which drive organizational performance.  
First, it has become clear that our operating company model, both at a management level and at a governance level, 
is quite complementary.  The focus is on a willingness to challenge conventional truths and each other fearlessly 
without making the issue personal.  This has allowed the board to feel a sense of freedom in debating and considering 
those organizational variables associated with long term success as it relates to strategy, financial stability and clinical 
performance — both with the management team and with themselves.  This has created a safe environment to 
engage and has created clarity around what is a management responsibility and what is a governance responsibility.  
This clarity of role and responsibility has maximized the use of skills. Banner Health’s “2020 Vision” is depicted in 
Attachment A.
Second, while Banner Health was originally created by consolidating two previously separate organizations, the 
company was designed and built in a manner that left no opportunity in the future to deconstruct. That forced a focus 
on future success and viability rather than old traditions and past loyalties.  Therefore from a behavioral perspective, 
the desire or need to maintain a constituency behavior model disappeared. It has enabled system leaders to recognize 
they are here to create a new company and lead it rather than defend the wishes and desires of past constituencies. 
The original board, which was created in September 1999 when the organizations came together, was made up of 
several members from each of the prior organizations (Samaritan Health System and Lutheran Health System) and 
they jointly recruited a fifteenth member from outside of their respective organizations.   
Third, the board developed a behavior that calmly considers difficult issues thoughtfully and candidly. This enables 
them to confront issues quickly without emotion but with logic. It also creates an environment that limits things  
from going unsaid and creates a healthy, engaged and productive culture.
Fourth, the structure of board meetings has created a behavior that emphasizes focus and preparedness. The board 
meets four times a year and the meetings span 2-3 days.  Because of this concentrated time period and the fact that 
the committee meetings occur in the early part of the 2-3 day meetings, there is no opportunity for relaxation time. 
The days are very packed which requires board activities to be focused. As a result, if someone is not well-prepared 
ahead of time, there is little opportunity to catch up during the educational program, committee meeting, or full 
board meeting. As a result, board members are highly engaged and participate actively.
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Organizational success starts with the Board and the members’ ability to work together in an efficient and effective 
manner focusing the organization on key critical success factors. By doing that properly, management will stay 
focused on what they do best and the Board will stay focused on what it does best — and, at the same time, making 
sure that they are meeting all of their fiduciary responsibilities and guiding the organization forward. As stated by  
Mr. Wilford Cardon, long-time Board chair:
“The Banner Board is successful because no board member represents a particular constituency which allows us to 
openly debate without fear of reprisal.  We disagree without being disagreeable.  We encourage differing opinions 
defended with facts.  However, because the Board understands that the only authority of the Board is in our collective 
decision not in our individual opinions, after a robust discussion and a vote, we all coalesce around the collective 
decision of the Board and unite with management to implement our collective decision in support of our mission.”
Peter Fine
President and CEO, Banner Health
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Carolinas HealthCare System
Charlotte, N.C.
Competency-Based Board Selection
The board of commissioners of Carolinas HealthCare System (“CHS”) uses a competency-based board selection 
process and a robust system for continuing education to build and maintain a stable, high-functioning board. The 
board devotes substantial effort to identifying potential candidates for board membership and clearly articulates 
to each candidate that the board considers board membership to be a long-term commitment on both sides. This 
dedicated focus on board development and succession planning has been consistent for decades.
The process for selection as a member of the board starts with the ongoing review of the collective competencies 
of the board and an examination of what competencies should be developed or supplemented. The nominating 
and governance committee (the “committee”) looks to identify and recommend potential board members who will 
contribute to the mix of skills of the board and who will approach board service as a long-term commitment. The 
committee evaluates each prospective nominee’s demonstrated interest in the health and welfare of the general 
public, strength of character, mature judgment and relevant technical skills. Further, the committee considers the 
performance of incumbents in determining whether to nominate them for re-election or re-appointment. The 
practice of approaching board development with a view to the long-term is a major factor in the stability and 
quality of the CHS board. At its last regularly scheduled meeting of each year, the board receives and acts upon the 
committee’s recommendations for a new class of commissioners to replace those whose terms will expire at the end  
of the year.
In addition to having a board of commissioners, CHS has a board of advisors that advises the CEO, the chairman, 
and the board of commissioners concerning matters relating to CHS’s facilities. Members of the board of advisors 
are appointed by the chairman of the board of commissioners, based on recommendations from the nominating 
and governance committee, and from residents of communities served by CHS who have demonstrated an interest 
in the health and welfare of the general public. In some respects, the board of advisors serves as a training ground 
for potential members of the board of commissioners. The board of advisors meets concurrently with the board of 
commissioners and members of the board of advisors participate with members of the board of commissioners on 
board committees and board educational sessions and conferences. This structure affords members of the board of 
advisors an outstanding “on-the-job” opportunity to learn about CHS and the healthcare sector prior to joining the 
board of commissioners.
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The board utilizes a robust committee structure that allows board members and management to devote appropriate 
time to explore together specific areas where board oversight is desirable; e.g., strategic planning committee; 
finance and compliance committee; and quality care and comfort committee. The board attempts to rotate board 
members among the several committees over time, taking into account individual board member preferences and 
each committee’s needs. In other words, a board member might serve several years on the quality care and comfort 
committee and then rotate off that committee to spend several years on the finance and compliance committee. 
Board members may also serve on more than one committee simultaneously depending upon expertise, interest and 
time available. This practice of rotating board members among the board committees provides board members the 
opportunity to learn more about specific areas of the organization and to develop, over time, a comprehensive picture 
of the organization.
The CHS board of commissioners relies on thoughtful, intentional selection of board candidates, utilization of a 
board of advisors and an organized approach to board committee service to build and maintain an excellent governing 
board. These structures and practices have helped CHS enjoy stability, clinical excellence and financial strength. 
Michael C. Tarwater, FACHE
President and CEO, Carolinas HealthCare System
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Catholic Health East
Newtown Square, Penn.
Development of Lay Leaders 
in Catholic Healthcare
Like most Catholic health care organizations nationwide, Catholic Health East (CHE) has been focused for some  
time on ministry formation - the grounding and development of lay leaders in the healing ministry of Jesus Christ  
and the foundations of Catholic health care – in order to secure the future leaders of our organizations. 
Following a fairly recent CEO transition and newly appointed Senior Leadership Team, all of whom were internal 
candidates, it became apparent that an entire new bench of lay leaders would need to be developed for senior-level 
management positions across the system. To help make this happen, leadership development became a top priority  
for the organization. This function transitioned from the human resources department to the president’s office, and 
gained both board and CEO level sponsorship of a sustained focus on succession planning.  
Building on foundational ministry formation work that was firmly established in the organization, it was decided that 
integrating ministry formation, classic leadership development and succession planning efforts would expedite building 
the needed leadership bench strength. To achieve this integration, the CHE Ministry Leadership Academy was 
established. Its purpose is to:  
•	 Continue	the	development	a	cadre	of	committed	well-formed	lay	leaders	into	servant	leaders	who	are	
transformative stewards of their health care ministries – the “sweet” spot where ministry, transformational  
and operational leadership overlap, and 
•	 Facilitate	smooth	succession	of	Regional	Health	Care	Corporation	(RHC)	CEOs	and	CHE-level	senior	
management teams positions in the near-term future.  
The curriculum framework is predicated on integrating three forms of leadership (see Attachment A), which are 
expressed in three learning objectives:
1. Ministry Leadership – integrate the core elements of ministry formation into policies, structures and the 
organization’s culture so that Catholic identity explicitly informs the work of the ministry and directs its daily 
operations.
2. Transformational Leadership – establish leadership capabilities essential to a ministry’s ongoing agility, innovation 
and growth.  
3. Operational Leadership – determine how to define, align and integrate core functions effectively throughout the 
organization.  
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The first cohort is comprised of 20 individuals who have been identified as “top talent”, either as part of our annual 
talent review process or strongly recommended by local leadership. Top talent is defined as individuals who currently 
exceed expectations in terms of the CHE Leadership Competencies, CHE Core Values and performance at the 
RHC-level. They act like leaders and demonstrate the capability of advancing to a significantly broader or more 
complex role within the next two to three years. Participants were also required to have actively participated in and 
completed Excellence in Ministry - CHE’s executive-level ministry formation program. Lastly, they needed to have 
a track record of leadership effectiveness and career aspirations consistent with CHE’s organizational and strategic 
needs.  Each cohort’s engagement is two years in duration. The current plan is to form three cohorts which will 
provide us 50 “ministry-ready” leaders within the next five years. 
Catholic Health East established a partnership with Seton Hall University to develop and deliver the program. Seton 
Hall is providing faculty from their Institute of Catholic Studies and Schools of Theology, Healthcare Sciences, 
Theology, Business & Law. We also involve adjunct faculty from other notable institutions and organizations. Because 
of the affiliation with Seton Hall, participants earn a leadership certificate upon completion that will be recognized in 
the broader Catholic community.  
The design is highly interactive, and responsive to current organizational challenges and opportunities. The established 
expertise of the academy participants is actively incorporated while simultaneously encouraging them to deepen their 
understanding of the essence of Catholic health care and how it should influence their leadership identity. The faculty 
sit with the participants and all share responsibility for the learning environment and the content. “Real” organizational 
work is brought into the various learning platforms — classroom sessions, exposure opportunities, inter-organizational 
rotations and inter-session contacts — in an Action Learning approach. This ensures the learning occurs in the context 
of real-life issues and situations and advances the “real” work of the organization at the same time. 
Prior to inviting an individual into the Academy, there are conversations confirming his/her career aspirations, 
identifying the specific CHE position(s) they will be prepared for during their Academy experience and an individual 
development plan is outlined that specifies everything required to ensure their readiness upon completion. Review of the 
Academy’s content and the participant’s growth is a standing agenda item for the Board’s Leadership & Compensation 
Committee. We also will measure the Academy impact by the number of “ministry-ready” individuals who are available 
to fill key positions when we need them, as well as the degree to which the participants can articulate how they have 
internalized and evolved into servant leaders who are transformative stewards of their health care ministries.  
 
Judith Persichilli
President and CEO, Catholic Health East
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Ministry Leadership 
 
Participants will strategize how to 
integrate the core elements of 
ministry leadership into policies, 
structures and organizational culture 
so that Catholic Identity explicitly 
informs our ministry’s life and 
directs its daily operations. 
Transformational Leadership 
 
Participants will strengthen the 
transformational leadership skills 
essential to their ministry’s 
ongoing agility, innovation and 
growth. 
Operational Leadership 
 
Participants will acquire an in-depth 
understanding and increased capability 
with operational leadership – how to 
define, align and integrate core functions 
effectively throughout the organization. 
To create servant 
leaders who are 
transformative 
stewards of their 
healthcare 
ministries 
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Catholic Health Initiatives
Englewood, Colorado
The Catholic Health Initiatives 
Discernment Process
Leading and governing Catholic health care ministries call us to balance key principles and values as we make critical 
decisions in the best interests of those we serve. 
Catholic Health Initiatives has developed a comprehensive discernment process to guide leaders and boards 
in making crucial operational and strategic decisions (Attachment A).  The Catholic Health Initiatives (CHI) 
Discernment Process focuses on the questions, “What is God calling us to do in light of our mission, vision and 
core values?”  “How do our decisions best translate our ministry into the future?” Discernment respects the presence 
of God’s Spirit and creates an environment conducive for the Spirit to act among us. It empowers participants to 
speak their truth courageously, in deep reverence for each person; listen attentively to the perspective of those whose 
viewpoints may differ from their own; and open their hearts carefully to hear God’s deepest wisdom in the voices  
of those around the table. 
The CHI Discernment Process is rooted in a values-based decision-making process that guided the health system 
through its first decade of development. While many of the steps in the discernment process are found in other 
significant business decision-making models, CHI’s process is distinctive in how it incorporates prayer and quiet 
reflection at key intervals throughout the process, and how it guides participants to reach, implement and evaluate 
decisions based on the system’s mission and core values. The process calls for careful consideration of who will be 
impacted by the decision and who will own the decision. It acknowledges the potential conflict among competing 
values and engages participants in identifying what values are affirmed and negated in potential actions.   
The CHI Discernment Process begins with focused prayer and guides participants to analyze a situation by  
defining the issue thoroughly, framing different perspectives and implications, and identifying and weighing possible 
alternatives. The process guides participants to reach a resolution based on balancing core values and how the decision 
will uphold the system’s mission and vision. Once the decision is reached, the process calls participants to define how 
the decision will be implemented, communicated and evaluated.    
The CHI Discernment Process provides a comprehensive, consistent framework to evaluate strategic and operational 
actions in light of the system’s mission, core values and ethics. Every leader in CHI reviews and practices the 
discernment process at a leadership orientation session. Board members at national and local levels across the system 
are also introduced to the process during their orientation sessions. It is expected that the CHI Discernment Process 
is used for making critical decisions that impact the ministry. These are decisions that have far-reaching effects on 
those served by the ministry today and well into the future, including acquisitions, divestitures, partnerships, mergers 
and capital allocations.  
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A CHI Discernment Process workbook outlines the steps of the process and includes a resource directory to support 
teams in their discernment process. The workbook enables participants to align their notes and resources with the 
steps of the process, thereby increasing the ease of thoughtful reflection as they deliberate the decision. The process 
details steps that, oftentimes, take place over time rather than any one moment. Perspectives emerge only as questions 
are asked and decisions are made when participants are ready to commit to a course of action in the name of Catholic 
Health Initiative’s mission and core values.
Kevin Lofton
President and CEO, Catholic Health Initiatives 
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Catholic Health Partners
Cincinnati Ohio
System Scorecard and Executive Evaluation
Creating a System Scorecard to measure strategic progress, while simultaneously integrating this tool into the 
Executive Evaluation Process, has been an important tool for advancing CHP’s culture and strategy. Over the past 13 
years this Scorecard has focused our culture to emphasize quality and performance results. It has also created a healthy 
balance between team work and individual performance while advancing the System’s Mission through prioritized 
strategic objectives.
CHP has evolved a balanced evidence-driven scorecard benchmarked to top quartile results across a spectrum of 
strategy-driven quality, human resources, and stewardship measures. The Scorecard is a by-product of the System’s 
Strategic Plan and is used to evaluate the corporate office team and the regional teams in our System by their 
respective Boards (Attachment A). 
Ultimately, the Scorecard determines gain sharing awards for all of CHP’s 35,000 associates. The Scorecard consists 
of four distinct parts and approximately 20 individual measures. Part 1 of the Scorecard focuses on outcome measures 
for quality, human resources and stewardship. Part 2 of the Scorecard measures progress on system wide strategic 
initiatives and is more process oriented (i.e. implementing a standard digitized health record throughout CHP). Part 3 
of the Scorecard focuses on individual objectives related to the leader’s particular position. Finally, Part 4 is a threshold 
or a screen that determines the eligibility for incentive compensation for the entire team. There are three thresholds 
(community benefit, quality and financial) or screens that must be achieved before the incentive compensation is offered 
to associates. The Part 1-3 results then determine the level of incentive compensation for the individual and the team. 
Fundamentally, the Scorecard has driven our Board conversations – markedly moving those conversations from financial 
issues to quality and talent management issues.
The Scorecard creates teamwork because the top 600 leaders in CHP have it incorporated into their individual 
evaluations. The Scorecard creates focus because it forces management and the boards to identify, define and measure 
the key strategic objectives for the year. The structure of the Scorecard allows results to be customized for regional team 
performance and also consolidates results for the corporate office leaders. Part II of the Scorecard allows for promotion 
of system-wide initiatives across all Regions and Part III of the Scorecard allows for a focus on individual performance 
priorities.
The Scorecard as a whole creates concrete measures for living our Mission that are approved by our boards each year.
Since inception, the Scorecard has had almost 50% of the objectives devoted to quality. The attached Scorecard has 9 
quality-focused objectives: preventable harm, inpatient mortality, readmission rate, LOS, inpatient experience, diabetes 
measures in physician practices, CarePath implementation, CMS core measures and patient safety culture survey results 
from AHRQ. This commitment to excellence and quality helps bring our values to life in our evaluations.
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At year end, the System’s Scorecard results are compared to both targets and top quartile national benchmarks.  
Each Board member then assesses these results and individually scores each objective. These Board scores are then  
used by the full Board to complete the Executive Evaluation Process.
The Scorecard is the core of our executive evaluation process and drives our culture and Mission by explicitly defining 
and measuring our priorities. That process also incorporates a rigorous 360 assessment (colleagues and direct reports) 
and behavioral assessment (CHP Board members and Regional Board members).
As part of the CHP executive compensation process, independent auditors perform a review of the CHP Incentive 
Compensation Plan to validate the accuracy of data reported on the System Scorecard, as well as the reported system 
thresholds. Additionally, an audit to validate the accuracy of CHP Board evaluation scores, as summarized for the 
Compensation Committee review is provided. Attachment B is a diagram of the CHP Executive Performance 
Evaluation Model.
Michael Connelly
President and CEO, Catholic Health Partners
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2011 Annual Plan
CHP System Scorecard
as of 1/20/2012
TARGET BENCHMARK CURRENT STATUS
0.24% 0.19%
0.22% 
Harm Measures, by 
definition, are usually 
preventable.  
"Benchmark" is 
Premier Top Quartile. 
Benchmark includes 
hospitals with 
preventable harm 
events
0.17%
(284 patients 
harmed)
December YTD
Through December, there has been a 56% reduction in harm from our 2008 baseline and a 29% reduction 
compared to last year in the five (5) harm measures used for the Part 1 objective.  Current performance, at 
0.17%, is exceeding the 2011 target of 0.19%.  Year-to-date, 284 patients have experienced one or more of the 
five harm events used in the Part 1 definition.  During the year we report seven (7) stage 3 or 4 pressure ulcers, 
down 74% from 2010.  Falls and trauma, which had been a challenge in 2010, have declined 20% since last year.  
Post-op deep vein thrombosis/pulmonary embolisms did not decrease in 2011, but are down 52% since 2008; 
post-op sepsis is down 21% since 2010, and central venous catheter related bloodstream infections are down 
42% since last year.
0.49
(1.46% unadjusted) 0.55 0.55
0.54
(1.47% unadjusted)
December YTD
Through December, the risk adjusted mortality observed to expected (O/E) ratio is better than target and has 
performed better than top decile in 8 of the last 12 months.  Unadjusted mortality rates finished the year at 1.47%.
2010 Jun - Nov
Baseline:
Acute Care: 21.0%
Home Care
(Risk Adjusted): 
24.4%
Acute Care:  20.7%
Home Care:  19.1%
Acute Care: 19.6%
Home Care: 15.0%
Acute Care:  21.7%
Home Care: 24.5%
Acute Care: Nov YTD
Home Care: Dec 
YTD
Raw rates increased; acute O/E ratio declined to 0.95.  System OE ratio is better than expected (target </=.99).  
Monthly rates demonstrate a decrease in variation.  Decreased variation seems to indicate two things: (1) the 
readmission population does appear to be “sicker” and (2) teams have had success in tackling low-lying 
opportunities – stronger discharge planning for those readmitters who are less acutely ill, more reliable 
assessment and discharge processes, more cross-continuum collaboration and alignment.  All facilities have 
detailed action plans.  CHP home office staff is conducting readmission system tracers to provide additional 
feedback and identify barriers. For 2012, the readmission metric will move from a raw rate to an OE ratio and 
count readmitted patients only once, rather than serial readmissions to better matches CMS’ method.
Benchmark:  Acute care based on CMS Hospital Compare top quartile for readmission to any US 
hospital; Home care based on Strategic Health Partners database top quartile.
1.07 1.04 1.00 1.04
December YTD
Through December, the geometric mean length of stay (GMLOS) O/E ratio has outperformed prior year, and is at 
the 2011 target; the O/E ratio is 1.04 compared to prior year ratio of 1.07. YTD unadjusted LOS is 4.09 days 
compared to prior year of 4.23 days.  This equals an approximately 22,000 day reduction from prior year, 
representing an $11M reduction at $500 per day.  
26% 35%
46% 
Top Quartile 
(VBP Attainment 
Rate)
26%
December YTD
Through December, the patient experience composite score is continuing to rebound following poor 1st quarter 
performance; overall performance is 26%, slightly higher than in 2010 performance. Performance remains well 
below our target of 35%.  November performance was 35%. Monthly value based purchasing (VBP) points 
have been at or above 30% of total points for 6 of the past 7 months.
86.5% 87.2% 88.2% 85.4%
2011
Minority Retention Rate declined 1.1% in 2011 while All Associate Rate declined 0.8%.  However, Minority 
Engagement (Gallup) reached parity with all associates, and both the absolute number and the percentage of 
minority associates increased in 2011.  The 2012 objective will focus on % diverse in SLT.
3.93 4.02 4.00 3.97
2011
System improvement was broad-based, with six facilities achieving meaningful improvement (Mercy Tiffin, St. 
Vincent, St. Rita's, St. Charles, St. Elizabeth and Community Mercy) and two experiencing a statistically 
significant decline (St. Joseph and Marcum and Wallace).  Minority engagement increased more than overall 
engagement; and at 3.91 it is statistically at parity with overall engagement.  Benchmark is Gallup 
Organization Grand Mean for healthcare 50th percentile.  Database contains 511 hospitals with 1.5 million 
workers. 
55
(Target: 37)
37 N/A 45
December YTD
Target is 90% of the 2011 plan for family practice, internal medicine, general pediatrics and their associated mid-
level professionals. 2011 Target excludes MHP-NEPA and TN recruitment plans. Regional targets are set at 90% 
of their plans on each region's respective Part 1.  Recruitment is defined as "new to the community", not 
employment.  
$324,073 $345,750 N/A $341,627
December YTD
Net/net patient revenue is based on all employed providers--physicians and mid-level providers.  Year-end 2011 
was 5.4% higher than 2010 baseline, but trailed 2011 Target by 1.2%.  The largest cause for this variance was 
due to the unmet employment goals of several high revenue producing specialist physicians.  Target is based on 
2011 OFP budgeted revenue.
2.9% 3.1%
(Stretch)
2.7% 3.3%
December YTD
3.1% is the operating margin adding back the contingency.
Benchmark and Target are consistent with the 5 Year Strategic Financial Plan, rather than the 2011 OFP 
(the "budget").
           Superior - Current performance is > 5% better than benchmark (external only)
           Excellent - Current performance is at Benchmark or Target
           Progress - Current performance is better than prior year but not at Target
           Poor - Current performance is < Prior Year
COMMENT
Primary Care Provider Recruitment
(Physician Engagement & Growth)
Preventable Harm 
(Quality)
Inpatient Mortality
(Quality)
PART 1 OPERATIONAL 
PERFORMANCE MEASURES
(KRA)
2010
(Latest 
Available)
2011
TARGET: set annually based on baseline measure, benchmarks, and current /prior performance with input from the appropriate EMT committees 
(Quality, Mission, HR, etc.), RCEOs and LTM.  Targets are set to insure steady progress towards achieving top quartile within a specified time frame 
(or to maintain/improve performance at top quartile).
BENCHMARK:  represents the "best practice" known for a specific metric.  CHP uses as many top quartile national measures from external sources as 
are available.  Benchmark data in health care can vary widely by level of maturity.
Readmission Rate
(Quality)
LOS (Quality)
Minority Retention Rate
(Human Potential)
Associate Engagement
(Human Potential)
Inpatient Experience
(Quality)
Operating Margin (%)
(Stewardship)
Net/Net Patient Revenue/Provider FTE
(Physician Engagement & Stewardship)
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2011 Annual Plan
CHP System Scorecard
as of 1/20/2012
~ All employed PCPs report the 
Diabetes 5 (D5)
~ Create infrastructure for 
collecting and reporting 
readmissions
Completed
~All employed PCPs report the Diabetes 5 (D5):  
Physician level reports are now available on CHP’s 
internal web site and have been shared with regional 
physician leadership. 
~D5 performance score: 19%
~Readmissions: Healthspan's Infomed data warehouse 
has been redesigned to identify hospital readmission 
rates by attributed PCP and available in Q4 2011.  
Humana has provided hospital readmission rates by 
attributed PCPs.  
~CHP readmission rate for patients attributed to CHP 
Physicians: 15%
~ Go-Live at HMHP (3), Jewish 
and all identified owned physician 
practices.
~ Expanded metric set
HMHP  -  August 21st
Toledo (Ambulatory)  - 
October 24th
CMHP - November 13th
The November 13th Springfield implementation was 
successful and completes the scheduled installs for 
2011.  The Toledo ambulatory implementation on 
October 24th completed the ambulatory 
implementations for 2011.   We attested for meaningful 
use and are receiving 26.1 M.
~ Standardize and improve CHP's 
management of associate health 
plans
~ Reduce rate of increase to 
<10%
3.6% increase
(Nov. YTD 2011 vs. 2010)
3.6%, like last year's result (2.3%), sets CHP's 
trend far below the U.S. average.  CHP's 
effective cost control is due in part to changes in 
plan design, vendor management, and in-
sourcing stop loss to the CHP captive.
~In-source and standardize employed 
physician business office (CBOs) by 
12/31/11
~Conduct pilot in 10 CHP program 
practices to continue transformation to 
Patient Centered Medical Home.
~CBO/CPBC on target with 
addition of Lima & Lorain in 
Q3.  Pre-Service Centers 
(PSCs) established in all 
regions.
~PCMH on target.
The Corporate Physician Business Center  is 
successfully expanding back-office support.  
NO & SWO are targeted for consolidation into 
the CPBC Q1 2012. PSC's in place and 
expanding functionality. Transforming CHP 
employed practices into NCQA recognized 
PCMH's is advancing with each region 
developing a specific 2012 rollout plan.
Decrease by 5% median time for 
emergency department arrival to 
ED departure for admitted 
patients among facilites above the 
national median.
Selected Emergency 
Departments have decreased 
Median LOS from 320 to 303 
minutes against a target of 303.
Among the 9 facilities identified with opportunity for 
improvement, the overall admitted median LOS though 
September has improved at 6 of 9 facilities and 3 of 9 
have achieved target.  Overall, median admitted LOS 
for these nine facilities hospitals has declined from 320 
minutes in 2010 to 303 minutes against a target fo 303.
Advance the quality and efficiency of the 
emergency services provided in each CHP 
Emergency Department.
(Growth--Copeland; Grossbart)
Comment
Identify and track quality indicators for owned 
physician practices.
(Quality & Physician Engagement--Grossbart; 
Copeland)
Complete Year 2 milestones of CarePATH 
strategy. 
(Quality--Sykes)
Address associate health claims and cost of 
health care claims.
(Human Potential--Gage)
PART 2:  STRATEGIC OBJECTIVES TARGET CURRENT Status
Strengthen infrastructure of employed 
physician practices.
(Physician Engagement--Copeland; Gravell)
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2011 Annual Plan
CHP System Scorecard
as of 1/20/2012
Transaction successfully 
negotiated and closed. Complete
Sale of Northeast PA assets to Community Health System 
complete effective May 1, 2011.  Distribution of proceeds 
complete to all parties.  Sisters of Mercy, Mid-Atlantic 
Community Foundation and Scranton Civic Foundation formed 
and operational.  Re-named Regional Hospital of Scranton, 
Tyler Memorial Hospital and Nantikoke Hospital running under 
ownership of CHS.
Transaction successfully 
negotiated and closed. Complete
Sale of East Tennessee assets to Health Management 
Associates complete effective October 1, 2011.  Distribution 
of proceeds complete to all parties.  Remainder Mercy 
Foundation, Trinity, and new diocesan foundation, St. Mary's 
Legacy Foundation, formed and will be operational by January 
2012.  Former Mercy Health Partners and all affiliates now 
running under Tennova banner for Health Management 
Associates.
2011 target:  64%
2009 Score:  61.1%
2007 Score:  58.3
62%
AHRQ Patient Safety Culture Survey:  The survey 
results identify a small improvement in 2011, to 62% 
from 61% in 2009 and 58% - 2007.  OB, error reporting, 
and select facilities showed significant improvement.
~ Complete CHP market 
assessments in each region All  Region Market Assessments completed 
Market assessment in each region to assess our 
readiness for payment reform, including 
participating in the Medicare ACO progam and 
other Payer's risk sharing agreements.
Days Cash On Hand  >170 226
December 
YTD
Target is a stretch goal above 2011 OFP budget 
of 167 Days Cash on Hand.
Initiate formal Mission formation 
program/process for leaders
Complete
New 2012 Part 2 will standardize 
leadership and formation 
program/process across CHP
Standard guiding principles developed and adopted.  
New Leader Orientation re-designed, CHP Leadership 
Video produced and introduced at LDI.  New 2012 Part 
2 will standardize adoption of these plus a day of 
renewal for RN leaders (successfully piloted in 3Q 
2011) and RISEN for front-line employees.
Advance CHP's talent management strategy. 
(Gage - Human Potential)
PART 3:  CONNELLY TARGET CURRENT Status Comment
Complete transaction for sale of assets in 
MHP-NEPA region. (Starcher - Growth)
Implement preferred strategic option for MHP-
TN region. (Starcher - Growth)
Strengthen CHP ability to invest in health care 
redesign. (Gravell - Stewardship)
Increase perception of patient safety as 
measured by AHRQ Survey on Patient Safety 
Culture. (Grossbart - Quality)
Foster development of ACOs with Medicare or 
other payers in selected regions. (Copeland - 
Growth)
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2011 Annual Plan
Incentive Thresholds
as of 1/20/2012
2% 2.1%
December YTD
Investment losses in 3rd and 4th quarters 
affected metric.
$294.3M $345.7M
December YTD
85.0% 94%
October 2010 - 
September 2011
Data harvested through November 17, 2011.
Affordability as measured by Net Income 
margin % (excluding interest rate swap, 
impairment and loss on advanced refunding 
of debt) 
Community Benefit 
Overall ACM Score 
Background and Definitions:
Incentive Compensation Thresholds are established as minimum affordability and performance levels for executives to be eligible for incentive compensation each year.  At the 
December 2010 Compensation and Evaluation Committee meeting the Committee will review and recommend 2011 incentive metrics to the CHP Board of Trustees for final approval.  
Management will be recommending the following metrics:
Net Income Margin % - Excess revenue before discontinued operations divided by total net operating revenue + total non-operating revenue (excluding interest rate swap, 
impairment and loss on advanced refunding of debt).  Proposed Threshold is 2% Net Income.
Community Benefit - Expenses identified as benefits to the underserved and/or community at large.   Proposed Threshold is 90% of budgeted community benefit. 
Overall ACM Score -  Overall ACM score measures total percentage of patients who received all appropriate care for heart attack, heart failure, pneumonia, or surgical care.  
Threshold  is  90% of the top quartile benchmark for the overall appropriate care measure. Proposed threshold is 83.8%.
CommentAnnual Incentive Metrics Threshold CURRENT Status
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Factors Used to Adjust Base Compensation 
 Current position in the pay range 
 Years of experience at current level and tenure with CHP 
 Leadership (leading system initiatives or representing the system on national/regional level) 
 360 Review by colleagues 
 
Executive Evaluation 
Performance Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Attachment B 
 
Incentive Compensation Stretch Objectives: 
 
The actual level of compensation is based on CHP System Scorecard performance and limited to 
board approved ranges. At least 75% of Part 1, 2, and 3 objectives on CHP System Scorecard must 
be achieved to be considered for targeted incentive compensation 
 
Eligibility for Incentive Compensation has 3 Thresholds: 
 
90% Budgeted Community benefit 
2% Net Income 
90% Quality Score 
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CHRISTUS Health
Irving, Texas
Generative Governance
As CHRISTUS Health neared its tenth anniversary, having been formed by the joining of two 140-year-old Catholic 
health systems, its governance process and structure were common:  an engaged group of health care professionals 
and women and men religious focused on their fiduciary and mission-oriented duties of guidance and oversight.  
Indeed, this had served the system well after the merger by creating a focus on developing culture, creating new 
processes and a greater focus on operations to ensure a return to stability and strength.
As the system’s second decade dawned, the governing board began to increase its focus on governance itself — its 
makeup, role, and ultimate purpose — with the intent to create even greater board engagement beyond the oversight 
of operations and monitoring of finances so critical in the early years and challenge members to shift to other 
approaches.
Guided by the work of Chait, Ryan and Taylor in Governance as Leadership: Reframing the Work of Nonprofit Boards, 
the CHRISTUS board chair embarked upon a process that would embrace the authors’ three levels of governance:  
fiduciary, strategic and generative.  
The CHRISTUS board, like most, typically worked within a preferred position on the triangle.  Their work shortly 
after the merger tended toward fiduciary — embracing the “familiar” board work of financial oversight; legal 
responsibility of accountability to the sponsors, members and other key stakeholders; and providing policy guidance 
to the newly-formed system.  This focus was appropriate as CHRISTUS worked to bring two health systems of over 
20 hospitals in 11 markets into one system.  During this phase, the system stabilized operations and finance with 
the board through facility divestments, consolidation of markets and ending relationships with some physicians and 
insurance companies.
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Irving,	Texas	
nerative	Governance	
As CHRISTUS Health neared its tenth anniversary, having been formed by the joining of two 140‐year‐old 
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duties of guidance and oversight.  Indeed, this had served the system well after the merger by creating a 
focus on developing culture, creating new processes and a greater focus on operations to ensure a 
return to stability and strength. 
 
As the system’s second decade dawned, the governing board began to increase its focus on governance 
itself ‐‐‐ its makeup, role, and ultimate purpose ‐‐‐ with the intent to create even greater board 
engagement beyond the oversight of operations and monitoring of finances so critical in the early years 
and challenge members to shift to other approaches. 
 
Guided by the w rk of Chait, Ry  and Taylor in Gover ance as L adership: Reframing the Work of 
Nonprofit Boards, the CHRISTUS board ch ir embarked upon a process t at would embrace the autho s’ 
three levels of governance:  fiduciary, strategic and generative.   
 
 
 
 
 
 
 
 
 
 
 
 
 
The CHRISTUS board, like most, typically worked within a preferred position on the triangle.  Their work 
shortly after the merger tended toward fiduciary ‐‐‐ embracing the “familiar” board work of financial 
oversight; legal responsibility of accountability to the sponsors, members and other key stakeholders; 
and providing policy guidance to the newly‐formed system.  This focus was appropriate as CHRISTUS 
worked to bring two health systems of over 20 hospitals in 11 markets into one system.  During this 
phase, the system stabilized operations and finance with the board through facility divestments, 
consolidation of markets and ending relationships with some physicians and insurance companies. 
 
After the first formative years, however, the board more clearly shifted its focus to a greater emphasis 
on strategic thinking and decision making.  This focus involved more problem solving, an immersion in 
strategic planning, and critical strategic decision‐making by board members.  For CHRISTUS, this resulted 
in some significant, longer‐range visioning and planning, and let to its first “Futures Task Force, ” an 18‐
month process of research, learning, visioning and strategic discussion that set a course for its next 10 
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After the first formative years, however, the board more clearly shifted its focus to a greater emphasis on strategic 
thinking and decision making.  This focus involved more problem solving, an immersion in strategic planning, and 
critical strategic decision-making by board members.  For CHRISTUS, this resulted in some significant, longer-
range visioning and planning, and let to its first “Futures Task Force, ” an 18-month process of research, learning, 
visioning and strategic discussion that set a course for its next 10 years.  The board engaged with management in 
developing specific scenarios of future states of health care, from those gleaning the directions that would form the 
base for the annual strategic planning process.
The results of the strategic thinking at the board level resulted in 
CHRISTUS entering the international health care arena by forming 
a partnership to create the CHRISTUS Muguerza Health System in 
Mexico, originally a two-hospital system which has since grown to seven 
hospitals and a network of clinics and ancillary services.
The true governance “breakthrough” occurred in recent years as the 
CHRISTUS board added the third mode of governance – the generative 
mode – to its work, purposefully examining opportunities and challenges 
from a broader perspective. Using the knowledge and data gleaned 
from the fiduciary and strategic modes, the board uses its insight to 
create fresh understanding of complex and ambiguous situations. At 
CHRISTUS, this is done by asking generative questions to flesh out 
different perspectives and viewpoints; by noticing clues, trends and 
patterns; and by seeking different frames of reference. It is evidenced 
when board members ask the questions, “What is this telling us about 
or organizational story or direction,” “How does this underscore our 
visioning and take us to the future,” or simply, “What is the underlying 
question we are really discussing?”
This mode of thinking allows a board to make sense of the facts and bring a different value than just reacting to them. 
It creates discussion and ideas that then can be translated into specific strategies, policies, plans and tactics.
At CHRISTUS, this drew the board to consider and ponder the underlying focus of “incarnational spirituality” for 
the system.  CHRISTUS’ mission — to extend the healing ministry of Jesus Christ — undergirds its vision’s ultimate 
purpose of providing services so that all “might experience God’s healing love.”  As the basic charism of the founding 
congregations, the Sisters of Charity of the Incarnate Word of Houston and San Antonio, this incarnational 
spirituality, then, calls the board to ponder how every decision represents God among us.
Appendix B
CHRISTUS Governance Principles
The CHRISTUS Health Principles of 
Governance, adopted in 2010, provide a 
frame for the health system’s  board to 
guide its pursuit of governance excellence 
and innovation:
• Commitment to integrity in Mission, 
Vision, Core Values and Catholic identity 
which reflects incarnational spirituality in 
governance policies and procedures.
• Commitment to simplicity in governance 
structures and practices.
• Commitment to communication among 
sponsors, governance to governance 
and governance to management.
• Commitment to systemness in 
governance.
• Commitment to continued Catholic and 
faith-based formation and development 
for governance leaders.
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In practice, the CHRISTUS board embraced the generative mode to ask those compelling questions, but also to 
develop a better governance process and structure.  The governance committee took on a new role and led the board 
to develop specific principles (see sidebar) and generated the second Futures Task Force for the system.  In this task 
force, board members embarked upon a more experiential learning, immersing themselves in environments such as 
high-tech health care companies in Silicon Valley, New Orleans shortly after hurricane Katrina, and even touring the 
poorest of the poor areas in need of reliable health care — all to inform those underlying questions that would provide 
direction for the future.  The result was solid strategic focus and parameters around which to lead the system to meet 
the challenges and responsibilities of the future.
The new health care environment we live in calls us to develop new models of care and meet expanding needs in new 
ways with fewer or different resources, and requires our boards to continue to challenge themselves to bring those 
generative questions and ideas forward.  It brings a deeper meaning to their board service, and provides invaluable 
insight that we look to our boards to offer.  Ultimately, it encourages the healthiest complimentary relationship with 
management and fulfills the intended purpose of a board.
Ernie Sadau
President and CEO, CHRISTUS Health
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Kaiser Foundation Hospitals and Health Plan
Oakland, California
Board Committee for Community Benefit
The Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Boards of Directors exercise oversight 
responsibility for the nation’s largest private, nonprofit health care system, commonly known as Kaiser Permanente. 
That system consists of the 9 million-member Kaiser Foundation Health Plans, operating in eight regions covering 
nine states and the District of Columbia, as well as Kaiser Foundation Hospitals, which owns hospitals or contracts 
for hospital services in each of the program’s regions. The Kaiser Permanente Medical Care Program also includes 
the eight regional Permanente Medical Groups, which are independent physician partnerships or professional 
corporations with their own governance structure. 
In 2001, the Board and the program’s outgoing CEO ordered an in-depth review of the program’s community 
benefit activities. The internal study concluded that the community benefit work, then managed by a small staff 
within the public affairs department, should be strengthened to enhance its internal and external visibility as well as 
its strategic focus and leadership. When a new CEO, George Halvorson, arrived in 2002, one of his first actions was 
to endorse the hiring of a senior executive-level leader for a separate community benefit program, Raymond J. Baxter, 
PhD, and to create a standing Board committee solely responsible for community benefit. The new committee, which 
was (and remains) a rarity among boards of health care organizations, was deemed one of the Board’s two “heart” 
committees, along with the Quality and Health Improvement Committee, in contrast to the two “head” committees, 
Finance and Audit and Compliance. Each Board member was expected to sit on one “head” committee and one 
“heart” committee. 
In 2003, Cynthia Telles, PhD, of the UCLA School of Medicine, became chair of the Board’s Community Benefit 
Committee. Under her leadership, a committee charter was drafted and approved setting out the committee’s 
responsibilities. These included strengthening the community benefit program and activities; regularly reviewing 
its strategies, policies and performance; monitoring related internal control systems and risk assessment and 
management; reviewing the design and management of major initiatives; overseeing related legal and regulatory 
compliance; and increasing public recognition of community benefit activities. 
The new committee soon approved a new funding policy setting a minimum threshold on annual community benefit 
contributions by each region, resulting in greater program predictability and the sustainability of multiyear initiatives. 
It also approved a strategic approach to community benefit funding that targeted four specific areas of activity: 
charitable care and coverage, support of the health care safety net; community health initiatives (primarily focused on 
healthy eating and active living); and development and dissemination of new health knowledge, focused on Kaiser 
Permanente’s large health care research and health professions education  program. 
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From the beginning, committee members have been actively and deeply involved in oversight of the community 
benefit department’s work. At each quarterly Board meeting, the committee receives an in-depth organization-
wide review of one of the strategic focus areas, and once or twice a year it visits a specific region to review its entire 
portfolio of activity. In addition, it receives detailed quarterly reports, for its approval, on each of hundreds of 
grants exceeding $100,000 dollars a year, as well as regular reports on internal and external audits and federal and 
state compliance issues, plus the annual Form 990 IRS reports relating to community benefit. A comprehensive 
annual report, originally prepared only for the Board, is now also distributed to external stakeholders in print and in 
electronic format on the department’s content-rich website. 
Over the past decade, the committee has proved to have a powerful and direct impact on the scope, effectiveness, and 
visibility of Kaiser Permanente’s community benefit work, which has grown to $1.8 billion in total investment as of 
2010. For example, beginning with the onset of the recession, the committee was directly responsible for driving a 
significant shift in community benefit programming that focuses resources on helping people who have lost their jobs 
and health care coverage to obtain healthy foods and to qualify for public health care coverage programs. It has also 
served as a powerful advocate for program performance measurement and evaluation. 
Today, the department and its community initiatives and partnerships are widely understood and strongly supported 
among Kaiser Permanente’s 170,000 employees and 15,000 physicians, and they are featured in extensive media 
coverage in support of the program’s reputation and brand. At the leadership level of the organization, the existence 
and work of the Board committee has underscored the message that the community benefit work is no less central 
to Kaiser Permanente’s governance and mission than that of other standing committees, including Governance, 
Accountability and Nominating, Audit and Compliance, and Finance.
In 2009, just seven years after it was created, the committee participated in another Kaiser Permanente governance 
innovation that was as unusual in corporate boardrooms as the committee itself. It underwent a comprehensive audit 
of its performance against its charter-defined authorities and duties, performed not by outside consultants but by 
Kaiser Permanente’s own Internal Audit Services. The exercise was part of a unique ongoing series of internal audits 
of board committees that began in 2008 with an audit of the board’s Governance, Accountability and Nominating 
Committee. 
The auditors interviewed the committee chair, the Board chair, the Governance committee chair, and community 
benefit program management. They reviewed over a year of committee materials, and they observed three committee 
meetings. The only hitch in the audit process came when auditors attempted to compare the committee’s activities to 
best practices among the community benefit committees of other health care organizations. As the final audit report 
noted, the only source identified for best practices for Board community benefit committees was the 2009 initial 
report on Governance in Nonprofit Community Health Systems, by Prof. Lawrence Prybil and others. 
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“We heard from several sources outside Kaiser Permanente,” wrote the auditors, “that they looked to the Kaiser 
Permanente community benefit program and the Community Benefit Committee for guidance on good governance 
practices in nonprofit health systems….”
The audit concluded with a “Meets Expectations” opinion, the auditors’ highest possible rating, and a 
recommendation to update one section of the charter, which was quickly implemented.
George Halvorson
Chairman and CEO, Kaiser Foundation Hospitals and Health Plan
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Mayo Clinic
Rochester, Minnesota
Mayo Clinic’s Vision for 2020
In November of 2007, the Mayo Clinic Board of Trustees asked “Does Mayo Clinic have a plan for 2020?”  The 
resulting initiative undertaken by the Board of Governors was a study dubbed the 2020 Initiative. The purpose of the 
initiative: “To develop a tangible construct to describe what Mayo Clinic should/must/will look like in 2020.” 
 As this project was begun, internal reflection revealed Mayo Clinic as an unrivaled health care leader, poised with 
strength and confidence, founded on sound principles, having proven success in many clinical areas, with an unmatched 
legacy of excellence and humanitarian achievement.  A number of strategic initiatives were already underway, including 
a focus on quality, research into individualized medicine and the science of health care delivery, and integration plans 
within the organization were well under development. The strategic plan had not been refreshed for a number of 
years, and the development of a longer-term action plan was needed. At this same time, there were concerns with 
environmental, regulatory, and reimbursement pressures. There was also concern that external influences could force 
change to the way care is delivered, or restrict access only to the insured, the wealthy or the favored patient. There were 
also acute concerns with the pressure being placed on resources, a shrinking labor force, and, most importantly, the strain 
on staff.
The 2020 Initiative sought individual and group-based input from more than 250 Mayo Clinic physicians, leaders, 
educators, and researchers, and found an unwavering confidence in the primary value that “the needs of the patient 
come first”, unyielding support for Mayo’s principles, and energy and enthusiasm for defining what Mayo Clinic would 
become. Mayo Clinic found that the vision statement “Mayo Clinic will be the premier patient centered academic medical 
organization” had been achieved and no longer reflected the full range of aspiration and organizational intents. 
In late 2008, the insights of the 2020 Initiative were brought to the 
forefront as the strategic plan was refreshed, and the vision, mission 
and core business statements of Mayo Clinic were updated. The 2020 
Initiative was the primary source of input for the new plan, and was an 
activity which drove the organization to reflect not only on the past, but 
also on the future.
In 2008, a reorganized Mayo Clinic with a single governing board, 
a single mission, single vision, single strategic plan, and a single 
operating plan brought alignment and purpose to the planning efforts. 
30
Mayo	Clinic	
Rochester,	Minnesota	
Mayo	Clinic’s	Vision	for	2020	
In November of 2007, the Mayo Clinic Board of Trustees asked “Does Mayo Clinic have a plan for 2020?”  
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resources, a shrinking labor force, and, most importantly, the strain on staff. 
 
The 2020 Initiative sought individual and group‐based input from more than 250 Mayo Clinic physicians, 
leaders, educators, and researchers, and found an unwavering confidence in the primary value that “the 
needs of the patient come first”, unyielding support for Mayo’s principles, and energy and enthusiasm 
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will be the premier patient centered academic medical organization” had been achieved and no longer 
reflected the full range of aspiration and organizational intents.  
 
In late 2008, the insights of the 2020 Initiative were brought to the forefront as the strategic plan was 
refreshed, and the vision, mission and core business statements of Mayo Clinic were updated. The 2020 
Initiative was the primary source of input for the new plan, and was an activity which drove the 
organization to reflect not only on the past, but also on the future. 
 
I  2008, a reorga ized Mayo Clinic with   single governing 
board, a singl  mission, single vision, single strategic plan, 
and a single operating plan brought alig ment and purpose 
to  he planning efforts.  
 
The 2020 Initiative was used as an anchor of vetted ideas 
that described Mayo Clinic as more than a place, more than 
a research center, and more than an educational 
institution. The 2020 goals were bigger than ever before, 
and the reach to patients and people needed to be greater 
as well. A construct that guided the concepts of our 
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The 2020 Initiative was used as an anchor of vetted ideas that described Mayo Clinic as more than a place, more 
than a research center, and more than an educational institution. The 2020 goals were bigger than ever before, and 
the reach to patients and people needed to be greater as well. A construct that guided the concepts of our thinking 
was patients here (within our facilities), patients there (with other providers or at home), and people everywhere 
(recognizing our commitment to those who are not currently patients). This construct has since been modified to 
highlight that we can run, grow, or transform what we do across the spectrum of here, there and everywhere.
The new vision, “Mayo Clinic will provide an unparalleled experience as the most trusted partner for health care,” 
guides the course to 2020.  The Board of Trustees has embraced the vision and strategic plan. This support has been 
demonstrated through dialogue, discussion, approval of resource allocations and through interaction in many spheres 
of influence. 
The new strategic plan has empowered the organization to think more broadly than Mayo Clinic’s walls.  A new 
affiliation strategy was announced and provider groups around the nation are joining forces.  Mayo has expanded 
beyond health care to transform the health care and information delivery process.  Engagement in health and wellness 
services has been encouraged through a location at the Mall of America, and staff are developing and implementing 
new ways to improve the health of people.  
The refreshed plan highlights bringing solutions and hope to patients. Innovative practice techniques, new discoveries 
and ongoing research in regenerative medicine, individualized medicine and the dissemination of the learnings from 
these initiatives are essential. This spreading of best practices and best knowledge allows Mayo Clinic to continue 
offering the best outcomes, safety and service possible while being affordable.  
Mayo Clinic sees great challenges ahead, yet the board, the physicians, scientists and allied health staff are guided  
by the words of our founders, and our future is clear.
John H. Noseworthy, M.D.
President and CEO, Mayo Clinic
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	John 	H. 	Noseworthy, 	M.D. 	
President 	and 	CEO, 	Mayo 	Clinic 	
“I look through a half‐opened door into the future, full of interest, intriguing beyond my 
power to describe, but with a full understanding that it is for each generation to solve its own 
problems and that no man has the wisdom to guide or control the next generation.”  
Dr. William J. Mayo on his 70th birthday 
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Mercy Health
Chesterfield, Missouri
Physician integration
In 1992, Mercy Health had the opportunity to enter into an “integration arrangement” with a 110-member multi-
specialty group, the Smith-Glynn-Callaway Clinic, located in Springfield, Missouri.  Mercy made the decision to 
proceed with integration, and to offer other physicians on the medical staff of St. John’s Regional Health Center, the 
same integration opportunity.  Mercy firmly believed that it was imperative for physicians and institutions to work 
closely together in planning for the future, in an environment in which both the cost and the quality of healthcare 
were to become major national issues.  We believed that an organization structure, in which a large physician clinic 
and a hospital were operated as sister corporations, was the appropriate structure to achieve the organization’s mission 
over the long term.
Subsequent to that decision, the Mercy Clinic in Springfield has grown into a 505-member integrated group.  In 
years following that decision, integration arrangements were successfully completed in Northwest Arkansas and 
Kansas.  During this period, the Board of Directors and leadership of Mercy made a long-term commitment to 
physician integration as a key strategy of the organization. Whenever physicians were ready in a regional market, 
Mercy resolved to pursue integration in that location.  
Over a ten year period, Mercy developed a reputation for their approach to physician integration. In the recent past, 
there has been a significant interest in the integration process in all of Mercy’s regional markets, and an integration 
structure is in place in each of their regional communities. Some are more established than others, but all are growing 
and developing a culture that brings physician leaders and lay leaders together in managing the enterprise of Mercy 
Health.  
In each regional market, the corporate structure under which the integration relationship is operated entails a 
physician clinic structure that is operated as a 501(c)3 organization and a sister hospital corporation.  Both entities 
have governing bodies with fiduciary responsibilities for their operations.  Both report to a regional Mercy holding 
company, which is the Corporate Member of each.  The relationship is depicted as follows:
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Physician	Integration	
In 1992, Mercy Health had the opportunity to enter into an “integration arrangement” with a 110‐
member multi‐specialty grou , the Smith‐Glynn‐Callaway Clinic, l cated in Spri gfield, Missouri.  Mercy 
made the decision to proceed with integration, and to offer other physicians on the medical s aff of St. 
John’s Regional Health Center, the same integration opportunity.  Mercy firmly believed that it was 
imperative for physicians and institutions to work closely together in planning for the future, in an 
nvironm nt in which both th  cost and the quality of healthcare were to become major n tional issues.  
We believed that an organization structure, in which a large physician clinic and a hospital were 
operated as sister corporations, was the appropriate structure to achieve the organization’s mission 
over the long term. 
 
Subsequent to that decision, the Mercy Clinic in Springfield has grown into a 505‐member integrated 
group.  In years following that decision, integration arrangements were successfully completed in 
Northwest Arkansas and Kansas.  During this period, the Board of Directors and leadership of Mercy 
made a long‐term commitment to physician integration as a key strategy of the organization. Whenever 
physicians were ready in a regional market, Mercy resolved to pursue integration in that location.   
 
Over a ten year period, Mercy developed a reputation for their approach to physician integration. In the 
recent past, there has been a significant interest in the integration process in all of Mercy’s regional 
markets, and an integration structure is in place in each of their regional communities. Some are more 
established than others, but all are growing and developing a culture that brings physician leaders and 
lay leaders together in managing the enterprise of Mercy Health.   
 
In each regional market, the corporate structure under which the integration relationship is operated 
entails a physician clinic structure that is operated as a 501(c)3 organization and a sister hospital 
corporation.  Both entities hav  governing bodies with fiduciary responsibilities for their operations.  
Both  eport t  a regional Mercy holding company, w ich is the Corporate Member of each.  The 
relationship i  depicted as follows: 
 
 
Mercy Regional
Holding Company
Mercy HospitalMercy Physicians 
Clinic
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In June, 2009, the Board of Directors made the decision to charter a Board Committee on Physician Engagement 
(see Attachment A).  The committee’s basic role is to assess and monitor progress of the strategy for integration as 
set by the Board, and to recommend appropriate Board action concerning the development of integration in each of 
their regional markets. The Board Committee undertook the responsibility of reviewing the integration arrangements 
that were being proposed in the markets in order to make appropriate recommendations to the Board. They also are 
reviewing the work that is being done to develop leaders – both physician leaders and lay leaders working together to 
further the strategic aspects of the organization.  
Today, the Board Committee on Physician Engagement meets prior to each Board of Directors meeting.  It 
consists of 6 individuals, including: the Board Chair; the President/CEO; a Sister of Mercy; a physician leader 
who is President/CEO of a regional health system; the President/CEO of a northeastern health care system; and 
a business leader in one of our Arkansas communities who had previously chaired a regional health system in that 
area. The Committee reviews quarterly reports on the status of integration in Mercy’s markets, reports on leadership 
development, and other key issues brought to their attention.  They recommend action when necessary to the Board 
of Directors, and report on the status of integration across Mercy.
As integration has developed in each of the regional markets, regional compensation systems have been designed 
based upon the input of physicians and lay leaders in each of those markets. Today, several compensation systems 
exist. All have similarities but also differences. Consideration is now being given to developing a system-wide 
physician compensation design, with significant input from physician leadership throughout all the clinics. The Board 
Committee on Physician Engagement is assuming the responsibility for overseeing this process.
The Committee’s activities are an important part of the Board’s function, given the importance of the integration 
strategy throughout Mercy Health.
Today, integration is rapidly taking place throughout Mercy. At this date there are approximately 1550 physicians 
who have entered into an integration arrangement or 33% of the active medical staff members throughout the system. 
Mercy expects this number to continue to grow.
Lynn Britton
President and CEO, Mercy Health
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Charter 
Board Committee on Physician Engagement 
 
Adopted by the Board of Directors, Mercy Health System June 3, 2009 
 
 
Purpose 
 
The Committee on Physician Engagement will advise the Mercy Board of Directors on matters 
related to Mercy’s integrated groups and strategy to pursue and cultivate integration in all of 
our markets.  Generally, its focus will include: 
 
 Integration 
o Scope related to the total activity in the Region 
o Review of arrangements involving the growth of the multi-specialty group 
o Culture and its development 
 
 Leadership development 
 
 Compensation system 
 
Ancillary to providing advice and input to the Mercy Board of Directors related to matters of 
integration, the Committee will provide an environment for Mercy physician leaders to interact 
with Mercy’s leaders and gain insight as to their approach to our challenges and opportunities. 
 
 
Membership 
 
Chair   Ron Ashworth, Chairman Board of Directors 
Members: 
   Lynn Britton, President and CEO SMHS 
Sister Padraic Hallaron, RSM 
Eric Jackson, General Manager, Oaklawn Jockey Club, Hot   
 Springs, AR 
Ron Paulus, M.D., President/CEO, Mission Health System,   
 Ashville, NC 
Ellen Zane, President and CEO Tufts-New England Medical   
 Center 
 
Staff:   Fred Ford, Senior Vice President Ambulatory Care 
   Shannon Sock, Senior Vice President Business Development 
   Donn Sorensen, Vice President Ambulatory Operations 
 
 
Frequency 
 
Committee will meet prior to each quarterly meeting of the Board.  The Chairman may call ad 
hoc meetings as necessary provided a minimum of four members are available. 
 
 
Form of Meeting 
 
Meetings will be held in person as schedules allow.  If necessary, meetings can occur via video 
conference, telephonic or other electronic formats. 
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Providence Health & Services
Renton, Washington
Board “Checking In and  
Checking Out” Practice
The simple yet profound statement “Know me, care for me, ease my way”™ has been adopted by Providence Health & 
Services to describe the experience we seek to provide for each patient we serve. It is likewise an underlying belief that all 
Providence people should recognize and model this behavior in their relationships within the system. An example of its 
presence beyond direct patient care can be found in the manner in which the members of the System Board of Directors 
enter into and close their quarterly meetings. The use of this tool for more than five years has served us well and we would 
suggest it as an “exceptional best practice” because of the way in which it has contributed to strengthening relationships 
and teambuilding among our system board members. 
Arriving at the meetings from several regions of the nation, having left busy schedules and demanding positions in order 
to give their time, experience, and talent in the governance of the system, the members need a way to “reconnect”.  The 
first item of business on the agenda of day one is relatively brief, but much valued. It is our “Checking In” session where 
each member brings the group up to date on what is going on in her/his life at present. Directors share a variety of events 
and activities which may be uplifting or sobering. Examples include recent vacation highlights, personal honors, the 
birth of grandchildren and the illness or death of loved ones. Each person concludes the update with the phrase “and I’m 
checking in” to signify that they are now fully engaged in the board meeting. This has become a way for us to stay current 
with and supportive of each other and to build long-lasting bonds. It also has proven to be the vehicle that allows us to 
focus as a team on the work ahead. Having shared with persons whom we value and respect what is uppermost in our 
minds when we arrive, we are then ready to let go and enter into the business before us. Moreover, the thoughts that are 
shared tend to ground us in what is really important in our lives and help us to focus together on our responsibilities as 
trustees of Providence Health & Services.
Equally important in this process is the ending session of the meetings. Having concluded the work of the days of the 
meetings and before departing from the board room, each member summarizes her/his experience of the meeting, its 
accomplishments and also makes suggestions for improvements or additions for future meetings. Each then concludes and 
signals a readiness to leave by merely saying to all “and I’m checking out”.  
Easy to accomplish and really relatively inconsequential as to time used, this practice has proven to be valued and effective 
in the development of the culture of our Board. It has also enabled members of the board to develop deeper and more 
personalized relationships and to enhance their overall effectiveness as a team.
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In reflecting on the use of this practice, the Chair of the Board, Sister Lucille Dean, remarked “So appreciated is this short 
but personal manner of launching and concluding our meetings that when there has been an occasion to omit it, we can 
count on the fact that at least one member of the board will point out the omission and request that we be more diligent 
in following the practice. Our ability to work well together has been enhanced by the fact that we have come to know 
more about each other as persons in a very meaningful way.”
John Koster, M.D.
President and CEO, Providence Health & Services
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Sutter Health
Sacramento, California
Restructuring Governance to 
Enable Strategic Alignment
Sutter Health’s history is one of change, evolution, and initiative. In 2007, a number of strategic imperatives 
compelled us to be proactive in evolving once again.
First, we recognized that several environmental trends threatened Sutter’s current business model. As the population 
ages, health care costs accelerate, and reimbursements diminish, we face the business imperative and responsibility to 
consumers to be more affordable. Second, we were aware that the variation across our multiple affiliate organizations 
would not be acceptable in a new era of quality and cost transparency. To transform our processes across the system 
would require unprecedented integration, standardization, and new operating paradigms. Lastly, we realized that 
historical boundaries and definitions of community have expanded in today’s health care environment. We need to 
act in a deliberate, coordinated manner to care for our patients across expanded geographies.  
Sutter’s future success depends upon our ability to coordinate closely among our affiliates and reform our cost 
structure. However, the overriding concern was that our organizational complexity would hinder our ability to execute 
our strategy.  
Sutter evolved over several decades from mergers and acquisitions of 27 affiliate organizations, with governance 
fragmented across 55 separate corporations. To consider a system-wide strategic decision, it required a minimum of 
six to 12 months to move through 20 review steps and gain agreement. Consequently, 17% of Affiliate CEOs’ and 
35% of System Executives’ time was spent on governance.
Acknowledging governance as a key enabler to strategic alignment, we decided to reassess our structures and 
processes. A Governance Assessment Steering Committee, consisting of board members from affiliates and the 
system, formed to oversee the assessment, evaluate options, and make recommendations. The year-long process 
involved internal interviews, case studies, and forums to promote transparent, two-way communication. The 
Committee evaluated approaches against the criteria of community benefit, financial sustainability, stakeholder 
responsiveness, system performance, philanthropy and concluded:
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1) We need to act in a more unified manner. Consolidation of several functional areas and a regional approach to 
service planning and delivery would facilitate higher quality, lower costs, and smoother intra-system coordination. 
As stewards of community assets, the Sutter Board believed that not changing our governance would inhibit our 
ability to innovate and lead in the transformation of health care delivery. 
2) Merge affiliate organizations into five regions. This structure would enable the advantages of region-wide 
planning but still keep strategy and communications close to local communities.  However, philanthropy, 
community benefit, and quality assurance should continue as local functions.  
3) Regional board members should act as a single point of responsibility.  To achieve integrated governance of 
both our medical foundations and hospital corporations while maintaining two legally separate corporate entities 
(a requirement in California), the two corporations would have “mirror boards” with concurrent meetings, 
deliberations, and decision making (while subject to conflict of interest policies). 
4) Additional supporting steps are needed to reinforce local/regional/system decision-making.  Governance changes 
alone would not assure future success, but rather facilitate and complement other necessary changes.  
The Governance Committee evaluated and ruled out alternative approaches ranging from a single system board to 
maintaining the status quo. The regional structure, on balance, was considered to be the best alternative to move 
the organization forward. After initial findings were presented, 85% of affiliate CEOs polled were “very willing to 
personally endorse these recommendations and be an advocate for regionalization.” With Board approval, regional 
integration was executed over the next three years: five regional hospital and medical foundations merged with 
appointed boards, key executives were named to fill new regional roles, and support functions were consolidated 
regionally.  
While Sutter Health acts as one entity in accessing capital and other select activities, the region is the core 
accountable business unit to implement strategy, service planning, and physician planning. We believe our new 
governance structure has enabled us to be more effective while maintaining sensitivity to our local communities.  
The Sutter Health board and management continue to monitor and assess the effectiveness of the regional 
governance model and believe that it has prepared us to be more efficient and flexible in the fulfillment of our  
not-for-profit mission as we enter the era of health care reform.
Pat Fry
President and CEO, Sutter Health
  101 
Appendix B
39
Sutter Health Governance in 2012: 
 1 System Management Team 
 1 System Board 
 5 Regional Management Teams 
 5 Regional Boards with local Committees 
  Philanthropy Boards 
Sutter Health Governance in 2007: 
 55+ Corporations (including subsidiaries and 20+ joint ventures 
 40 Full Boards (26 Affiliate Boards, 1 Regional Board, 1 System Board, 12 Philanthropy Boards) 
 750+ Board Members (Affiliate, System and Philanthropy/Foundation)investing 39,597 hours annually  
 17,901 hours invested annually by management (estimated $4.1M in annual resource cost + 
opportunity cost) 
 20,782 hours invested annually by staff (estimated $1.9M in annual resource cost + opportunity cost) 
 Affiliate CEOs spend ~325 hours annually or 17% of their time on governance 
 System Executives spend ~683 hours annually or 35% of their time on governance  
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Trinity Health
Novi, Michigan
Founding Principles
At the time Trinity Health was founded on May 1, 2000, the new entity formed to sponsor Trinity Health, Catholic 
Health Ministries, established guiding principles to direct the organization’s mission and development. These fifteen 
principles are now referenced as the “Founding Principles” (Attachment A). These principles are based on Catholic 
Social Teaching, most notably the moral imperatives to care for people who are poor and underserved, the sacredness 
of human life, the common good of the communities we serve, stewardship of resources, and collaboration in decision 
making – all of which guide our performance as a Catholic health system. 
The intent of the Principles was to give Trinity Health the foundation on which to build a strong and unified health 
system that drew strength from the legacies of its founding congregations. The founders understood that creating a 
strong and unified system, would, in turn, help strengthen each of the local Ministry Organizations (hospitals) as they 
strive to improve the delivery of health care in their local communities across the country.
The Founding Principles serve as a significant philosophical document outlining the expectations for the business 
enterprise.  These Principles guided development of the Board role and responsibilities document, which includes  
the criteria and competencies for appointment to the Trinity Health Board of Directors. They also helped direct  
efforts to purposefully shape the organization’s culture early in the formation of Trinity Health.
Twelve years after Trinity Health’s founding, the Principles continue to frame the responsibilities for governance 
accountabilities, such as strategic planning engagement and a variety of stewardship responsibilities. The principles 
also continue to serve as an accountability tool for both governance and management in assessing faithfulness to our 
Mission and the congruence of the system’s priorities and strategic direction. For example, as Trinity Health takes 
on new partners, the Principles serve as guideposts for integrating new organizations into the Trinity Health culture. 
Additionally, when major business decisions are being made that have a significant impact on the organization, the 
Principles are taken into account as part of the process used to determine the best course of action.  
The members of Catholic Health Ministries, who also serve as the Trinity Health Board of Directors, have periodically 
reviewed the Principles to assess the system’s faithfulness to them, and also their impact on Trinity Health and the 
communities served. One of the amazing outcomes of the formal reviews of the Founding Principles is their enduring 
quality. There has never been a single request or recommendation to delete or add to them. The Principles are 
experienced as a living document that provides counsel, direction and affirmation to the Board and management  
as they advance the ministry to carry out its Mission, Vision, and Values. 
Joseph Swedish
President and CEO, Trinity Health
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Founding Principles of Catholic Health Ministries and Trinity Health
Catholic Health Ministries, the entity formed to sponsor Trinity Health, established several guiding principles to direct 
the organization’s mission and development. These principles have been integrated with the principles articulated as 
part of the system’s organizational design and are now referenced as the “Founding Principles.” 
1. Trinity Health will be characterized by a demonstrated commitment to persons who are poor and underserved, 
with particular attention to the needs of women and children, working to assure access, recognition of health as 
a basic social right, and effective advocacy. 
2. Trinity Health will be committed to the integration, assessment and development of mission in all of its activities, 
decisions and strategies. 
3. In all of its actions and decisions, Trinity Health will recognize and respect the sacredness of all life, the dignity 
of all persons, and the needs of the whole person - spirit, body and mind. 
4. Decision-making within Trinity Health will be characterized by the following attributes: social analysis and 
mission discernment, reflecting a commitment to meeting the needs of the communities it serves, promoting 
diversity, and locating decision-making at the most appropriate level. 
5. Trinity Health’s culture will be characterized by collegiality, interdependence and accountability, with respect for 
the traditions of the founding organizations while creating its own mission and culture. 
6. Sponsorship in Trinity Health will be mediated through governance structures that enhance and promote a spirit 
of a community of persons committed to the mission, full partnership of religious and laity in governance, 
management and sponsorship, and continued reflection on the evolution of sponsorship. 
7. The members of Catholic Health Ministries, our sponsor, will possess the competencies so required, will be 
committed to a personal and communal formation in sponsorship, and will be periodically assessed. 
8. Trinity Health will be committed to partnering with physicians to assure quality outcomes, cost-effective, 
compassionate and accessible care. 
9. Trinity Health will be an active collaborator consolidating and rationalizing services in its markets and partnering 
with Catholic and other health and social service organizations to improve the health and overall well-being of 
those communities. 
10. Trinity Health will strive to be the employer of choice, committed to the development of its human resources and 
to creating workplaces that nurture the human spirit and respect diversity. 
11. Trinity Health will leverage its strengths and geography in order to facilitate the sharing and adoption of best 
practices and learnings across the System as well as to assure its financial stability. 
12. Trinity Health through its corporate structure, services, and collective actions will add value, synergy and bring 
economies to its members. 
13. Trinity Health will act as a unified System, recognizing its interdependency in fulfillment of its mission and vision. 
14. Trinity Health will develop and monitor standards for mission accountability, financial viability, patient and 
employee satisfaction, quality enhancement and stewardship of its resources - human, financial, environmental. 
15. Trinity Health will faithfully attend to the recruitment, development and retention of governance, management, 
physician partners and staff.  
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